object
epilepsi
affect
one
everi
children
young
peopl
uk
nation
report
publish
rcpch
recommend
hospit
review
servic
improv
focu
appropri
diagnosi
investig
manag
consequ
aim
project
investig
assess
manag
epilept
patient
larg
hospit
trust
explor
patient
demograph
compar
local
trust
data
nation
data
method
outpati
clinic
inpati
discharg
letter
audit
retrospect
patient
follow
least
year
area
explor
includ
patient
demograph
diagnosi
epilepsi
includ
profession
input
assess
classif
manag
epilepsi
result
demograph
male
femal
age
diagnosi
rang
month
year
psychiatr
cognit
comorbid
profession
patient
input
consult
paediatrician
special
interest
epilepsi
refer
epilepsi
specialist
nurs
year
refer
tertiari
centr
assess
classif
evid
appropri
first
clinic
assess
patient
eeg
mri
classifi
seizur
type
epilepsi
syndrom
categori
manag
treat
carbamazepin
contraind
carbamazepin
given
advic
regard
physic
activ
water
safeti
still
diagnosi
year
conclus
littl
evid
dissemin
advic
regard
physic
activ
water
safeti
access
epilepsi
nurs
epilepsi
specialist
essenti
appropri
safeti
advic
manag
psychiatr
cognit
comorbid
highlight
need
effect
mental
health
servic
object
estim
time
onset
treatment
effect
addon
cannabidiol
cbd
reduc
convuls
seizur
frequenc
associ
dravet
syndrom
ds
use
posthoc
pool
analysi
phase
randomis
placebocontrol
trial
method
patient
receiv
gw
pharmaceut
plantderiv
highli
purifi
cbd
medicin
oral
object
recent
studi
examin
epilepsi
onset
year
age
identifi
uncontrol
seizur
predictor
poor
development
outcom
conduct
posthoc
analysi
efficaci
safeti
patient
dravet
syndrom
ds
year
old
method
patient
ds
enter
openlabel
extens
ole
studi
complet
one
two
phase
studi
ole
particip
initi
receiv
kgday
month
dose
titrat
optim
effect
maximum
dose
maximum
day
patient
also
receiv
stiripentol
maximum
aim
investig
view
health
care
profession
challeng
face
diagnos
treat
seizur
picu
role
brain
function
monitor
method
explanatori
sequenti
mix
method
approach
quan
qual
equal
weight
stage
collect
qualit
data
via
questionnair
sent
uk
picu
unit
questionnair
use
identifi
member
staff
semistructur
interview
themat
analysi
use
interpret
qualit
data
result
questionnair
respons
collect
picu
nurs
consult
advanc
nurs
practition
member
staff
respond
thought
seizur
easi
hard
diagnos
picu
seen
misdiagnosi
seizur
use
form
neurophysiolog
monitor
picu
use
amplitud
integr
electroencephalographi
themat
analysi
show
picu
staff
need
feel
control
patient
difficulti
diagnos
seizur
left
staff
feel
control
anxiou
suggest
reason
diagnost
difficulti
includ
lack
train
seizur
semiolog
sed
paralys
drug
lack
experienc
staff
ask
opinion
know
child
background
neurolog
state
seizur
type
parent
present
cerebr
function
monitor
consid
way
improv
diagnosi
reduc
ambigu
rais
confid
picu
staff
small
number
staff
prefer
monitor
patient
clear
treat
seizur
without
clinic
featur
improv
outcom
conclus
health
care
profession
picu
need
feel
control
patent
difficulti
diagnos
treat
seizur
accur
caus
ambigu
concern
picu
staff
want
cerebr
function
monitor
improv
accuraci
diagnosi
treatment
futur
work
need
show
improv
accuraci
treatment
improv
outcom
poster
pcdh
epilepsi
rare
recognis
genet
epilepsi
syndrom
experi
three
femal
sibl
aim
report
three
case
protocadherin
relat
epilepsi
three
femal
sibl
famili
inherit
case
child
year
month
old
sibl
develop
seizur
month
cluster
brief
tonic
seizur
associ
stare
clonic
prolong
generalis
poster
present
perspect
understand
healthcar
profession
includ
occup
therapist
treatment
care
babi
infantil
spasm
earlyonset
epilepsi
qualit
design
dm
middleton
univers
roehamptononlin
birmingham
uk
object
explor
perspect
understand
alli
healthcar
profession
occup
therapist
physiotherapist
speech
languag
therapist
work
children
epilepsi
order
guid
advoc
popul
group
method
qualit
studi
design
use
interpret
themat
analysi
data
particip
semistructur
interview
result
profession
work
across
acut
commun
set
previou
experi
work
children
epilepsi
awar
need
theme
emerg
hous
social
need
epilepsi
psychosoci
mental
health
need
therapi
approach
train
alli
healthcar
profession
adolesc
young
girl
women
epilepsi
conclus
gap
servic
provis
certain
area
share
within
present
epilepsi
requir
addit
consider
safeti
condit
may
requir
crucial
interest
public
health
children
famili
epilepsi
abl
advoc
resourc
specif
need
poster
time
onset
cannabidiol
cbd
treatment
effect
resolut
advers
event
patient
dravet
syndrom
pool
analysi
two
randomis
control
trial
solut
kgday
trial
placebo
week
cbd
treatment
start
reach
day
day
percent
reduct
cumul
convuls
seizur
frequenc
treatment
day
includ
previou
treatment
day
time
advers
event
ae
assess
result
overal
patient
randomis
cbd
placebo
cbd
led
significantli
greater
percent
reduct
convuls
seizur
frequenc
placebo
vs
placebo
vs
placebo
pool
data
treatment
differ
seizur
reduct
emerg
titrat
maintain
throughout
studi
nomin
signific
p
achiev
day
day
onset
first
report
ae
occur
titrat
patient
ae
ae
resolv
within
week
onset
patient
end
studi
increas
altast
upper
limit
normal
occur
patient
placebo
concomit
valproat
elev
resolv
either
spontan
continu
cbd
discontinu
cbd
reduc
cbd
valproat
andor
clobazam
dose
conclus
cbd
treatment
effect
seizur
reduct
ae
may
occur
earli
titrat
major
ae
resolv
studi
poster
low
dose
fenfluramin
hydrochlorid
oral
solut
provid
longterm
clinic
meaning
reduct
seizur
frequenc
dravet
syndrom
interim
analysi
longterm
openlabel
extens
studi
object
character
longterm
safeti
durabl
effect
adjunct
fenfluramin
ffa
treat
dravet
syndrom
ds
method
patient
ds
enter
longterm
openlabel
extens
ole
complet
one
two
phase
studi
studi
placebo
ffa
max
studi
placebo
ffa
max
stiripentol
exclud
studi
mandatori
studi
patient
receiv
ffa
month
dose
titrat
effect
thereaft
effect
toler
assess
month
interv
result
interim
analysi
patient
continu
ole
complet
month
ffa
mean
dose
median
durat
rang
entir
ole
median
percentag
chang
monthli
convuls
seizur
frequenc
mcsf
ffa
vs
pretreat
phase
studi
baselin
p
clinic
meaning
profound
mcsf
reduct
baselin
month
median
mean
longest
interv
convuls
seizur
day
rang
caregiv
investig
rate
patient
much
improvedveri
much
improv
common
advers
event
includ
appetit
decreas
pyrexia
nasopharyng
diarrhea
valvular
heart
diseas
pulmonari
hypertens
observ
patient
conclus
treatment
ffa
result
robust
sustain
reduct
mcsf
gener
well
toler
valvular
heart
diseas
pulmonari
arteri
hypertens
observ
patient
time
ffa
may
import
novel
antiepilept
drug
longterm
ds
treatment
poster
low
dose
fenfluramin
hydrochlorid
oral
solut
provid
longterm
clinic
meaning
reduct
convuls
seizur
frequenc
young
year
old
dravet
syndrom
particip
analysi
longterm
openlabel
studi
result
total
particip
enrol
ole
year
old
upon
entri
phase
studi
median
baselin
monthli
convuls
seizur
frequenc
mcsf
doubleblind
treatment
seizuresmonth
rang
patient
subgroup
time
ole
interim
analysi
median
decreas
mcsf
year
subgroup
entir
observ
period
compar
baselin
p
compar
overal
studi
popul
frequent
report
advers
event
includ
pyrexia
upper
respiratori
tract
infect
decreas
appetit
diarrhea
valvular
heart
diseas
pulmonari
arteri
hypertens
observ
conclus
treatment
provid
sustain
clinic
meaning
reduct
mcsf
ds
particip
year
old
importantli
effect
control
seizur
young
age
group
might
expect
mitig
neg
neurodevelopment
outcom
report
associ
treatmentrefractori
seizur
improv
provis
epilepsi
care
children
england
wale
method
relev
health
board
trust
hbt
invit
regist
particip
identifi
hbt
lead
snapshot
survey
complet
via
bespok
onlin
platform
hbt
lead
describ
local
provis
april
data
analys
rcpch
includ
region
nation
aggreg
longitudin
comparison
previou
report
result
hbt
paediatr
epilepsi
servic
across
england
wale
regist
particip
submit
data
hbt
employ
consult
paediatrician
expertis
epilepsi
epilepsi
specialist
nurs
esn
provis
defin
epilepsi
clinic
see
patient
secondari
level
hbt
agre
referr
pathway
tertiari
paediatr
neurolog
servic
satellit
paediatr
neurolog
clinic
host
hbt
conclus
improv
overal
number
epilepsi
nurs
specialist
paediatrician
expertis
specif
clinic
children
young
peopl
epilepsi
find
led
comprehens
recommend
hb
commission
inform
updat
epilepsi
best
practic
tariff
theme
within
nh
long
term
plan
poster
diagnos
manag
seizur
picu
explanatori
sequenti
mix
method
approach
tonic
clonic
seizur
awak
sleep
eeg
show
tempor
focal
slow
label
non
lesion
focal
epilepsi
normal
mri
scan
discharg
keppra
multipl
admiss
cluster
brief
seizur
age
month
associ
sometim
febril
ill
poor
respons
intraven
a
diagnos
autism
month
child
month
old
younger
sibl
seizur
onset
month
seizur
tonic
natur
brief
multipl
cluster
period
day
eeg
show
nonspecif
slow
seizur
array
cgh
reveal
chromosom
microdelet
keppra
commenc
increas
recurr
cluster
seizur
age
month
requir
admiss
poor
respons
iv
a
famili
histori
reveal
halfsist
biolog
father
daughter
epilepsi
global
development
delay
diagnos
pcdh
epilepsi
gene
test
request
sibl
heterozyg
pcdh
mutat
delay
social
commun
skill
year
diagnosi
autism
month
child
year
old
half
sibl
father
child
relationship
test
posit
pcdh
develop
normal
far
seizur
conclus
pcdh
epilepsi
increasingli
recognis
one
earli
onset
infantil
encephalopathi
gene
test
like
yield
diagnosi
famili
histori
typic
phenotyp
poster
seizur
development
cognit
outcom
children
post
hemispherotomi
tt
tay
dr
reed
vj
josan
sr
rust
jt
tan
univers
manchest
manchest
uk
neuropsycholog
team
paediatr
psychosoci
servic
royal
manchest
children
hospit
manchest
uk
neurosurgeri
salford
royal
nh
foundat
manchest
uk
paediatr
neuropsycholog
royal
manchest
children
hospit
manchest
uk
paediatr
neurolog
royal
manchest
children
hospit
manchest
uk
introduct
patient
focal
refractori
epilepsi
secondari
structur
hemispher
chang
shown
retrospect
studi
significantli
improv
seizur
outcom
follow
hemispher
disconnect
aim
studi
report
seizur
cognit
outcom
cohort
investig
prognost
factor
seizur
outcom
method
singlecentr
retrospect
studi
children
adolesc
hemispherotomi
refractori
epilepsi
royal
manchest
children
hospit
result
twentytwo
patient
includ
median
rang
age
seizur
onset
surgeri
month
respect
median
rang
time
seizur
onset
surgeri
month
common
aetiolog
antenatalperinat
middl
cerebr
arteri
infarct
malform
cortic
develop
year
surgeri
last
followup
median
rang
month
achiev
complet
seizur
freedom
number
antiepilept
medic
decreas
last
followup
lateralis
ictal
interict
eeg
aetiolog
age
first
seizur
associ
seizur
recurr
five
formal
neuropsycholog
test
use
wechsler
intellig
scale
children
wisc
show
improv
cognit
abil
across
subset
postsurgeri
ten
children
show
reduct
median
vineland
adapt
behaviour
score
indic
failur
progress
rather
regress
skill
nine
newli
report
behaviour
psychiatr
issu
includ
sleep
problem
challeng
behaviour
autist
spectrum
disord
sixteen
report
parentscar
show
improv
verbal
abil
postop
rest
unchang
verbal
abil
conclus
present
cohort
children
earli
onset
seizur
hemispherotomi
rel
earli
age
cohort
show
good
seizur
outcom
cognit
improv
prognost
factor
seizur
outcom
identifi
small
group
mri
phenotyp
diseas
contrast
ahc
patient
mri
abnorm
hypoplast
corpu
callosum
patient
normal
mri
patient
carri
mutat
associ
mild
clinic
phenotyp
patient
clinic
ataxia
cerebellar
atrophi
mri
patient
cerebellar
atrophi
atax
two
patient
sever
intellectu
disabl
cerebr
atrophi
conclus
mutat
subtl
radiolog
find
cluster
around
callos
dysmorph
well
pontin
cerebellar
abnorm
seem
form
distinct
mri
phenotyp
ahc
capo
studi
larger
cohort
requir
accur
defin
mutationspecif
phenotyp
allow
quantit
analysi
poster
longterm
safeti
efficaci
adjunct
perampanel
paediatr
patient
age
partialonset
seizur
po
primari
generalis
tonicclon
seizur
pgtc
studi
r
flamini
patten
ly
ngo
pediatr
adolesc
neurodevelopment
associ
atlanta
ga
usa
eisai
ltd
hatfield
hertfordshir
uk
eisai
inc
woodcliff
lake
nj
usa
object
studi
multicentr
openlabel
singlearm
studi
perampanel
oral
suspens
ml
paediatr
patient
age
po
without
secondarili
generalis
seizur
sg
pgtc
report
longterm
safeti
efficaci
data
adjunct
perampanel
paediatr
patient
studi
method
analysi
includ
cumul
data
enrol
patient
core
studi
treatment
extens
phase
treatment
assess
includ
monitor
treatmentemerg
advers
event
teae
median
percent
chang
seizur
frequenc
per
day
baselin
respond
seizurefreedom
rate
result
patient
enrol
core
studi
po
sg
pgtc
patient
enter
extens
patient
discontinu
extens
common
primari
reason
discontinu
advers
event
inadequ
therapeut
effect
patient
mean
standard
deviat
sd
time
sinc
diagnosi
year
mean
sd
durat
exposur
week
baselin
patient
receiv
two
concomit
antiseizur
medic
teae
report
patient
somnol
commonli
report
median
percent
reduct
po
sg
pgtc
frequenc
week
respect
maintain
week
respect
seizurefreedom
rate
po
sg
pgtc
week
respect
conclus
longterm
adjunct
perampanel
gener
safe
well
toler
efficaci
paediatr
patient
age
po
withwithout
sg
pgtc
poster
longterm
adjunct
perampanel
healthrel
qualiti
life
hrqol
paediatr
patient
age
partialonset
seizur
po
primari
generalis
tonicclon
seizur
pgtc
studi
ea
portillo
patten
g
meier
malhotra
ly
ngo
paediatr
neurolog
unit
depart
paediatr
hospit
universitario
virgen
del
roc
sevilla
spain
eisai
ltd
hatfield
hertfordshir
uk
eisai
inc
woodcliff
lake
nj
usa
object
studi
multicentr
openlabel
studi
adjunct
perampanel
oral
suspens
paediatr
patient
age
po
withwithout
secondarili
generalis
seizur
sg
pgtc
report
longterm
hrqol
data
use
euroqol
dimensionsyouth
scale
studi
method
analysi
includ
cumul
data
enrol
patient
core
studi
extens
phase
treatment
respect
assess
baselin
week
week
includ
five
domain
mobil
selfcar
usual
activ
paindiscomfort
feel
worriedsadunhappi
visual
analogu
scale
va
also
assess
increas
va
correspond
improv
data
observ
case
result
enrol
patient
includ
analys
proport
patient
report
lot
problem
similar
baselin
vs
week
mobil
vs
selfcar
vs
usual
activ
vs
paindiscomfort
vs
feel
worriedsadunhappi
vs
outcom
also
similar
problem
baselin
vs
week
mobil
vs
selfcar
vs
usual
activ
vs
paindiscomfort
vs
feel
worriedsadunhappi
vs
mean
standard
deviat
chang
va
baselin
week
conclus
longterm
adjunct
perampanel
treatment
neg
affect
hrqol
base
domain
patient
age
year
po
withwithout
sg
pgtc
poster
efficaci
safeti
adjunct
perampanel
partialonset
seizur
po
adult
adolesc
paediatr
popul
studi
studi
patient
receiv
perampanel
without
enzymeinduc
antiseizur
medic
eiasm
eiasm
treatment
period
efficaci
assess
includ
median
percent
chang
seizur
day
baselin
respond
rate
seizurefre
rate
safeti
assess
includ
incid
treatmentemerg
advers
event
teae
result
median
percent
reduct
seizur
frequenc
day
greater
perampanel
vs
placebo
p
adolescentadult
patient
paediatr
patient
respond
rate
mainten
period
greater
perampanel
day
vs
placebo
p
adolescentadult
patient
paediatr
patient
seizurefreedom
rate
greater
perampanel
vs
placebo
p
adolesc
adult
patient
paediatr
patient
teae
occur
adolescentadult
patient
perampanel
vs
placebo
patient
paediatr
patient
teae
observ
pediatr
patient
similar
report
adolesc
adult
conclus
studi
suggest
perampanel
efficaci
gener
safe
paediatr
adolesc
adult
patient
po
withwithout
sg
method
patient
complet
either
rct
could
enter
ole
trial
patient
receiv
gw
pharmaceut
plantderiv
highli
purifi
cbd
medicin
oral
solut
primari
endpoint
safeti
secondari
efficaci
endpoint
median
percentag
chang
baselin
drop
total
seizur
frequenc
result
overal
elig
patient
lg
enter
ole
median
followup
week
patient
withdrew
mean
age
year
year
male
baselin
median
seizur
day
drop
seizur
total
seizur
extend
followup
incid
advers
event
ae
seriou
ae
ae
lead
discontinu
common
ae
diarrhoea
convuls
pyrexia
somnol
vomit
upper
respiratori
tract
infect
decreas
appetit
ae
alanin
aminotransferas
increas
occur
patient
death
none
deem
treatmentrel
investig
median
percentag
reduct
seizur
frequenc
window
drop
seizur
total
seizur
conclus
longterm
treatment
addon
cbd
patient
lg
produc
sustain
seizur
reduct
new
safeti
concern
poster
manag
statu
epilepticu
children
dravet
syndrom
jaa
holland
u
rajalingam
paediatr
hinchingbrook
hospit
huntingdon
uk
object
statu
epilepticu
report
second
greatest
caus
mortal
children
dravet
syndrom
aim
review
evid
convuls
statu
manag
children
dravet
syndrom
guid
local
practic
method
literatur
review
result
pubm
search
use
search
term
dravet
statu
epilepticu
return
result
relev
one
articl
present
specif
data
report
effect
medic
use
acut
seizur
manag
base
upon
retrospect
questionnair
data
defin
statu
epilepticu
seizur
last
minut
longer
efficaci
agent
report
termin
seizur
within
minut
intraven
barbitur
patient
benzodiazepin
patient
rectal
benzodiazepin
chloral
hydrat
intraven
phenytoin
lidocain
report
less
effect
remain
articl
present
expert
consensu
opinion
advis
earli
administr
seizur
onset
buccal
intraven
benzodiazepin
provis
rescu
medic
home
use
individualis
plan
recommend
one
author
advoc
give
three
dose
benzodiazepin
sequenti
articl
summaris
consensu
panel
describ
sodium
valproat
prefer
second
line
option
benzodiazepin
ineffect
overal
agreement
possibl
medic
sever
articl
advis
caution
use
phenytoin
acut
seizur
manag
one
sourc
discuss
possibl
harm
high
dose
barbitur
conclus
statu
epilepticu
manag
children
dravet
syndrom
featur
earli
rapidli
act
benzodiazepin
administr
second
line
treatment
phenytoin
barbitur
commonli
use
standard
statu
epilepticu
manag
protocol
potenti
concern
around
use
patient
group
concern
howev
appear
larg
theoret
absenc
evid
favour
specif
manag
protocol
individualis
care
plan
design
involv
patient
carer
poster
low
dose
fenfluramin
hydrochlorid
oral
solut
significantli
reduc
frequenc
gener
tonicclon
seizur
dravet
syndrom
pool
analysi
two
phase
clinic
trial
jh
cross
gilnagel
b
gun
battaglia
k
riney
g
farfel
mistri
b
galer
g
morrison
gammaitoni
k
pagano
great
ormond
street
hospit
london
uk
servicio
de
neurologia
hospit
ruber
internacion
madrid
spain
sticht
epilepsi
instellingen
zwoll
netherland
gemelli
hospit
rome
itali
mater
children
hospit
brisban
qld
australia
zogenix
inc
int
emeryvil
ca
usa
zogenix
inc
int
maidenhead
uk
object
low
dose
fenfluramin
hcl
oral
solut
significantli
reduc
frequenc
convuls
seizur
patient
dravet
syndrom
ds
two
phase
clinic
trial
conduct
pool
analysi
trial
analyz
effect
frequenc
tonicclon
seizur
tc
recent
identifi
major
risk
factor
sudden
unexpect
death
epilepsi
method
frequenc
gener
tc
focaltobilater
tc
patient
ds
enrol
one
two
phase
clinic
trial
ad
current
antiepilept
drug
regimen
analyz
result
patient
male
mean
age
enrol
random
placebo
mgkgday
median
baselin
monthli
frequenc
gener
tc
rang
four
dose
group
decreas
treatment
group
respect
placebo
group
focaltobilater
tc
experienc
fewer
patient
median
baselin
frequenc
month
treatment
median
percentag
reduct
focaltobilater
tc
frequenc
group
respect
placebo
group
common
advers
event
includ
decreas
appetit
diarrhea
fatigu
valvular
heart
diseas
pulmonari
arteri
hypertens
seen
particip
time
conclus
substanti
reduc
frequenc
tc
may
import
effect
new
treatment
option
ds
patient
object
mutat
affect
associ
expand
spectrum
phenotyp
includ
development
delay
hear
impair
door
syndrom
rang
epilepsi
number
differ
movement
disord
includ
ataxia
spastic
episod
paroxysm
dystonia
also
describ
report
two
unrel
patient
biallel
variant
exerciseinduc
dystonia
major
diseas
featur
method
patient
diagnos
wholeexom
sequenc
clinic
inform
obtain
review
medic
note
clinic
correspond
avail
video
footag
result
patient
found
compound
heterozyg
mutat
associ
episod
dystonicdyskinet
movement
disord
reliabl
trigger
exert
case
patient
exert
specif
bodi
part
induc
specif
localis
symptom
exampl
sing
would
precipit
orolingu
dyskinesia
girl
experienc
truncal
dystoniaspecif
later
flexion
trunkbrought
prolong
walk
girl
also
epilepsi
note
exerciseinduc
movement
postur
captur
eeg
ictal
correl
conclus
although
mutat
establish
genet
caus
epilepsi
studi
confirm
paroxysm
event
peopl
mutat
epilept
natur
includ
genet
differenti
diagnosi
patient
complex
neurolog
syndrom
associ
paroxysm
exerciseinduc
dyskinesia
object
heterozyg
de
novo
mutat
recent
report
development
epilept
encephalopathi
associ
movement
phenotyp
fulli
delin
order
better
defin
expand
phenotyp
movement
disord
diseas
report
seri
unrel
patient
present
complex
movement
disord
well
epilepsi
development
impair
method
case
identifi
uk
neurogenet
servic
great
ormond
street
hospit
nation
hospit
neurolog
neurosurgeri
london
intern
collabor
centr
data
collect
retrospect
patient
clinician
use
standardis
proforma
result
nine
individu
identifi
age
year
epilepsi
achiev
seizur
freedom
last
review
commonest
seizur
type
focal
onset
impair
awar
andor
focal
bilater
tonicclon
seizur
also
paroxysm
movement
disord
includ
hemipleg
asymmetr
episod
weak
generalis
dyskinesia
episod
focal
dystonia
episod
ataxia
individu
affect
movement
disord
least
two
differ
type
episod
movement
disord
improv
significantli
treatment
carbamazepin
three
children
cognit
abil
vari
averag
sever
intellectu
disabl
one
case
development
delay
predat
onset
epilepsi
conclus
mutat
caus
complex
neurolog
phenotyp
associ
epilept
nonepilept
paroxysm
paroxysm
event
occur
peopl
known
mutat
therefor
assum
alway
epilept
natur
studi
confirm
wide
varieti
movement
disord
report
includ
fall
within
spectrum
altern
hemiplegia
childhood
ahc
thu
consid
potenti
gene
ahc
complex
movement
disord
phenotyp
epilepsydyskinesia
syndrom
poster
evalu
seizur
recognit
use
electroencephalographi
paediatr
intens
care
unit
object
paediatr
intens
care
unit
picu
seizur
challeng
detect
given
patient
complex
comorbid
sedat
led
overand
undertreat
seizur
grow
literatur
use
continu
electroencephalographi
picu
consid
gold
standard
univers
avail
littl
standard
electroencephalographi
eeg
studi
aim
investig
indic
eeg
request
efficaci
use
antiepilept
drug
a
picu
hypothesis
difficulti
clinic
differenti
epilept
nonepilept
event
suboptim
use
a
method
retrospect
studi
examin
eeg
report
year
tertiari
picu
data
collect
particip
characterist
eeg
indic
find
a
use
result
eeg
report
particip
includ
median
age
month
iqr
indic
eeg
often
multipl
per
eeg
includ
suspect
clinic
seizur
suspect
subclin
seizur
prognost
suspect
encephalopathi
particip
suspect
seizur
sedat
particip
encephalopath
clinic
episod
suspect
seizur
captur
eeg
eegconfirm
seizur
captur
movement
shown
seizur
qualit
describ
patient
suspect
seizur
electrograph
seizur
clinic
correl
confirm
seizur
particip
without
preexist
epilepsi
antiepilept
chang
prior
captur
event
seizur
present
case
neither
clinic
electrograph
seizur
activ
particip
confirm
clinic
seizur
a
chang
conclus
challeng
clinician
differenti
seizur
nonseizur
movement
picu
moreov
issu
overmed
low
eventcaptur
rate
eeg
propos
multidisciplinari
educ
strategi
invest
ceeg
address
issu
introduct
glucos
transport
defici
syndrom
rare
neurometabol
disord
caus
impair
glucos
transport
brain
major
patient
caus
autosom
domin
heterozyg
mutat
gene
keton
bodi
gener
ketogen
diet
kd
provid
brain
altern
energi
sourc
gold
standard
therapi
report
experi
cohort
patient
royal
manchest
children
hospit
method
retrospect
case
note
review
patient
royal
manchest
children
hospit
result
patient
male
femal
age
rang
year
averag
age
diagnosi
year
month
rang
histori
seizur
patient
averag
seizur
onset
year
month
seizur
type
absenc
generalis
tonicclon
myoclon
myoclon
astat
tonic
focal
bilater
tonicclon
ketogen
diet
use
patient
rang
month
year
month
signific
advers
effect
occur
requir
discontinu
six
patient
compli
kd
seizur
free
take
antiepilept
drug
a
one
patient
occasion
tonicclon
seizur
ill
loss
ketosi
seizur
free
month
five
patient
noncompli
kdtwo
good
seizur
control
a
potenti
limit
motiv
two
sibl
parent
learn
difficulti
learn
difficulti
report
patient
symptom
includ
ataxia
dysarthria
tremor
dystonia
one
patient
present
episod
hemiplegia
conclus
patient
heterogen
group
lead
challeng
diagnosi
manag
prognosi
ketogen
diet
effect
manag
cohort
complianc
limit
factor
object
conduct
survey
regard
manag
relaps
children
epilepsi
follow
wean
a
method
conduct
onlin
survey
east
england
eoe
via
eastern
paediatr
epilepsi
network
epen
regard
manag
relaps
children
epilepsi
wean
a
epen
network
paediatrician
nurs
specialist
eoe
manag
lead
manag
children
epilepsi
within
dgh
region
question
survey
ask
variou
aspect
manag
patient
relaps
includ
choic
antiepilept
medic
restart
start
investig
undertaken
final
length
a
treatment
second
attempt
wean
might
consid
result
receiv
respons
paediatrician
dgh
across
eoe
larg
degre
variat
respons
question
survey
frequenc
semiolog
seizur
relaps
seem
play
key
role
decis
make
thought
view
famili
patient
interest
note
variat
respons
whether
investig
would
undertaken
deem
necessari
clinician
respond
would
continu
a
anoth
year
attempt
wean
conclus
variabl
manag
epilepsi
relaps
eoe
suspect
may
also
case
nation
investig
would
envisag
extend
survey
nation
via
open
ukwhich
organis
link
variou
region
paediatr
epilepsi
network
across
uk
would
enabl
establish
standard
guidelin
manag
epilepsi
relaps
futur
object
de
novo
domin
mutat
dhdd
recent
identifi
caus
development
epilept
encephalopathi
dhdd
encod
dehydrodolichyl
diphosph
synthas
essenti
dolichol
monophosph
synthesi
protein
glycosyl
report
two
halfsibl
new
pathogen
matern
inherit
dhdd
missens
variant
identifi
wholeexom
sequenc
method
case
note
literatur
review
result
sibl
age
year
present
month
global
development
delay
hypotonia
frequent
absenc
eyelid
myoclonia
age
develop
aton
drop
attack
myoclon
seizur
tremor
ataxia
facial
dyskinesia
dyskinesia
mobil
deterior
age
larg
nonambul
sever
learn
disabl
possibl
cognit
deterior
insati
appetit
also
featur
sibl
age
year
develop
blank
spell
associ
eyelid
flicker
month
aton
drop
attack
age
develop
delay
present
progress
greater
sibl
dyskinesia
tremor
ataxia
deterior
mobil
featur
neither
dysmorph
eeg
show
burst
irregular
generalis
spike
wave
associ
head
nod
eyelid
flutter
photosensit
shown
treat
antiepilept
medic
mri
scan
normal
clobazam
zonisamid
improv
seizur
control
mother
mild
learn
difficulti
tremor
dyspraxia
generalis
tonic
clonic
seizur
age
year
well
control
lamotrigin
compar
six
known
case
literatur
report
confirm
aton
seizur
dyskinesia
import
featur
disord
addit
common
characterist
myoclon
compon
seizur
hypotonia
tremor
learn
disabl
variabl
sever
conclus
first
report
famili
inherit
dhdd
relat
development
epilept
encephalopathi
describ
variabl
sever
phenotyp
within
famili
member
featur
describ
consist
previous
observ
object
evalu
whether
durat
treatment
effect
relaps
rate
children
cae
attend
paediatr
neurolog
centr
cypru
whether
eeg
use
prognost
tool
method
electron
patient
databas
review
patient
cae
discontinu
treatment
attend
paediatr
neurolog
clinic
year
result
fourteen
patient
cae
treatment
identifi
male
age
present
rang
year
median
patient
underw
eeg
confirm
diagnosi
present
seizur
absenc
exclud
twelv
patient
treat
valproic
acid
depakin
ethosuximid
zarontin
absenc
resolv
first
line
monotherapi
whilst
refractori
requir
combin
therapi
posit
famili
histori
present
nonident
twin
attent
deficit
learn
difficulti
patient
initi
eeg
consist
cae
patient
also
underw
eeg
post
seizur
control
confirm
resolut
mean
time
seizur
cessat
month
mean
durat
treatment
year
patient
discontinu
treatment
year
seizur
freedom
prior
withdraw
treatment
patient
eeg
normal
mildli
abnorm
brief
generalis
discharg
photosensit
brief
electrograph
absenc
relaps
occur
patient
requir
reinstig
treatment
mild
abnorm
eeg
prior
come
treatment
correl
higher
relaps
rate
differ
relaps
rate
patient
treatment
year
patient
follow
mean
year
conclus
treat
patient
cae
less
year
affect
relaps
rate
provid
patient
seizur
free
also
confirm
eeg
normalis
may
use
addit
predictor
background
mutat
encod
part
channel
complex
caus
autosomalrecess
sever
infantil
encephalopathi
rare
case
profound
global
development
delay
psychomotor
retard
individu
report
date
defici
character
hypotonia
strabismu
oral
motor
dysfunct
postnat
growth
defici
development
delay
major
individu
learn
walk
individu
lack
express
languag
addit
featur
includ
nystagmu
extrem
hypertonia
highpitch
cri
repetit
selfstimulatori
behaviour
constip
clubfeet
joint
contractur
scoliosi
loss
skill
suggest
neurodegener
case
present
recent
confirm
diagnosi
gene
mutat
microcephali
profound
global
development
delay
learn
disabl
bilater
squint
cortic
blind
seizur
disord
sleep
apnoea
head
drop
movement
disord
feed
difficulti
scoliosi
constip
term
babi
normal
antinat
histori
induct
labour
iugr
good
apgar
birth
develop
respiratori
distress
cardiac
problem
birth
weight
g
neurolog
floppi
reduc
muscl
tone
microcephali
short
neonat
admiss
discharg
cardiac
endocrin
neonat
neurodevelopment
delay
followup
spoken
word
commun
cri
abl
sit
transient
never
walk
wheelchair
bound
gmfc
mac
cfc
edac
level
need
full
support
patent
carer
ddd
studi
confirm
gene
mutat
cousin
also
note
gene
mutat
via
exom
sequenc
similar
clinic
pictur
conclus
earli
diagnosi
key
genet
counsel
children
ensur
global
support
report
individu
span
age
birth
year
diagnosi
establish
proband
development
delay
hypotonia
identif
biallel
pathogen
variant
molecular
genet
test
poster
cognit
diseas
burden
posit
dravet
syndromea
followup
studi
develop
diseas
burden
sleep
profil
patient
dravet
syndrom
method
followup
studi
previous
involv
ds
patient
detail
development
clinic
inform
avail
particip
complet
structur
postal
questionnair
epilepsi
sever
diseas
burden
adapt
behaviour
assess
system
sleep
disturb
scale
children
pediatr
qualiti
life
inventori
pedsql
strength
difficulti
questionnair
result
origin
cohort
contact
carer
complet
outcom
measur
development
quotient
followup
significantli
lower
compar
earlier
studi
affect
individu
sever
profound
learn
disabl
observ
steepest
declin
cognit
function
youngest
age
origin
studi
onset
poorer
development
quotient
correl
earli
onset
initi
development
concern
later
mobil
problem
higher
level
behaviour
problem
wors
pedsql
score
carer
health
wellb
neg
affect
case
least
one
two
carer
quit
job
due
child
ill
sleep
problem
measur
total
sleep
scale
score
report
patient
whilst
least
one
abnorm
sleep
scale
categori
individu
abnorm
sleep
score
receiv
treatment
rsspearman
rho
correl
coeffici
conclus
studi
highlight
ongo
cognit
declin
ds
particularli
affect
younger
patient
alongsid
often
untreat
sleep
problem
signific
diseas
burden
primari
carer
new
therapeut
opportun
horizon
earli
intervent
appear
crucial
avert
observ
sever
cognit
declin
poster
forc
normalis
factor
behaviour
deterior
ketogen
diet
e
hassan
vj
whiteley
hj
tan
depart
neurolog
royal
manchest
children
hospit
manchest
uk
therapi
dietet
royal
manchest
children
hospit
manchest
uk
school
health
societi
univers
salford
salford
uk
introduct
number
report
demonstr
correl
improv
seizur
manag
deterior
behaviour
psychosi
adult
children
forc
normalis
concept
deterior
behaviour
better
seizur
control
achiev
antiepilept
drug
a
epilepsi
surgeri
ketogen
diet
kd
treatment
option
children
refractori
epilepsi
approxim
show
least
reduct
seizur
patient
reach
seizur
freedom
month
treatment
although
forc
normalis
discuss
literatur
follow
a
neurosurg
intervent
report
follow
use
kd
case
children
commenc
kd
last
year
royal
manchest
children
hospit
respond
diet
least
improv
seizur
noncompli
present
patient
care
kd
servic
whose
behaviour
deterior
kd
seizur
reduct
behaviour
chang
describ
parent
includ
poor
sleep
unsettl
agit
headbang
shout
five
six
patient
stop
kd
treatment
subsequ
improv
behaviour
conclus
report
patient
ketogen
diet
seizur
freedom
show
improv
behaviour
unlik
small
cohort
whose
behaviour
deterior
forc
normalis
explor
paediatr
patient
caus
behaviour
deterior
follow
surgic
medic
manag
intract
seizur
associ
factor
deterior
behaviour
yet
explor
depth
ketogen
diet
object
want
determin
lacosamid
use
children
local
outcom
year
method
undertook
regist
retrospect
clinic
audit
use
hospit
electron
record
ascertain
everi
patient
age
year
dispens
lacosamid
januari
electron
health
record
review
data
collect
use
standard
proforma
includ
patient
demograph
age
seizur
onset
seizur
type
ecg
mri
find
baselin
seizur
frequenc
seizur
frequenc
month
lacosamid
maximum
dose
prescrib
mgkgday
advers
effect
month
result
patient
male
median
age
year
rang
mean
age
onset
year
rang
epileptiform
activ
eeg
abnorm
mri
focal
seizur
minimum
one
seizur
week
previous
tri
antiepilept
drug
a
drug
resist
epilepsi
prior
start
lacosamid
alreadi
fail
previou
a
patient
lacosamid
alongsid
anoth
a
mean
daili
dose
lacosamid
rang
month
patient
report
reduct
seizur
frequenc
remain
lacosamid
year
start
experienc
advers
side
effect
conclus
local
audit
lacosamid
mostli
prescrib
drug
resist
epilepsi
use
polytherapi
third
patient
saw
signific
reduct
seizur
frequenc
lacosamid
although
also
start
treatment
period
patient
remain
lacosamid
month
experienc
one
advers
side
effect
larg
gene
encod
alpha
subunit
neuron
ion
channel
express
wide
throughout
central
nervou
system
cn
pathogen
variant
gene
associ
mani
phenotyp
commonli
episod
ataxia
type
spinocerebellar
ataxia
type
rarer
phenotyp
includ
famili
hemipleg
migrain
paroxysm
tonic
upgaz
epilepsi
intellectu
disabl
autism
present
case
month
old
girl
present
new
onset
paroxysm
abnorm
eye
movement
intercurr
ill
refer
clinician
felt
episod
may
epilept
howev
electroencephalogram
eeg
captur
movement
nonepilept
downbeat
nystagmu
initi
investig
includ
cerebrospin
fluid
glucos
neurotransmitt
normal
neuroimag
next
year
nystagmu
becam
constant
otherwis
normal
develop
month
gait
note
abnorm
unsteadi
broad
base
even
account
age
nystagmu
ataxia
chang
sever
day
day
could
sever
day
follow
better
day
never
complet
resolv
famili
histori
abnorm
eye
movement
ataxia
subsequ
genet
test
reveal
p
missens
variant
describ
twice
previous
differ
phenotyp
patient
neither
parent
carri
genet
variant
case
first
report
case
variant
present
downbeat
nystagmu
follow
ataxia
age
present
initi
present
featur
differ
typic
phenotyp
associ
gene
broaden
phenotyp
also
broaden
differenti
diagnos
associ
abnorm
eye
movement
infanc
import
follow
yet
undiagnos
patient
may
go
develop
new
reveal
symptom
highlight
object
undertak
questionnairebas
survey
retrospect
explor
parentscar
recal
view
safeti
risk
advic
given
time
child
epilepsi
diagnosi
method
questionnair
distribut
throughout
scotland
via
scottish
paediatr
epilepsi
network
spen
parent
carer
children
ask
complet
questionnair
prior
seizur
clinic
appoint
result
questionnair
suitabl
inclus
seizur
burden
evenli
distribut
seizuremonth
seizuremonth
seizureweek
absenc
respond
could
recal
postdiagnosi
inform
provid
water
safeti
take
medic
regularli
sportsact
seizur
sleep
first
aid
prolong
seizur
andor
sudep
statist
signific
differ
durat
epilepsi
diagnosi
could
recal
inform
given
sd
could
sd
test
major
inform
given
via
clinic
discuss
receiv
written
inform
direct
websit
andor
independ
search
inform
right
water
safeti
take
a
regularli
sportsact
seizur
sleep
firstaid
seizur
approxim
respond
want
inform
seizur
sleep
water
safeti
sportsact
respond
felt
worri
follow
inform
seizur
sleep
prolong
seizur
regard
sudep
conclus
substanti
proport
parentscar
recal
receiv
safeti
inform
epilepsi
despit
standard
practic
spen
appear
unrel
durat
child
epilepsi
repeat
time
reinforc
may
benefit
high
proport
parentscar
felt
concern
follow
inform
provid
nocturn
seizur
prolong
seizur
sudep
recognis
support
place
discuss
poster
seizur
outcom
respons
vagu
nerv
stimul
therapi
children
young
peopl
v
rasiah
n
barn
carter
k
da
r
robinson
z
tahir
varadkar
great
ormond
street
hospit
children
nh
foundat
trust
ucl
gosh
institut
child
health
london
uk
aim
vagu
nerv
stimul
vn
therapi
establish
treatment
pharmacoresist
epilepsi
newer
responsivevn
rvn
system
use
ictaltachycardia
detect
biomark
seizur
onset
automat
deliv
addit
stimul
detect
abort
seizur
review
seizur
outcom
children
young
peopl
cyp
implant
rvn
great
ormond
street
method
data
collect
prospect
patient
aspiresr
rvn
insert
time
period
reduct
seizur
frequenc
sever
wean
medic
treatment
complic
sideeffect
assess
timepoint
year
month
year
year
postimplant
result
cyp
mean
age
rvn
insert
year
posit
respons
grade
reduct
seizur
frequenc
sever
ie
durat
benefit
though
benefit
cyp
nonrespond
increas
month
children
show
respons
show
respons
nonrespond
respons
overal
sustain
respons
lessen
children
month
year
reduct
medic
burden
achiev
attempt
cyp
patient
achiev
seizur
freedom
replac
vn
older
model
rvn
show
benefit
complic
infrequ
devic
remov
infect
requir
one
child
small
bodi
size
success
replac
possibl
within
year
conclus
vn
use
treatment
option
cyp
pharmacoresist
epilepsi
seizur
outcom
rvn
cyp
better
standard
vn
respons
sustain
benefit
may
seen
year
therapi
continu
least
month
patient
respond
later
optimis
duti
cycl
current
made
replac
older
vn
devic
rvn
led
addit
benefit
find
consist
report
outcom
adult
seri
though
seizur
freedom
seen
cyp
centr
cyp
seem
benefit
whose
epilepsi
structur
aetiolog
focal
seizur
although
number
larg
enough
assess
signific
poster
mutat
twin
present
apnoeic
episod
suspect
seizur
possibl
dyston
event
object
report
case
monochorion
diamniot
twin
present
age
month
infantil
seizur
apnoeic
episod
eiee
gene
panel
reveal
mutat
gene
support
clinic
diagnosi
altern
hemiplegia
childhood
ahc
method
case
report
result
twin
r
present
stare
episod
eye
deviat
tonic
postur
limb
episod
occur
mainli
cluster
affect
either
side
requir
rescu
medic
termin
profound
apnoeic
episod
need
resuscit
also
note
twin
present
week
later
similar
present
development
make
satisfactori
progress
twin
r
show
mild
delay
array
cgh
twin
r
normal
sever
investig
perform
includ
two
normal
standard
eeg
normal
sleep
eeg
normal
ecg
echo
show
small
pfo
mri
scan
demonstr
left
side
mesial
tempor
lobe
sclerosi
similar
mri
find
report
twin
investig
urin
organ
acid
amino
acid
plasma
amino
acid
carnitin
acylcarnitin
transferrin
glycoform
mucopolysaccharidosi
screen
ammonia
lactat
normal
pyridoxin
tri
improv
levetiracetam
ad
afterward
chang
carbamazepin
sodium
valproat
commenc
eventu
episod
prolong
clinic
seizur
eiee
gene
panel
reveal
de
novo
mutat
twin
flunarizin
commenc
follow
result
video
telemetri
manag
captur
epilept
nonepilept
episod
twin
r
epilept
episod
characteris
sole
apnoeic
episod
due
left
tempor
seizur
activ
spread
onto
opposit
hemispher
concord
imag
find
left
mesial
tempor
sclerosi
conclus
knowledg
mutat
allow
clinic
correl
diagnosi
ahc
match
wide
clinic
spectrum
ahc
includ
paroxysm
dystonia
epilepsi
poster
epilepsi
child
develop
centr
popul
pc
kenyon
njv
cordeiro
gl
duffi
rainbow
hous
child
develop
centr
irvin
ayrshir
uk
object
assess
case
child
develop
centr
cdc
popul
epilepsi
enabl
characteris
caseload
method
case
note
children
epilepsi
diagnosi
code
cdc
databas
retrospect
review
demograph
investig
treatment
data
result
children
identifi
diagnos
year
age
half
third
birthday
patient
eeg
abnorm
eeg
genet
test
perform
genet
caus
epilepsi
identifi
mri
scan
structur
caus
epilepsi
identifi
global
development
delay
diagnosi
learn
disabl
one
third
diagnosi
cerebr
palsi
autism
spectrum
disord
hemiplegia
seizur
free
major
epilepsi
control
one
medic
adher
concern
identifi
conclus
compar
gener
paediatr
epilepsi
clinic
group
children
diagnos
earlier
life
higher
rate
genet
structur
caus
identifi
less
like
seizur
free
result
case
autism
spectrum
disord
asd
develop
hand
wave
front
face
bright
light
year
multipl
myoclon
seizur
occur
screen
use
famili
live
complet
dark
eeg
demonstr
photosensit
generalis
spikeslow
wave
hand
wave
spikewav
myoclonia
clonazepam
commenc
case
learn
difficulti
famili
histori
generalis
seizur
present
age
year
forehead
rub
lead
loss
part
eyebrow
eeg
show
photosensit
generalis
spikewav
absenc
eyelid
myoclonia
em
sodium
valproat
use
replac
lamotrigin
due
weight
gain
case
famili
histori
generalis
seizur
present
age
year
hand
wave
front
face
requir
nurseri
provid
dimlylit
set
eeg
demonstr
generalis
polyspikewav
spikewav
myoclonia
photic
stimul
lamotrigin
ineffect
replac
sodium
valproat
case
like
asd
develop
hand
wave
front
face
bright
light
age
year
trigger
generalis
tonic
convuls
gtc
noninduc
gtc
dappl
sunlight
ongo
anxieti
thought
selfharm
eeg
show
photosensit
burst
spikespolyspik
lamotrigin
ineffect
seizur
stop
sodium
valproat
conclus
selfinduc
seizur
sunflow
syndrom
difficult
treat
associ
physic
psycholog
social
impair
sodium
valproat
effect
medic
may
problemat
predominantli
femal
patient
group
inform
need
parent
whose
child
diagnos
glutar
aciduria
type
help
preserv
neurodevelopment
outcom
object
assess
inform
need
support
parent
time
diagnosi
child
support
prevent
metabol
decompens
preserv
neurodevelopment
function
method
focu
group
five
parent
conduct
use
topic
guid
direct
discuss
record
fulli
transcrib
data
analys
use
themat
analysi
two
research
involv
initi
code
data
key
analyt
decis
result
two
main
theme
identifi
understand
condit
explor
parent
need
understand
scientif
complex
awar
worst
case
scenario
associ
loss
metabol
control
brain
injuri
parent
report
clinician
give
enough
inform
forc
use
inform
sourc
sometim
seek
scientif
paper
inform
manag
crise
insuffici
parent
understand
doctor
meant
commenc
emerg
regim
child
sick
parent
report
live
terror
child
experienc
metabol
decompens
perman
brain
injuri
manag
condit
explain
parent
coordin
control
involv
carer
outlin
parent
need
activ
partner
medic
manag
feel
control
parent
want
know
result
regular
biochem
test
reassur
found
easili
access
parent
could
leav
child
care
anoth
adult
suffici
knowledg
known
cheat
offer
child
food
transit
school
particular
challeng
conclus
studi
highlight
import
address
parent
initi
ongo
inform
need
fulfil
role
protect
child
metabol
decompens
perman
brain
injuri
poster
normal
transferrin
isoelectr
focus
child
relat
congenit
disord
glycosyl
object
congenit
disord
glycosyl
cdg
larg
group
rare
multisystem
diseas
caus
defect
linkag
oligosaccharid
newli
synthesis
protein
lipid
sever
cdg
subtyp
result
mutat
subunit
conserv
oligomer
golgi
cog
complex
includ
autosom
recess
disord
caus
pathogen
variant
gene
two
case
previous
report
transferrin
isoform
abnorm
consist
defect
nglycosyl
method
describ
femal
born
nonconsanguin
parent
present
sever
global
development
delay
dysmorph
featur
postnat
progress
microcephali
complex
epilepsi
rhizomelia
spastic
quadriplegia
feed
problem
earli
infanc
result
mri
brain
show
global
cerebr
atrophi
predominantli
supratentori
rel
cerebellar
spare
trio
exom
sequenc
analysi
identifi
compound
heterozyg
variant
proband
matern
inherit
pathogen
splice
site
variant
patern
inherit
like
pathogen
splice
site
variant
messeng
rna
analysi
show
variant
caus
aberr
splice
skip
exon
introduct
prematur
stop
codon
exon
like
result
nonsens
mediat
decay
analysi
transferrin
isoform
normal
isoelectr
focuss
mass
spectrometri
sinc
also
affect
oglycosyl
apolipoprotein
ciii
apociii
isoelectr
focuss
undertaken
howev
normal
conclus
transferrin
apociii
isoelectr
focus
screen
test
nand
oglycosyl
defect
howev
limit
case
cdg
normal
transferrin
apociii
glycoform
escap
screen
test
first
case
patient
normal
biochem
marker
describ
case
also
demonstr
diagnost
power
next
gener
sequenc
rare
metabol
disord
biochem
screen
may
inconclus
poster
development
delay
young
infant
nonclass
combin
malon
methyl
malon
aciduria
cmamma
caus
homozyg
missens
mutat
gene
kd
dayasiri
eg
goh
sk
kodagali
jb
baruteau
ga
anand
oxford
univers
hospit
nh
foundat
trust
oxford
uk
great
ormond
street
hospit
london
uk
introduct
acylcoa
synthetas
famili
member
activ
malonylcoa
methymalonylcoa
respect
thioester
defici
caus
nonclass
cmamma
rare
inborn
error
metabol
characteris
presenc
methyl
malon
acid
higher
concentr
malon
acid
urin
revers
seen
classic
cmamma
caus
malonylcoa
decarboxylas
defici
mcd
case
report
old
male
infant
second
born
consanguin
south
asian
parent
present
sever
failur
thrive
recurr
vomit
older
sibl
failur
thrive
neurodevelopment
delay
die
month
without
genet
diagnosi
initi
blood
test
reveal
metabol
acidosi
pancytopenia
coagulopathi
neuroimag
unremark
subsequ
evalu
reveal
normal
level
methionin
homocystein
red
cell
folat
signific
methylmalon
aciduria
mild
malon
aciduria
without
evid
abnorm
metabolit
propionylcoa
metabolit
hydroxypropion
methylcitr
tiglylglycin
urin
suggest
diagnosi
nonclass
cmamma
confirm
homozyg
missens
variant
gene
reveal
trioexom
sequenc
neurodevelopment
assess
month
reveal
global
development
delay
gener
hypotonia
gross
motor
fine
motor
speech
social
without
regress
carnitin
supplement
avoid
secondari
deplet
caus
excret
mma
parent
advis
avoid
prolong
fast
provid
emerg
regimen
powder
carbohydr
drink
mix
event
acut
deterior
conclus
report
describ
unusu
paediatr
present
nonclass
cmamma
urin
organ
acid
allow
identif
increas
mma
excret
highli
suggest
diagnosi
thu
avoid
addit
investig
determin
urinari
mmama
ratio
help
differenti
classic
nonclass
form
method
conduct
retrospect
case
note
analysi
five
paediatr
case
confirm
diagnosi
late
onset
pomp
diseas
refer
highli
specialis
metabol
servic
result
three
five
patient
current
age
present
delay
motor
mileston
earli
childhood
mean
age
one
patient
initi
present
episod
thigh
pain
high
ck
addit
year
repres
recurr
abdomin
pain
high
ck
remain
one
present
muscl
pain
upon
exercis
high
ck
apart
one
muscl
weak
affect
limb
girdl
muscl
axial
muscl
remain
one
present
proxim
muscl
weak
age
year
patient
remain
ambul
one
develop
scoliosi
two
noninvas
ventil
cardiac
involv
ventricular
dysfunct
requir
target
treatment
observ
one
patholog
show
vacuol
deposit
three
patient
nonspecif
myopath
chang
one
four
enzym
replac
therapi
ert
toler
well
conclus
late
onset
pomp
diseas
multisystem
diseas
consid
case
isol
respiratori
problem
lower
back
pain
rigid
spine
myopathi
exercis
intoler
elev
serum
ck
symptom
attribut
anoth
disord
poster
delay
diagnosi
misdiagnosi
ataxiatelangiectasia
systemat
review
pubm
scopu
cochran
librari
also
search
search
protocol
avail
inclus
criteria
date
languag
age
human
particip
clinic
relev
exclus
criteria
refer
ataxiatelangiectasia
within
articl
origin
articl
anim
studi
articl
clinic
relev
result
search
return
articl
titl
abstract
review
remov
duplic
full
text
review
includ
articl
case
seri
case
report
identifi
exclus
articl
found
access
mean
age
first
sign
symptom
case
review
date
month
rang
mean
age
diagnosi
case
report
month
rang
mean
time
month
present
clinician
diagnosi
rang
median
case
report
case
document
altern
diagnosi
prior
diagnosi
children
incorrectli
diagnos
cerebr
palsi
hyperigm
syndrom
mean
delay
incorrect
diagnosi
diagnosi
month
longest
delay
month
conclus
studi
first
comprehens
systemat
review
scientif
literatur
ataxiatelangiectasia
aim
describ
natur
histori
condit
along
result
natur
histori
nhat
studi
systemat
defin
possibl
condit
present
cours
prognosi
peopl
present
gait
ataxia
disturb
truncal
ataxia
common
present
featur
case
without
ataxia
development
delay
regress
choreoathetoid
movement
second
common
neurolog
present
sign
dysarthria
case
least
associ
ataxia
dystonia
present
sign
case
includ
associ
ataxia
initi
present
neurolog
sign
symptom
conclus
studi
first
comprehens
systemat
review
scientif
literatur
ataxiatelangiectasia
result
show
peopl
diagnosi
present
initi
least
one
neurolog
sign
symptom
complet
review
lead
natur
histori
nhat
studi
longitudin
retrospect
crosssect
studi
role
serum
oxysterol
diagnosi
niemann
pick
c
alcheikh
g
connolli
n
cluskey
osullivan
royal
hospit
belfast
health
social
care
trust
belfast
uk
introduct
neimann
pick
c
neuroviscer
diseas
caus
cellular
cholesterol
traffick
disrupt
histor
diagnosi
niemann
pick
c
made
use
filipin
stain
skin
fibroblast
cultur
recent
genet
test
gene
avail
mutat
either
gene
also
affect
cellular
traffick
cholesterol
detect
oxid
cholesterol
metabol
also
diagnost
nieman
pick
c
serum
oxysterol
use
first
line
test
subsequ
genet
confirm
posit
predict
valu
method
present
case
boy
refer
genet
initi
absenc
gaze
sever
restrict
downward
gaze
development
delay
regress
skill
frequent
fall
last
year
parent
school
observ
progress
deterior
symptom
gelast
cataplexi
markedli
decreas
tone
increas
difficulti
memori
loss
slur
speech
symptom
strongli
suggest
niemann
pick
c
diseas
oxysterol
request
show
elev
oxysterol
level
normal
rang
start
miglustat
genet
confirm
diagnosi
result
overal
child
parent
report
sinc
commenc
miglustat
confid
recent
seen
hop
skip
nt
seen
quit
conclus
oxysterol
suitabl
biomark
neimann
pick
c
diseas
use
first
line
genet
confirm
gene
later
stage
modifi
treatment
miglustat
avail
import
attempt
diagnos
condit
earli
possibl
oxysterol
level
use
screen
test
neimann
pick
c
clinic
suspect
introduct
biotinidas
defici
rare
autosom
recess
inborn
error
biotin
metabol
biotinidas
catalys
biocytin
biotin
defici
present
neurolog
symptom
includ
hypotonia
seizur
feed
difficulti
lethargi
optic
atrophi
sensorineur
deaf
case
femal
present
histori
seizur
development
delay
examin
reveal
generalis
axial
hypotonia
delay
smile
continu
seizur
despit
initi
treatment
includ
levetiracetam
carbamazepin
mri
brain
normal
initi
interict
eeg
day
post
admiss
reveal
signific
abnorm
ambulatori
eeg
day
show
focal
onset
epilept
seizur
sharp
slow
wave
activ
origin
predominantli
left
occipitopariet
region
normal
investig
includ
pair
plasma
csf
glucos
lactat
cultur
csf
neurotransmitt
microarray
epilepsi
gene
panel
day
post
admiss
biotinidas
result
report
show
activ
biotin
commenc
daili
seizur
abruptli
stop
discharg
home
day
wean
levetiracetam
carbamazepin
develop
normal
followup
genet
test
declin
famili
discuss
biotinidas
defici
present
neonat
period
year
age
mean
age
month
recent
year
understand
pathogen
chang
biotinidas
gene
increas
sequenc
novel
mutat
import
implic
famili
consider
given
offer
affect
famili
genet
counsel
treatment
avail
oral
biotin
rapidli
improv
symptom
seizur
usual
resolv
within
day
symptom
show
improv
within
week
object
present
previous
well
boy
known
c
mutat
experienc
week
vomit
lethargi
exercis
intoler
method
mildli
dehydr
fulli
conscious
tachycard
hypotens
ph
lactat
electrolyt
fbc
inflammatori
marker
normal
admit
picu
fluid
manag
sodium
bicarbon
tachycardia
persist
first
hour
though
remain
stabl
good
urin
output
noninvas
monitor
echocardiogram
normal
ga
lactat
rang
follow
day
deterior
kussmaul
respir
tachypnoea
increas
tachycardia
hypotens
venou
blood
reveal
ph
lactat
becam
unrespons
refractori
hypotens
multiorgan
failur
arteri
blood
show
ph
lactat
indetermin
hour
blood
lactat
level
rhabdomyolysi
acut
kidney
injuri
occur
ck
requir
haemofiltr
encephalopathi
multipl
white
matter
microhaemorrhag
mri
brain
acut
liver
failur
thrombocytopenia
coagulopathi
ensu
multipl
inotrop
requir
prognosi
guard
sedat
unrespons
apnoeic
areflex
howev
eeg
show
alpha
rhythm
prompt
ongo
heroic
effort
requir
prolong
haemofiltr
ventil
inotrop
day
intens
care
result
patient
made
astound
recoveri
requir
month
neurorehabilit
return
cognit
baselin
achiev
grade
gcse
month
later
liver
renal
dysfunct
resolv
conclus
case
demonstr
mitochondri
metabol
crise
mela
sever
result
profound
acidbas
derang
patient
expect
surviv
uniqu
without
signific
neurodis
neuron
ceroid
lipofuscinosi
children
central
africa
gl
fisher
n
shah
p
watt
ja
te
water
naud
noah
ark
children
hospit
univers
hospit
wale
cardiff
uk
object
effect
rapid
diagnosi
neuron
ceroid
lipofuscinos
ncl
becom
relev
advent
diseasemodifi
treatment
ncl
stereotyp
clinic
present
describ
two
case
nonconsanguin
famili
origin
democrat
republ
congo
variant
ncl
method
retrospect
case
seri
result
index
case
initi
diagnos
focal
epilepsi
review
child
myoclon
seizur
context
slow
development
declin
mild
spastic
ophthalmolog
diagnost
help
put
diagnosi
ncl
suggest
lymphocyt
inclus
neither
enzym
dna
analysi
avail
stage
although
dna
retain
brother
present
nystagmu
visual
inattent
examin
show
myoclon
jerk
bull
eye
maculopathi
abnorm
peripher
retin
vascular
leak
mri
imag
show
element
cerebellar
atrophi
review
also
case
brother
scan
lymphocyt
contain
fingerprint
bodi
suggest
variant
ncl
confirm
dna
sequenc
consist
diagnosi
ncl
ident
dna
alter
also
found
index
case
conclus
ncl
describ
children
central
africa
present
investig
laboratori
find
evolut
consist
children
variant
ncl
obes
screen
patient
affect
duchenn
muscular
dystrophi
dmd
tertiari
paediatr
neuromuscular
centr
effect
metformin
use
weight
control
confirm
insulin
resist
neocleou
spinti
r
madhu
p
dharmaraj
c
degoed
k
cook
c
greav
alder
hey
hospit
liverpool
uk
royal
preston
hospit
preston
uk
object
assess
whether
patient
affect
duchenn
muscular
dystrophi
dmd
current
follow
alder
hey
hospit
uk
receiv
obes
screen
clinic
appropri
assess
whether
metformin
use
insulinresist
effect
control
weight
method
use
neurolog
depart
record
list
patient
dmd
current
servic
transit
adult
servic
last
year
gener
patient
record
system
meditech
use
collect
patient
demograph
latest
weightheight
valu
bmi
patient
classifi
overweightobes
complet
obes
screen
assess
well
initi
appropri
treatment
metformin
patient
metformin
follow
paramet
collect
weight
pre
poststeroid
age
start
excess
weight
gain
confound
variabl
medic
weightheightbmi
initi
metformin
interv
sideeffect
cessat
medic
reason
result
sixteen
patient
found
weight
centil
patient
weight
centil
height
use
nondmd
standardis
bmi
classif
patient
identifi
overweight
obes
patient
receiv
obes
screen
found
insulin
resist
start
metformin
patient
overal
start
metformin
exhibit
overal
weight
loss
patient
found
gain
weight
patient
show
weight
increas
month
postmetformin
initi
subsequ
weight
loss
conclus
need
valid
agre
bmi
classif
dmd
screen
insulin
resist
patient
group
consid
implement
standard
practic
especi
patient
classifi
overweightobes
largerscal
studi
would
requir
assess
effect
metformin
patient
popul
object
niemannpick
diseas
npd
autosom
recess
metabol
disord
preval
worldwid
mark
vari
degre
lipid
storag
foam
cell
infiltr
tissu
associ
hepatosplenomegali
pulmonari
insuffici
central
nervou
system
involv
npd
type
b
allel
disord
caus
mutat
sphingomyelin
gene
character
primari
defici
acid
sphingomyelinas
activ
result
accumul
sphingomyelin
contrast
npda
npdb
milder
lateronset
form
neurolog
involv
paper
report
three
paediatr
case
npdb
present
atyp
phenotyp
mark
neurolog
involv
method
three
patient
diagnos
age
hepatosplenomegali
first
girl
present
psychomotor
regress
age
epilept
seizur
age
die
age
second
year
old
girl
present
growth
retard
kyphosi
neurodevelop
regress
sinc
age
third
year
old
boy
mild
phenotyp
mark
development
delay
aggress
behaviour
splenectomi
perform
age
result
genet
test
perform
patient
present
mutat
gene
confirm
diagnosi
niemannpick
type
b
g
mutat
common
case
addit
heterozyg
mutat
del
found
first
second
case
respect
conclus
case
present
complex
phenotyp
mark
psychomotor
regress
atyp
npd
type
b
sever
diseas
seem
correl
genet
mutationth
sever
phenotyp
associ
work
necessari
clearli
delin
genotypephenotyp
relationship
npd
object
acut
enceph
syndrom
ae
group
symptom
sign
help
diagnos
enceph
sinc
definit
treatment
role
fluid
seem
crucial
therefor
object
studi
describ
associ
low
admiss
weight
weight
loss
hospit
clinic
marker
dehydr
outcom
patient
acut
enceph
syndrom
describ
associ
chang
weight
blood
lactat
level
admiss
discharg
indic
hydrat
acid
base
statu
outcom
children
acut
enceph
syndrom
method
children
age
month
year
fever
alter
sensorium
andor
new
onset
seizur
septemb
septemb
attend
kanti
children
hospit
kathmandu
nepal
recruit
weightforag
wfa
use
z
score
serum
lactat
assess
admiss
discharg
total
fluid
input
output
monitor
daili
result
patient
low
admiss
wfa
lost
weightafteradmiss
lwaa
group
low
wfa
nt
lwaa
group
b
time
risk
death
time
risk
bad
outcom
death
sequela
group
compar
b
bad
outcom
significantli
associ
less
admiss
wfa
fluid
deficit
trend
higher
admiss
serum
lactat
death
significantli
low
wfa
lwaa
longer
ill
dextros
normal
salin
higher
sodium
higher
urea
admiss
method
conduct
prospect
crosssect
studi
recruit
children
age
month
year
attend
kanti
children
hospit
kathmandu
nepal
alter
sensorium
two
follow
fever
seizur
focal
neurolog
deficit
csf
pleocytosi
electroencephalogram
comput
tomographi
suggest
enceph
year
patient
csf
cell
count
mm
lymphocyt
predomin
absenc
nonvir
pathogen
csf
blood
bm
csf
cell
count
polymorph
predomin
csf
protein
csfplasma
glucos
andor
posit
gram
stain
andor
bacteri
cultur
je
anti
jeigm
csf
andor
serum
cn
infect
defin
suspect
case
treat
clinician
without
fever
lp
show
csf
cell
result
bm
found
je
caus
although
definit
ae
significantli
associ
cn
infect
significantli
associ
p
sensit
specif
ppv
npv
bm
p
sensit
specif
ppv
npv
conclus
valid
ae
definit
bm
significantli
use
screen
tool
children
diseas
special
resourc
poor
set
endem
area
confirmatori
test
easili
avail
object
aim
case
seri
rais
awar
autosom
recess
encephalopath
syndrom
present
birth
multiethn
popul
england
although
aicardi
goutier
syndrom
ag
rare
import
lie
fact
present
may
mistaken
neurolog
condit
associ
congenit
infect
result
patient
seen
paediatr
outpati
neurolog
clinic
age
present
rang
neonat
period
first
week
life
patient
pakistani
origin
consanguin
marriag
unev
antenat
period
normal
birth
weight
head
circumfer
initi
present
seem
poor
feed
irrit
observ
includ
truncal
hypotonia
limb
spastic
intermitt
dyston
postur
coincid
onset
poor
head
growth
chilblain
patient
abnorm
movement
diffus
slow
wave
electroencephalogram
activ
nystagmu
visual
inattent
poor
visual
acuiti
typic
find
age
month
ct
scan
show
cerebr
calcif
mri
suggest
brain
atrophi
strike
abnorm
rais
level
csf
interferonalpha
infa
absenc
infect
metabol
disord
csf
inf
reliabl
diagnost
marker
thu
use
differenti
patient
ag
condit
three
patient
gene
mutat
conclus
ag
rare
disord
howev
patient
consanguin
marriag
depict
microcephali
poor
tone
global
development
delay
diagnosi
ag
consid
ag
progress
neurolog
condit
earli
support
prognosi
provid
affect
famili
thoma
ht
yeo
sv
barron
paediatr
neurolog
kk
hospit
kampong
java
singapor
univers
newcastl
newcastl
uk
object
report
associ
mild
encephalopathi
revers
splenial
lesion
mer
primari
dengu
viru
infect
case
impli
exist
wider
spectrum
neurolog
involv
dengu
viru
infect
case
descript
girl
present
acut
confus
dysarthria
bilater
limb
weak
follow
histori
fever
symptom
resolv
hour
neurolog
examin
complet
normal
later
experienc
second
episod
slur
speech
dysphasia
right
arm
weak
last
hour
contigu
lesion
involv
genu
bodi
splenium
corpu
callosum
bilater
posterior
periventricular
white
matter
evid
mri
brain
scan
restrict
diffus
cerebrospin
fluid
analysi
show
inflamm
polymeras
chain
reaction
assay
respiratori
virus
neg
clinic
radiolog
featur
consist
mild
encephalopathi
revers
splenial
lesion
mer
day
admiss
develop
generalis
maculopapular
rash
leukopenia
white
blood
cell
count
thrombocytopenia
platelet
serolog
igmigg
dengu
viru
neg
posit
dengu
antigen
thu
indic
primari
dengu
viru
infect
given
fluid
rehydr
advis
bedrest
discharg
day
admiss
well
sequela
conclus
mer
mild
form
viru
associ
encephalopathi
vae
spectrum
clinicoradiolog
syndrom
associ
common
childhood
viral
infect
clinic
neurolog
symptom
patient
occur
earli
cours
ill
typic
vae
oppos
late
ill
typic
postinfecti
encephalopathi
syndrom
associ
dengu
viru
infect
eg
acut
dissemin
encephalomyel
shoulder
burden
sepsi
norfolk
norwich
univers
hospit
nh
trust
norwich
uk
sheffield
children
hospit
sheffield
uk
aim
report
case
boy
present
right
brachial
plexu
neuriti
secondari
meningococc
group
b
sepsi
brachial
plexu
neuriti
neuralg
amyotrophi
also
known
parsonag
turner
syndrom
rare
disord
affect
brachial
plexu
caus
variou
infecti
agent
character
acut
onset
intens
pain
shoulder
arm
follow
weak
sensori
loss
atrophi
method
boy
previous
fit
well
present
emerg
depart
acut
onset
excruci
pain
right
shoulder
radiat
arm
hand
associ
paresthesia
hour
later
develop
evolv
nonblanch
purpur
rash
chest
back
shoulder
right
arm
gradual
develop
weak
right
arm
sensori
loss
ulnar
aspect
right
hand
began
complain
headach
photophobia
subsequ
vomit
treat
meningococc
sepsi
intraven
ceftriaxon
receiv
three
fluid
bolus
hypotens
shock
vitamin
k
correct
associ
coagulopathi
receiv
analgesia
right
shoulder
pain
result
blood
cultur
blood
pcr
confirm
neisseria
meningitidi
group
b
type
nt
subtyp
mri
shoulder
show
inflamm
consist
brachial
plexu
neuriti
motor
impair
affect
right
side
myotom
sensori
impair
involv
right
dermatom
patient
treat
oral
prednison
gabapentin
whilst
receiv
neurorehabilit
physiotherapi
occup
therapi
made
pleas
recoveri
month
current
motor
sensori
deficit
right
shoulder
arm
conclus
brachial
plexu
neuriti
consid
differenti
child
present
sudden
onset
pain
weak
shoulder
arm
review
literatur
brachial
plexu
neuriti
associ
meningococc
infect
describ
previous
best
knowledg
first
report
case
kind
introduct
previou
cohort
studi
paediatr
multipl
sclerosi
ms
report
low
frequenc
primari
progress
ms
cours
ppm
rang
agedepend
increas
rate
primaryprogress
cours
well
describ
adult
ms
popul
object
method
describ
five
patient
present
prior
age
year
fulfil
mcdonald
criteria
ppm
patient
identifi
nation
hospit
neurolog
neurosurgeri
nhnn
uk
childhood
inflammatori
demyelin
ukcid
network
result
patient
present
median
age
year
rang
least
histori
progress
deterior
balanc
progress
worsen
lower
limb
function
time
patient
develop
lower
limb
spastic
three
patient
develop
cognit
difficulti
three
visual
problem
three
bladder
involv
median
edss
year
rang
cerebrospin
fluid
csf
oligoclon
band
detect
patient
test
dissemin
space
first
mri
seen
patient
periventricular
cortic
juxtacoritc
infratentori
spinal
cord
lesion
patient
show
new
lesion
repeat
mri
imag
contrast
enhanc
present
diseas
cours
three
patient
genet
investig
exclud
mimic
trial
iv
methylprednisolon
unsuccess
patient
patient
symptomat
treatment
spastic
pain
includ
oralintrathec
baclofen
gabapentin
sativex
conclus
given
rariti
primari
progress
cours
paediatr
ms
present
progress
neurolog
symptom
sign
young
peopl
prompt
evalu
genet
caus
nevertheless
five
patient
present
clinic
mri
immunolog
featur
consist
diagnosi
primari
progress
multipl
sclerosi
object
clinic
cours
nmdarantibodi
enceph
variabl
difficult
predict
aim
identifi
clinic
featur
present
diseas
episod
associ
wors
function
outcom
andor
relaps
diseas
cours
method
systemat
review
literatur
conduct
identifi
publish
case
individu
report
data
clinic
treatment
characterist
first
episod
outcom
month
monophas
vs
relaps
diseas
cours
record
result
case
identifi
articl
femal
year
old
onset
receiv
immunotherapi
first
episod
corticosteroid
ivig
therapeut
apheresi
secondlin
immunotherapi
use
first
episod
frequent
rituximab
cyclophosphamid
emerg
secondlin
treatment
intravenousintrathec
methotrex
subcutaneousintraven
bortezomib
intraven
tocilizumab
use
lifethreaten
advers
event
death
relat
immunotherapi
occur
univari
analysi
case
month
followup
data
poor
final
outcom
defin
modifi
rankin
scale
mr
score
occur
associ
young
elderli
age
onset
movement
disord
decreas
conscious
autonom
dysfunct
mechan
ventil
higher
mr
score
acut
phase
longer
hospit
stay
extrem
delta
brush
eeg
abnorm
mri
csf
pleocytosi
elev
csf
protein
p
subset
case
follow
month
analys
identifi
associ
relaps
cours
occur
univari
analysi
factor
protect
relaps
day
delay
firstlin
immun
therapi
therapeut
apheresi
ivig
rituximab
secondlin
treatment
first
episod
p
conclus
wors
function
outcom
nmdarantibodi
enceph
associ
young
elderli
age
onset
wors
diseas
sever
acut
phase
relaps
diseas
cours
associ
delay
insuffici
earli
immunotherapi
object
describ
three
children
famili
hemophagocyt
lymphohistiocytosi
fhlh
present
atyp
chronic
demyelin
ill
initi
work
diagnosi
clipper
chronic
lymphocyt
inflamm
pontin
perivascular
enhanc
respons
steroid
made
two
case
method
retrospect
case
seri
result
case
girl
present
diplopia
squint
evolv
ataxia
mri
show
multipl
enhanc
white
matter
lesion
pon
medulla
cerebellum
rais
possibl
clipper
symptom
neuroimag
respond
partial
treatment
ivig
steroid
genet
test
reveal
compound
heterozygot
mutat
gene
consist
griscelli
syndrom
type
fhlh
case
boy
nocturn
headach
squint
evolv
time
mri
show
demyelin
swell
predominantli
cerebellum
signific
radiolog
resolut
steroid
follow
recurr
demyelin
wean
steroid
brain
biopsi
lesion
consist
clipper
genet
test
reveal
heterozygot
variant
consist
fhlh
v
case
girl
intermitt
fever
derang
lft
recurr
bilater
optic
neuriti
respons
steroidsivig
mri
brain
show
multipl
area
demyelin
larg
subcort
white
matter
oligoclon
band
posit
csf
develop
pleural
effus
high
ferritin
derang
coagul
lymphadenopathi
rash
found
cutan
tcell
lymphoma
genet
test
reveal
homozyg
mutat
gene
consist
fhlh
three
children
await
stem
cell
transplant
conclus
fhlh
present
isol
atyp
demyelin
ill
neuroimag
suggest
clipper
may
sign
system
inflamm
propos
children
atyp
recurr
cn
inflamm
present
consist
clipper
undergo
genet
panel
test
fhlh
natur
killer
cell
function
test
object
common
paediatr
present
mogab
diseas
acut
dissemin
encephalomyel
adem
optic
neuriti
increas
recognit
associ
mogab
seizur
children
present
case
seri
affect
children
method
retrospect
anonymis
case
note
review
affect
children
present
uk
paediatr
neurolog
centr
patient
follow
median
year
rang
result
case
femal
mogabposit
epilepsi
patient
identifi
median
age
first
present
rang
common
preced
mogab
diseas
multiphas
adem
mdem
adem
ademon
adem
transvers
myeliti
nmosd
median
time
recurr
seizur
onset
month
rang
focal
epilepsyseizur
common
eeg
abnorm
found
patient
demonstr
slowingencephalopathi
generalis
focal
epileptiform
discharg
report
patient
brain
mri
abnorm
patient
multifoc
hazi
poorli
margin
lesion
involv
grey
white
matter
leukodystrophylik
pattern
cortic
enceph
report
subtl
chang
brainstem
patient
receiv
immunotherapi
requir
least
antiepilept
drug
a
children
continu
ongo
breakthrough
seizur
median
mr
modifi
rankin
scale
last
followup
rang
indic
signific
disabl
despit
symptom
clinic
examin
age
appropri
behaviour
develop
conclus
focal
epilepsi
common
like
follow
mdem
present
children
mogab
relaps
natur
mogab
diseas
high
risk
longterm
cognit
impair
preclin
studi
urgent
requir
determin
whether
epilepsi
due
ongo
inflamm
result
mri
chang
commonli
seen
help
inform
futur
manag
decis
regard
immunotherapi
poster
matern
midgest
cytokin
dysregul
mother
children
autism
spectrum
disord
autism
spectrum
disord
asd
development
disord
characteris
spectrum
deficit
social
interact
commun
combin
stereotyp
repetit
behaviour
recent
evid
suggest
matern
immun
activ
mia
pregnanc
may
predispos
offspr
asd
aim
studi
examin
midgest
cytokin
profil
mother
children
subsequ
asd
diagnosi
maternalchild
dyad
recruit
prospect
populationbas
pregnanc
studi
scope
studi
new
zealand
children
confirm
diagnosi
asd
year
enrol
nest
cohort
along
match
neurotyp
control
cytokin
concentr
pg
ml
mean
sem
examin
matern
serum
sampl
taken
week
gestat
use
mesoscal
discoveri
proinflammatori
cytokin
chemokin
assay
mother
recruit
scopenz
studi
children
complet
followup
report
asd
year
analys
alongsid
neurotyp
match
control
downregul
occur
week
gestat
case
compar
control
mean
sem
anova
reveal
relationship
concentr
week
gestat
f
also
concentr
asd
statu
posthoc
uncorrect
fisher
lsd
reveal
signific
differ
case
control
week
gestat
ifnc
also
downregul
week
gestat
case
compar
control
anova
reveal
relationship
ifni
concentr
week
gestat
f
posthoc
uncorrect
fisher
lsd
reveal
signific
differ
case
control
week
gestat
shown
alter
cytokin
express
week
gestat
mother
children
progress
develop
asd
add
grow
bodi
evid
matern
immun
regul
may
play
role
foetal
neurodevelop
object
acut
dissemin
encephalomyel
adem
immun
mediat
inflammatori
cn
disord
predominantli
affect
white
matter
wide
differenti
describ
rare
mimic
adem
essenti
consid
order
avoid
catastroph
outcom
case
histori
old
girl
present
day
histori
confus
dysarthria
ataxia
leftsid
squint
preced
week
gener
malais
headach
examin
confirm
encephalopathi
left
third
cranial
nerv
palsi
mri
brain
suggest
adem
mri
spine
normal
recommend
work
adem
perform
rapid
resolut
symptom
occur
follow
intraven
methylprednisolon
day
year
later
present
acut
left
lower
limb
ischaemia
underw
emerg
embolectomi
poplit
arteri
obstruct
myxomat
materi
identifi
preoper
echocardiogram
confirm
larg
atrial
mass
surgic
remov
patholog
confirm
atrial
myxoma
retrospect
review
initi
mri
imag
conclud
embol
phenomena
like
explan
first
present
conclus
rare
primari
cardiac
tumour
left
side
embolis
cerebrovascular
system
earli
identif
import
untreat
caus
multipl
embol
event
sudden
cardiac
death
adult
present
neurolog
symptom
mimic
multipl
sclerosi
present
acut
neurolog
symptom
masquerad
adem
paediatr
previous
report
care
follow
essenti
late
neurolog
complic
includ
cerebr
arteri
aneurysm
recognis
case
highlight
adem
diagnosi
exclus
mimic
acut
focal
neurolog
encephalopathi
hyperintens
mri
requir
care
consider
includ
embol
phenomena
clinic
examin
alon
exclud
consider
echocardiographi
recommend
describ
year
old
boy
rare
demyelin
disord
balo
concentr
sclerosi
routin
optician
review
rais
concern
papilloedema
asymptomat
child
ct
brain
identifi
welldemarc
highdens
lesion
left
posterior
frontal
lobe
surround
oedema
mri
brain
contrast
identifi
lesion
central
rim
enhanc
slight
diffus
restrict
altern
layer
high
low
signal
intens
gave
onion
bulb
appear
differenti
includ
balo
concentr
sclerosi
singl
demyelin
lesion
tumour
routin
blood
test
unremark
csf
oligoclon
band
normal
csf
indic
marker
immunolog
includ
ana
anca
antimog
anticardiolipin
aquaporin
antibodi
neg
normal
complement
level
esr
mildli
elev
taken
episod
acut
tonsil
imag
month
later
demonstr
increas
size
lesion
biopsi
reveal
inflammatori
demyelin
patholog
mediat
perivascular
parenchym
tand
blymphocyt
infiltr
macrophag
activ
associ
demyelin
lack
perivenular
distribut
evid
neoplasia
vascul
granuloma
viral
infect
includ
neg
pcr
test
treatment
corticosteroid
given
child
remain
asymptomat
imag
month
present
reveal
lesion
substanti
reduc
size
still
rim
enhanc
singl
demyelin
lesion
difficult
predict
clinic
cours
opt
adopt
wait
see
polici
offer
surveil
imag
clinic
review
balo
concentr
sclerosi
rare
demyelin
diseas
character
concentr
lamella
altern
demyelin
partial
myelin
tissu
mri
show
one
concentr
mulitlay
ringlik
lesion
usual
cerebr
white
matter
case
report
describ
case
predominantli
young
adult
report
case
children
object
cognit
acquir
neurodevelopment
deficit
report
children
opsoclonusmyoclonu
syndrom
om
associ
sever
relaps
diseas
cours
howev
pauciti
data
regard
cognit
dysfunct
children
stabl
neurolog
diseas
report
serial
cognit
assess
children
om
demonstr
evolv
cognit
dysfunct
milder
diseas
cours
method
retrospect
analysi
clinic
featur
present
investig
treatment
clinic
cours
includ
relaps
neuropsycholog
test
result
four
children
f
diagnos
om
month
follow
year
neuroblastoma
identifi
one
child
om
sever
score
rang
present
patient
underw
immunotherapi
accord
european
om
protocol
patient
remiss
month
rang
treatment
maintain
year
one
child
remain
relaps
free
whilst
children
one
clinic
relaps
immunotherapi
respons
case
progress
cognit
dysfunct
report
despit
remiss
stabl
treatment
month
rang
om
score
one
sequenti
neuropsycholog
test
score
show
mean
declin
fsiq
viq
piq
time
om
remissionst
diseas
longer
term
followup
time
point
conclus
case
demonstr
progress
cognit
dysfunct
occur
children
om
milder
diseas
long
complet
treatment
children
continu
develop
widen
gap
comparison
peer
damag
cerebellarcort
circuit
onset
diseas
becom
appar
time
inde
persist
ongo
low
grade
inflamm
may
explain
deterior
past
decad
seen
increas
case
acut
flaccid
paralysi
afp
associ
enteroviru
infect
present
cluster
approxim
everi
year
report
three
case
afp
due
present
novemberdecemb
case
two
patient
develop
afp
follow
viral
upper
respiratori
tract
infect
one
develop
lower
limb
hypotonia
weak
inpati
admiss
refractori
epilepsi
two
requir
admiss
paediatr
intens
care
unit
respiratori
compromis
requir
tracheostomi
ventil
mri
show
acut
flaccid
myeliti
afm
consist
case
consist
central
cord
hyperintens
cervic
region
multipl
segment
subsequ
enhanc
thalamu
cauda
equina
followup
imag
one
patient
ventral
surfac
enhanc
conu
cauda
equina
anoth
mri
third
patient
normal
electromyographi
nerv
conduct
studi
normal
two
patient
reveal
sever
generalis
motor
axon
polyneuronopathi
third
two
patient
receiv
intraven
immunoglobulin
corticosteroid
plasma
exchang
therapi
show
slow
motor
improv
distal
proxim
pattern
one
patient
without
mri
chang
receiv
longterm
oral
corticosteroid
receiv
addit
treatment
return
baselin
neurolog
function
within
week
discuss
case
demonstr
rang
clinic
cours
peripher
neurolog
present
secondari
infect
highlight
import
send
repeat
sampl
multipl
site
diagnosi
suspect
given
initi
sampl
test
neg
send
sampl
nation
surveil
laboratori
confirmatori
test
ongo
nation
multin
surveil
studi
hope
continu
advanc
understand
treatment
diseas
poster
nmda
receptor
enceph
potenti
complic
biolog
therapi
juvenil
idiopath
arthriti
n
abbassi
rossor
r
close
skippen
k
armon
p
bale
g
ambegaonkar
paediatr
neurolog
addenbrook
hospit
cambridg
uk
paediatr
rheumatolog
addenbrook
hospit
cambridg
uk
girl
present
headach
confus
agit
follow
seizur
present
month
polyarticular
arthriti
manag
subsequ
year
methotrex
alon
ad
etanercept
antitnf
alpha
tocilizumab
anti
abatacept
cd
tcell
modifi
prior
present
flare
diseas
follow
period
control
necessit
chang
monoclon
antibodi
therapi
present
manag
methotrex
abatacept
prednisolon
polyarticular
rheumatoid
factor
neg
juvenil
idiopath
arthriti
jia
present
patient
agit
nonverb
one
generalis
seizur
examin
demonstr
acut
confus
increas
tone
brisk
reflex
bilater
clonu
lower
limb
iv
ceftriaxon
acyclovir
clarithromycin
commenc
full
blood
count
liver
function
test
inflammatori
marker
unremark
infect
serolog
noncontributori
csf
unreact
normal
protein
jc
viru
pcr
neg
mri
brain
day
present
show
increas
flair
signal
intens
white
matter
right
pariet
lobe
inkeep
inflammatori
process
eeg
show
diffus
slow
delta
brush
commenc
iv
methylprednisolon
follow
prednisolon
continu
deterior
underw
plasmapheresi
treatment
presum
nmda
receptor
enceph
subsequ
confirm
antinmda
receptor
antibodi
serum
csf
commenc
rituximab
bcell
deplet
anticd
continu
undergo
plasmapheresi
cours
week
gradual
improv
discharg
home
inpati
stay
sever
adult
two
paediatr
case
nmda
receptor
enceph
report
patient
biolog
therapi
autoimmun
diseas
autoimmun
diseas
common
alreadi
affect
one
autoimmun
condit
unclear
contribut
autoimmun
histori
immunomodul
made
develop
condit
introduct
incid
acut
flaccid
myeliti
afm
associ
enteroviru
infect
occur
biennial
cluster
sinc
report
us
bmj
recent
europ
previous
case
transvers
myeliti
tm
anteriorhorn
cell
peripher
nerv
involv
collect
term
tmplu
neurolog
aim
identifi
case
tmplu
retrospect
cohort
children
identifi
potenti
case
undiagnos
afm
evalu
clinic
radiolog
featur
alongsid
longterm
outcom
method
consecut
case
children
age
present
larg
paediatr
neurosci
centr
fulfil
transvers
myeliti
consortium
work
group
criteria
modifi
paediatr
popul
neurolog
retrospect
evalu
addit
featur
anterior
horncel
involv
fulfil
criteria
afm
current
treat
option
neurol
peripher
nervou
involv
collect
evalu
contemporari
tmplu
cohort
result
case
tm
identifi
exclud
analysi
ms
adem
case
tmplu
identifi
associ
viral
prodrom
flaccid
asymmetri
note
present
correspond
nerv
conduct
studi
reveal
motor
axonopathi
sensori
spare
anterior
horn
cell
involv
confirm
case
case
anterior
horn
cell
involv
poor
outcom
case
good
outcom
peripher
involv
normal
mri
brain
conclus
tmplu
detect
cohort
biennial
cluster
note
clinic
present
investig
longterm
outcom
appear
consist
group
acut
necrotis
encephalopathi
sever
associ
influenza
background
object
acut
necrotis
encephalopathi
ane
rare
potenti
lifethreaten
condit
associ
viral
infect
famili
recurr
form
identifi
mutat
nuclear
pore
ran
bind
protein
report
morbid
mortal
associ
influenza
infect
method
perform
review
paediatr
ane
case
evalu
clinic
biochem
microbiolog
neuroimag
appear
well
outcom
result
cohort
compris
children
boy
age
rang
month
year
month
confirm
genet
diagnosi
neg
episod
encephalopathi
recurr
case
episod
infecti
aetiolog
identifi
coronaviru
parainfluenza
adenoviru
h
influenza
influenza
clinic
featur
fever
encephalopathi
consist
seizur
sixth
nerv
palsi
promin
csf
reveal
absent
pleocytosi
normalelev
protein
neg
virolog
symmetr
involv
thalami
bilater
present
case
case
associ
haemorrhag
extern
capsuleclaustrum
involv
specif
sensit
outcom
follow
influenza
infect
strike
death
veget
limb
motor
movement
disord
case
previou
episod
encephalopathi
noninfluenza
infect
recoveri
albeit
moder
sever
disabl
case
never
immunis
influenza
infect
suffer
grave
outcom
conclus
influenza
infect
ane
poorest
outcom
therefor
vaccin
mandatori
consider
known
case
ane
introduct
acut
flaccid
paralysi
afp
character
rapid
onset
limb
weak
describ
six
case
afp
children
age
month
year
age
present
tertiari
paediatr
neurolog
servic
east
england
period
novemb
retrospect
analysi
six
case
perform
review
clinic
cours
manag
well
radiolog
electrophysiolog
laboratori
result
result
case
boy
present
novemb
viral
urti
requir
escal
care
picu
due
signific
respiratori
compromis
subsequ
recoveri
child
found
unilater
upper
limb
flaccid
paralysi
child
posit
enteroviru
serotyp
case
seri
present
acut
weak
lower
limb
mri
brain
spine
show
enhanc
lumbar
spinal
root
made
good
recoveri
enteroviru
detect
either
case
final
three
children
seri
present
autumn
weak
unilater
upper
limb
follow
viral
urti
three
posit
enteroviru
unfortun
shown
minim
recoveri
motor
function
affect
upper
limb
one
child
girl
show
sever
clinic
cours
involv
prolong
period
intens
care
tracheostomi
longterm
ventil
undergon
neurorehabilit
upper
right
arm
nerv
transfer
conclus
case
seri
four
patient
present
acut
viral
urti
associ
upper
extrem
weak
subsequ
four
posit
enteroviru
cluster
acut
limb
weak
paediatr
patient
link
outbreak
nonpolio
enterovirus
term
acut
flaccid
myeliti
afm
object
present
interest
case
recurr
antimog
demyelin
diseas
provok
discuss
regard
possibl
immunomodulatori
therapi
method
year
old
girl
present
initi
year
age
headach
vomit
initi
treat
atyp
tuberculosi
mening
base
csf
cell
count
later
develop
nerv
palsi
diagnos
optic
neuriti
antimog
antibodi
posit
commenc
iv
methylprednisolon
clinic
improv
discharg
wean
oral
prednisolon
antibodi
neg
follow
treatment
result
month
later
first
relaps
acut
declin
visual
acuiti
mri
show
new
lesion
optic
chiasm
optic
nerv
associ
bilater
reduc
visual
evok
potenti
treat
iv
methylprednisolon
rapid
improv
follow
switch
wean
oral
prednisolon
antimog
antibodi
neg
follow
treatment
symptom
free
year
second
relaps
present
facial
palsi
swallow
difficulti
slur
speech
mri
show
brainstem
periventricular
white
matter
demyelin
posit
antimog
antibodi
treat
iv
methylprednisolon
follow
oral
prednisolon
maintain
low
dose
prednisolon
antimog
antibodi
remain
weakli
posit
despit
symptom
free
stop
patient
request
due
low
mood
abdomin
pain
februari
recurr
symptom
yet
repeat
mog
antibodi
sent
await
conclus
case
show
interest
relapsingremit
pattern
antimog
demyelin
diseas
appear
steroid
respons
howev
second
relaps
antimog
antibodi
remain
weakli
posit
despit
steroid
therapi
discuss
welcom
whether
prophylact
immun
modul
therapi
consid
child
azathioprin
mycophenol
mofetil
rituximab
object
highlight
util
earli
mr
imag
children
present
acut
sever
encephalopathi
consid
whether
might
subgroup
children
myelin
oligodendrocyt
glycoprotein
antibodi
mogab
associ
demyelin
might
candid
earli
intens
immunomodul
method
report
two
case
mogabassoci
acut
demyelin
relaps
new
neurolog
symptom
initi
steroid
therapi
discontinu
result
two
toddler
initi
admit
intens
care
acut
encephalopathi
acut
symptomat
seizur
initi
ct
head
picu
admiss
one
report
normal
suggest
diffus
cerebr
oedema
children
improv
support
care
discharg
home
within
week
children
present
follow
week
new
neurolog
symptom
without
encephalopathi
mr
imag
demonstr
demyelin
treat
steroid
children
relaps
steroid
wean
andor
stop
repeat
mr
imag
stage
demonstr
new
enhanc
lesion
subsequ
found
children
mogab
posit
conclus
relianc
cranial
ct
imag
context
young
child
acut
encephalopathi
seizur
mislead
predict
sever
mogabassoci
demyelin
syndrom
onset
challeng
mr
imag
acut
phase
earli
follow
imag
may
identifi
subgroup
case
hb
year
old
boy
present
sudden
onset
diplopia
pain
ophthalmoplegia
follow
day
histori
frontal
headach
examin
left
vith
nerv
palsi
partial
left
iiird
nerv
palsi
normal
right
eye
movement
remaind
neurolog
gener
system
examin
normal
initi
ct
head
scan
precontrast
mri
brain
normal
discharg
local
hospit
follow
normal
blood
test
imag
clinic
cours
nine
day
later
symptom
worsen
includ
sever
vomit
worsen
frontal
headach
photophobia
treat
possibl
underli
infect
caus
ceftriaxon
acyclovir
given
broad
underli
differenti
diagnos
hb
extens
infecti
immunolog
blood
workup
unremark
repeat
mri
brain
scan
contrast
reveal
lesion
left
cavern
sinu
possibl
vascular
origin
differenti
includ
cerebrovascular
venou
sinu
thrombosi
tumour
inflammatori
caus
tb
sarcoid
zoonos
hb
continu
conserv
manag
complet
cours
ceftriaxon
acyclovir
repeat
mri
imag
month
later
show
resolut
lesion
diagnosi
tolosahunt
syndrom
provision
made
hb
symptom
continu
improv
repeat
mri
scan
month
later
show
ongo
resolut
lesion
discuss
accord
beta
classif
tolosahunt
syndrom
hb
fulfil
diagnost
criteria
given
present
unilater
headach
granulomat
inflamm
cavern
sinu
mri
palsi
ipsilater
iiird
ivth
vith
cranial
nerv
steroid
use
report
benefici
although
evid
requir
paediatr
popul
refractori
case
may
respond
azathioprin
methotrex
object
present
case
internuclear
ophthalmoplegia
unrespons
steroid
treatment
clinic
improv
folin
acid
supplement
method
retrospect
chart
review
result
patient
present
acut
internuclear
ophthalmoplegia
ataxia
bilater
ptosi
background
hypoplasia
corpu
callosum
optic
atrophi
visual
impair
learn
difficulti
asd
mri
brain
demonstr
symmetr
high
signal
intens
region
medial
longitudin
fasciculu
periaqueduct
grey
matter
investig
exclud
inflammatori
caus
treat
high
dose
steroid
follow
mri
show
improv
post
steroid
clinic
improv
subsequ
csf
investig
show
low
level
normal
rang
commenc
folin
acid
daili
symptom
improv
follow
eye
movement
significantli
improv
ptosi
follow
mri
brain
show
partial
resolut
area
abnorm
signal
periaqueduct
grey
matter
conclus
internuclear
ophthalmoplegia
sign
usual
associ
inflammatori
demyelin
caus
case
respond
steroid
treatment
associ
low
level
tetrahydrofol
respond
treatment
folin
acid
sometim
associ
underli
mitochondri
disord
muscl
biopsi
case
show
evid
mitochondri
diseas
mri
brain
shown
partial
resolut
abnorm
signal
periaqueduct
grey
matter
introduct
paediatr
intracrani
aneurysm
rare
pattern
diseas
differ
adult
far
less
literatur
avail
provid
case
exampl
present
progress
child
dissect
vertebrobasilar
arteri
aneurysm
present
boy
present
local
hospit
suddenonset
headach
photophobia
vomit
blood
observ
normaldischarg
symptom
recur
sever
follow
day
manag
mening
lumbar
punctur
bloodi
consid
fail
mri
brain
day
postadmiss
demonstr
vertebrobasilar
aneurysm
transfer
region
neurosurg
centr
transfer
neurosurgicalneurovascular
centr
cerebr
angiographi
reveal
dissect
vertebrobasilar
aneurysm
fusiform
compon
extend
beyond
aici
pica
origin
wideneck
saccular
compon
procedur
progress
load
aspirin
clopidogrel
underw
endovascular
procedur
follow
daycoil
embol
flowdivert
stent
aneurysm
ongo
low
dose
dual
antiplatelet
therapi
made
excel
recoveri
neurolog
deficit
imag
xray
cervic
spine
possibl
arcuat
foramen
atlantoaxi
instabl
normal
ultrasound
liverspleen
normal
discharg
home
day
posttransf
patient
background
past
medic
historyund
gp
month
headach
traumasignific
fall
bicycl
year
forc
later
flexion
neck
posit
may
contribut
factor
aneurysm
develop
signific
famili
histori
lifestylean
activ
boy
enjoy
weightlift
motocross
weightlift
also
posit
contribut
factor
conclus
provid
case
hope
rais
awar
paediatr
intracrani
aneurysm
stimul
discuss
concern
manag
aetiolog
poster
cavernoma
children
cddft
experi
two
case
jayachandran
chandraiah
darlington
memori
hospit
cddft
darlington
uk
aim
report
two
case
congenit
cavernoma
diagnos
children
present
neurolog
symptom
case
case
femal
present
multipl
left
facial
focal
seizur
form
twitch
full
awar
famili
histori
epilepsi
typic
event
captur
last
second
awak
eeg
report
focal
seizur
aris
right
hemispher
mri
brain
scan
show
popcorn
ball
lesion
within
frontalfronto
pariet
lobe
one
side
right
left
evid
bleed
remain
seizur
free
carbamazepin
ccm
gene
result
await
neurosurgeon
opinion
intervent
local
follow
case
male
present
confus
year
age
also
transient
loss
vision
vomit
headach
minut
unrespons
episod
admiss
diagnosi
migrain
mri
brain
scan
op
show
multipl
cavern
haemangioma
cerebrum
cerebellum
largest
demonstr
fluid
level
left
parietooccipit
region
famili
histori
reveal
father
seizur
secondari
brain
cavernoma
posit
mutat
neurosurgeon
advis
activ
monitor
present
year
focal
onset
seizur
impair
awar
eeg
normal
mri
show
new
cavernoma
left
tempor
horn
bleed
remain
well
carbamazepin
plan
yearli
mri
scan
conclus
congenit
cavernoma
brain
sporad
famili
multipl
locat
includ
brain
stem
result
physic
disabl
secondari
bleed
major
case
bleed
spontan
diagnos
mri
scan
neurolog
event
object
intellectu
disabl
syndrom
characteris
development
delay
variabl
physic
featur
autism
diagnosi
increas
better
access
broad
genet
test
present
case
report
child
mutat
whose
present
notabl
signific
cerebr
venou
ectasia
case
child
present
age
year
gross
motor
delay
sit
weightbear
along
rel
macrocephali
centil
strabismu
promin
superfici
forehead
vein
intracrani
imag
arrang
ct
angiogram
rais
possibl
arterioven
fistula
subsequ
cathet
angiographi
exclud
demonstr
extens
tortuou
cerebr
venou
ectasia
venou
ectasia
felt
explain
development
difficulti
initi
genet
test
includ
microarray
pten
analysi
normal
made
development
progress
remain
global
delay
compar
peer
reanalysi
dna
panel
gene
associ
intellectu
disabl
identifi
de
novo
heterozyg
pathogen
variant
gene
p
east
anglian
medic
genet
servic
discuss
act
transcript
factor
like
involv
develop
mani
differ
tissu
type
wide
rang
genet
aberr
affect
includ
point
mutat
larg
structur
anomali
lead
overlap
clinic
phenotyp
patient
demonstr
mani
relev
clinic
featur
includ
development
delay
autist
trait
rel
macrocephali
promin
forehead
strabismu
earli
gross
motor
development
delay
howev
descript
associ
neurovascular
anomali
syndrom
scarc
singl
case
report
record
venou
angioma
none
cerebr
venou
ectasia
knowledg
follow
studi
whole
exom
genom
sequenc
may
help
determin
whether
addit
genet
caus
child
cerebr
venou
ectasia
whether
relat
object
rcpch
guidelin
publish
increas
awar
stroke
children
standard
best
practic
need
urgent
within
ct
angiographi
children
present
suspect
stroke
criteria
thrombolysi
set
aim
review
acut
manag
investig
pai
children
sinc
introduct
guidelin
emphasi
identifi
candid
thrombolysi
method
retrospect
note
review
singl
region
neurolog
centr
timefram
result
eighteen
case
identifi
two
mortal
age
rang
year
mean
present
peripher
hospit
region
centr
case
pednihss
score
document
present
dedic
vascular
imag
cta
mra
initi
imag
present
hemiparesi
seizur
dysphasia
headach
ataxia
case
stroke
post
cardiac
surgeri
idiopath
stroke
post
varicella
angiiti
arteri
dissect
cardiomyopathi
embol
stroke
complic
central
line
insert
present
acut
hemiparesi
clear
time
onset
case
receiv
thrombolysi
imag
within
hour
present
vascular
imag
mra
cta
present
case
discuss
acut
paediatr
neurolog
case
suitabl
thrombolysi
due
cardiomyopathi
retrospect
case
suitabl
candid
thrombolysi
conclus
result
highlight
continu
need
enhanc
awar
paediatr
stroke
medic
emerg
acut
stroke
present
peripher
hospit
therefor
need
region
multidisciplinari
integr
pathway
amongst
emerg
depart
physician
paediatrician
radiologist
ensur
prompt
vascular
neuroimag
discuss
paediatr
neurologist
possibl
thrombolysi
suspect
pai
poster
nudg
fall
weak
common
miss
caus
paediatr
stroke
r
shyam
r
bahri
kumar
v
jain
depart
paediatr
neurolog
santokba
durlabhji
hospit
medic
research
institut
jaipur
india
norwich
medic
school
univers
east
anglia
norwich
uk
object
studi
retrospect
analys
paediatr
stroke
evalu
outcom
stroke
relat
minor
injuri
isol
characterist
featur
outcom
patient
method
paediatr
patient
age
present
acut
stroke
januari
januari
retrospect
recruit
tertiari
care
hospit
north
india
cohort
stroke
follow
minor
injuri
analys
clinic
profil
investig
outcom
measur
intern
paediatr
stroke
studi
score
system
ipss
result
total
case
postminor
injuri
f
mean
age
remain
mean
age
common
aetiolog
moyamoya
diseas
transient
unilater
arteriopathi
postminor
injuri
group
reveal
median
time
minut
trauma
stroke
onset
transient
episod
hemidystonia
hemiparet
side
median
day
symptom
onset
children
result
avail
anaemia
ct
head
show
calcif
lenticulostri
vessel
subsequ
brain
mri
confirm
ct
find
basal
ganglia
ischaemia
mr
angiogram
thrombophilia
screen
done
first
patient
normal
henc
pursu
subsequ
follow
up
show
good
recoveri
major
median
ipss
score
children
conclus
trivial
injuri
lead
basal
ganglia
stroke
common
caus
paediatr
stroke
occur
exclus
less
yearold
ct
head
diagnost
calcif
lenticulostri
blood
vessel
ischemia
inform
reveal
vascular
imag
thrombophilia
workup
children
commonli
anaem
potenti
caus
associ
often
transient
episod
hemidystonia
hemiparet
side
day
wit
neurolog
outcom
children
entiti
good
introduct
rcpch
launch
guidanc
paediatr
stroke
march
present
seri
paediatr
patient
present
stroke
follow
public
audit
group
patient
key
standard
rcpch
guidanc
method
retrospect
analys
case
april
april
identifi
case
neurolog
databas
audit
acut
manag
use
rcpch
guidanc
standard
result
identifi
children
stroke
last
year
age
rang
month
year
mean
age
year
present
children
haemorrhag
stroke
ischaem
stroke
major
involv
anterior
cerebr
circul
underli
aetiolog
identifi
patient
haemorrhag
stroke
patient
die
patient
brain
imag
within
hour
present
one
patient
elig
thrombolysi
howev
due
contraind
underw
thrombectomi
discuss
stroke
pathway
well
develop
adult
servic
due
rariti
stroke
childhood
challeng
recognis
symptom
treatment
often
delay
symptom
children
need
high
index
suspicion
find
audit
support
develop
wale
paediatr
stroke
pathway
aim
facilit
activ
stroke
pathway
children
present
fast
symptom
also
hope
increas
awar
stroke
childhood
withdrawn
object
stroke
common
childhood
neurolog
disord
affect
least
children
uk
year
major
children
residu
sequela
across
wide
domain
function
signific
person
societ
consequ
recent
rcpch
guidelin
propos
criteria
hyperacut
treatment
would
requir
rapid
recognit
potenti
diagnosi
clinician
describ
acut
care
pathway
group
children
confirm
arteri
ischaem
stroke
ai
method
parent
children
age
day
year
refer
gosh
ai
approach
sent
questionnair
explor
experi
navig
healthcar
system
initi
present
respons
tabul
possibl
report
frequenc
qualit
result
themat
code
categoris
analysi
result
elig
parent
respond
gp
first
port
call
major
ten
parent
state
idea
initi
symptom
might
repres
directli
ask
suspect
stroke
nearli
state
fast
featur
f
face
arm
speech
time
note
third
patient
patient
given
diagnosi
stroke
first
present
initi
discharg
correct
diagnosi
stroke
provid
patient
notabl
need
improv
educ
paediatr
stroke
healthcar
provid
rais
nearli
parent
survey
conclus
studi
demonstr
need
educ
deliv
prehospit
primari
secondari
healthcar
set
recognis
acut
stroke
children
essenti
step
deliveri
hyperacut
treatment
background
hereditari
spastic
paraparesi
refer
heterogen
group
inherit
neurodegen
disord
character
progress
lower
limb
spastic
weak
mark
genet
heterogen
hsp
mode
inherit
describ
differ
loci
caus
gene
implic
present
case
child
complex
diagnosi
hsp
homozyg
missens
mutat
underli
hereditari
spastic
paraplegia
case
present
child
initi
diagnos
bilater
cerebr
palsi
dipleg
pattern
gmfc
ii
gross
motor
speech
languag
delay
famili
histori
consanguin
mri
scan
initi
describ
show
evid
periventricular
leukomalacia
refer
consider
sdr
follow
tertiari
assess
clinic
concern
overal
diagnosi
may
need
reexplor
review
mri
scan
demonstr
similar
case
seri
hsp
rarer
form
hsp
subsequ
test
posit
second
case
similar
clinic
find
identifi
region
mri
scan
find
present
summari
rare
import
caus
cerebr
palsi
phenotyp
test
consid
differenti
diagnosi
investig
patient
present
cp
recommend
patient
suitabl
sdr
focus
children
function
gmfc
level
ii
iii
sdr
consid
gmfc
level
iv
v
howev
decis
progress
challeng
goal
children
significantli
differ
focu
around
comfort
pain
relief
rather
mobil
describ
case
boy
mix
pattern
movement
disord
involv
limb
initi
manag
oral
medic
baclofen
trihexiphenidyl
intramuscular
botulinum
toxin
due
child
vp
shunt
famili
nt
wish
consid
itb
pump
despit
optimis
oral
medic
intramuscular
botulinum
toxin
spastic
signific
issu
advers
impact
qualiti
life
escal
baclofen
unsuccess
due
loss
head
control
durat
action
botulinum
toxin
inject
appear
limit
week
tone
increas
result
signific
difficulti
move
handl
view
option
select
dorsal
rhizotomi
explor
goal
improv
eas
person
care
sleep
postop
outcom
greatli
exceed
famili
expect
along
reduct
tone
lower
limb
delight
report
sever
unexpect
improv
includ
improv
function
abil
left
upper
limb
facilit
switch
access
improv
truncal
control
make
move
handl
easier
reduct
extens
postur
particularli
problemat
preoper
signific
improv
sleep
improv
mood
result
local
team
explor
eye
gaze
technolog
function
benefit
significantli
improv
qualiti
life
patient
famili
research
benefit
sdr
group
patient
encompass
care
comfort
outcom
sleep
assess
measur
pain
introduct
clonidin
becom
increasingli
repurpos
manag
childhood
dystonia
one
potenti
advantag
clonidin
avail
patch
transderm
deliveri
aim
review
use
transderm
clonidin
patch
institut
method
retrospect
note
review
children
young
peopl
cayp
dystonia
issu
transderm
clonidin
patch
identifi
pharmaci
record
result
total
cayp
identifi
median
age
initi
clonidin
year
month
rang
prior
initi
patch
cayp
alreadi
receiv
clonidin
includ
acut
receiv
iv
clonidin
infus
one
child
difficult
iv
access
experienc
acut
deterior
dystonia
lost
follow
follow
transfer
local
servic
commonest
indic
transderm
clonidin
concern
onoff
effect
enter
dose
concern
enter
absorpt
transderm
clonidin
discontinu
cayp
patch
would
nt
adher
receiv
patch
temporari
bridg
iv
enter
clonidin
due
sever
local
cutan
reaction
one
addit
clonidin
naiv
child
experienc
signific
hypotens
transderm
dose
toler
reduc
dose
follow
remain
children
rang
month
year
median
median
transderm
dose
rang
addit
enter
clonidin
use
cayp
efficaci
transderm
clonidin
difficult
determin
cayp
retrospect
score
clinic
global
improvementscal
suggest
signific
improv
conclus
cayp
receiv
enter
clonidin
switch
transderm
clonidin
patch
appear
well
toler
cayp
continu
longer
term
use
prospect
work
requir
determin
efficaci
safeti
profil
transderm
clonidin
object
review
indic
outcom
follow
itb
children
young
peopl
cayp
centr
method
patient
identifi
undergo
itb
pump
insert
report
avail
retrospect
note
review
perform
data
extract
use
standardis
data
collect
proforma
result
median
age
itb
pump
insert
rang
hypertonia
describ
dystonia
spastic
andor
dyskinesia
median
length
follow
year
rang
choic
outcom
measur
depend
upon
goal
identifi
surgeri
care
provid
child
health
index
live
disabl
cpchild
data
avail
cayp
baselin
cayp
year
cpchild
improv
median
score
year
wilcoxon
sign
rank
test
burkefahnmarsden
dystonia
rate
scale
bfmdr
data
avail
cayp
baselin
median
motor
disabl
cayp
year
median
motor
median
disabl
clinic
pictur
dystonia
gross
motor
function
measur
gmfm
avail
cayp
baselin
cayp
year
median
cayp
beyond
year
gmfm
bfmdr
statist
signific
pain
measur
paediatr
pain
profil
avail
cayp
baselin
cayp
year
cayp
beyond
year
median
troublesom
pain
improv
baselin
year
conclus
heterogen
cohort
cayp
motor
disord
itb
appear
improv
eas
care
comfort
indic
chang
cpchild
multipl
measur
requir
fulli
captur
benefit
seen
cohort
focus
individu
need
intervent
object
evalu
neurosurg
intervent
outcom
manag
hemidystonia
method
pubm
databas
search
includ
term
hemidystonia
hemidystonia
unilater
dystonia
dystonia
pallidotomi
thalamotomi
dystonia
db
deep
brain
stimul
dystonia
itb
intrathec
baclofen
may
paper
includ
written
english
present
outcom
data
human
particip
undergo
neurosurg
intervent
manag
hemidystonia
refer
list
includ
paper
also
review
individualis
patient
data
extract
facilit
comparison
across
patient
without
valid
dystonia
scale
score
individu
patient
outcom
categoris
scale
rang
worsen
compar
baselin
mark
improv
result
identifi
report
meet
inclus
criteria
describ
uniqu
patient
age
abl
method
case
commonli
target
thalamu
db
case
gpi
recent
year
db
report
far
commonli
abl
surgeri
report
follow
rang
month
year
one
patient
underw
itb
individu
data
avail
case
individu
outcom
data
object
measur
avail
db
ablat
case
commonli
bfmdr
report
outcom
db
patient
worsen
compar
baselin
chang
slight
improv
moder
improv
mark
improv
mark
improv
abl
case
worsen
chang
slight
improv
moder
improv
mark
improv
mark
improv
complic
report
db
case
shield
batteri
syndrom
one
infect
abl
case
depress
transient
hemiplegia
conclus
avail
evid
neurosurg
treatment
hemidystonia
low
qualiti
suggest
gener
posit
result
complic
report
introduct
acut
flaccid
myeliti
afm
recent
characteris
condit
caus
multipl
muscl
paralysi
lifechang
disabl
children
medic
treatment
effect
howev
recoveri
denerv
muscl
function
possibl
via
nerv
transfer
surgeri
treatment
complex
specif
individu
carri
specialist
team
object
describ
clinic
featur
manag
outcom
nerv
transfer
surgeri
follow
afm
outbreak
method
retrospect
analysi
patient
afm
treat
nerv
transfer
surgeri
surgic
criteria
persist
motor
deficit
paralysi
month
post
onset
neurophysiolog
sign
denerv
donor
nerv
avail
result
eight
patient
mf
age
month
mean
refer
march
juli
initi
onset
infect
involv
four
limb
trunk
involv
phrenic
nerv
mean
date
initi
assess
within
specialist
centr
month
post
onset
rang
time
upper
limb
paralysi
right
left
bilater
lower
limb
paralysi
follow
consult
declin
surgic
intervent
await
surgeri
patient
proceed
surgeri
case
present
threeormor
nerv
root
involv
nervetransf
perform
median
per
patient
surgic
complic
encount
earli
clinic
function
outcom
cohort
follow
surgeri
current
collat
evalu
present
full
confer
conclus
studi
support
intern
experi
nerv
transfer
surgeri
improv
function
outcom
afm
deliveri
care
nh
requir
coordin
referr
specialist
centr
experi
cohort
inform
decis
make
improv
patient
outcom
famili
expect
next
outbreak
afm
poster
catastroph
case
acut
flaccid
myeliti
chakrabarti
c
lundi
g
doherti
bhattacharya
p
moriarti
peak
royal
belfast
hospit
sick
children
belfast
uk
royal
victoria
hospit
belfast
uk
object
acut
flaccid
myeliti
afm
rare
seriou
neurolog
condit
characteris
acut
onset
flaccid
weak
one
limb
distinct
abnorm
spinal
cord
grey
matter
magnet
reson
imag
mri
without
featur
suggest
upper
motor
neuron
disord
recent
year
global
increas
incid
afm
associ
case
nonpolio
enteroviru
longterm
prognosi
case
remain
poor
present
sever
case
afm
boy
catastroph
consequ
method
retrospect
review
clinic
cours
neuroimag
treatment
neurorehabilit
result
boy
present
clinic
enceph
deterior
hour
develop
encephalopathi
multipl
cranial
nerv
deficit
complet
flaccid
paresi
requir
picu
support
csf
week
apart
show
resolv
lymphocyt
pleocytosi
increas
protein
gdl
serial
mri
brain
spinal
cord
show
extens
signal
abnorm
involv
thalamu
dorsal
pon
medulla
cervic
cord
conu
along
cauda
equina
nerv
conduct
studi
consist
sever
acut
motor
axon
neuropathi
eeg
show
posterior
domin
encephalopathi
infect
includ
metabol
immunolog
mog
ab
genet
test
neg
immunomodul
therapi
methylprednisolon
ivig
plasma
exchang
result
clinic
improv
resolut
signal
chang
thalami
brainstem
spinal
cord
along
mild
generalis
cerebr
atrophi
note
repeat
mri
month
month
follow
present
remain
fulli
ventil
signific
motor
improv
despit
intens
rehabilit
includ
use
passiv
rang
movement
devic
function
electr
stimul
conclus
one
sever
case
afm
repres
wider
spectrum
afm
involv
encephalopathi
domin
bulbar
sign
quadriparesi
mirror
movement
disord
mmd
rare
movement
disord
preval
less
million
involuntari
symmetr
movement
observ
limb
contralater
voluntari
limb
movement
report
children
mmd
case
girl
follow
unev
pregnanc
normal
deliveri
born
nonconsanguin
parent
present
difficulti
fine
motor
activ
like
write
parent
notic
age
eight
left
hand
would
make
similar
movement
right
hand
activ
like
write
comb
etc
matern
grandfath
mmd
case
girl
follow
event
pregnanc
normal
deliveri
nonconsanguin
parent
present
mmd
age
year
first
notic
whilst
write
continu
affect
activ
daili
live
famili
histori
mmd
children
neurodevelopment
normal
normal
mri
brain
spine
mmd
describ
congenit
due
prenat
insult
week
gestat
kallman
syndrom
klippelfeil
syndrom
acquir
due
hemipleg
stroke
parkinson
diseas
adult
pathogenesi
thought
due
lesion
supplementari
motor
area
corpu
callosum
cervic
lesion
mutat
dcc
gene
present
case
multimod
mri
neurophysiolog
studi
reveal
motor
system
complet
disorganis
abnorm
cross
brain
stem
level
abnorm
commun
brain
hemispher
children
posit
famili
histori
case
upper
limb
commonli
involv
diagnosi
usual
clinic
treatment
symptomat
support
school
limit
repeat
complex
sustain
movement
involv
hand
poster
acut
spinal
cord
infarct
children
review
present
aetiolog
investig
outcom
children
shehata
ar
hart
cd
rittey
e
davi
depart
paediatr
neurolog
sheffield
children
hospit
nh
foundat
trust
sheffield
uk
aim
acut
spinal
cord
infarct
poorli
understood
paediatr
popul
review
case
present
singl
paediatr
neurolog
centr
uk
explor
common
theme
present
aetiolog
outcom
materi
method
case
spinal
cord
infarct
present
singl
centr
identifi
spinal
databas
medic
record
review
determin
clinic
present
aetiolog
investig
manag
outcom
result
six
childrenyoung
peopl
identifi
male
femal
age
rang
year
particip
present
symptom
seemingli
trivial
movement
trauma
includ
kick
back
whilst
play
footbal
bend
forward
tie
hair
get
walk
garden
perform
crab
gymnast
movement
obviou
precipit
initi
present
neck
back
pain
patient
progress
bilater
lower
limb
weak
sensori
deficit
lost
reflex
urinarybowel
involv
mri
imag
fail
reveal
diagnosi
perform
earli
particip
level
lesion
particip
isol
conu
aetiolog
investig
includ
thrombophilia
screen
fail
reveal
caus
particip
initi
receiv
steroid
differenti
diagnosi
includ
inflammatori
disord
patient
receiv
aspirin
gain
motor
improv
none
return
normal
residu
bladder
problem
bowel
sequela
conclus
spinal
cord
infarct
may
relat
minor
trauma
movement
associ
chiari
malform
previous
describ
adult
outcom
poor
although
motor
improv
seen
children
return
normal
function
aetiolog
investig
treatment
vari
within
singl
centr
nation
recommend
requir
standardis
practic
cost
care
longterm
ventil
patient
r
belderbo
v
kumar
l
alkhalidi
east
lancashir
nh
trust
lancashir
uk
background
advanc
neonat
paediatr
intens
care
increas
surviv
children
life
threaten
life
limit
condit
signific
rise
children
longterm
home
invas
ventil
high
profil
case
media
recent
debat
whether
intervent
implement
focuss
ethic
without
evid
cost
benefit
analysi
children
longterm
invas
ventil
high
cost
group
complex
vari
underli
medic
condit
requir
input
multipl
team
includ
hour
carer
medic
multidisciplinari
team
input
well
recurr
hospit
picu
admiss
addit
cost
equip
drug
make
costli
intervent
limit
healthcar
system
ration
decis
made
drug
therapi
subject
health
econom
analys
studi
aim
assess
cost
per
annum
ltv
cost
benefit
analysi
object
identifi
patient
ltv
includ
comorbid
assess
cost
ltv
quantifi
costbenefit
analysi
measur
outcom
deathadmissionsrecoveri
method
review
patient
requir
home
longterm
invas
ventil
juli
analysi
cost
clinic
visit
hospit
admiss
cost
equip
cost
medic
outcom
qualiti
life
mortal
admiss
length
stay
decannul
abil
commun
mobil
analysi
abil
parent
work
result
patient
die
age
decannul
ongo
ltv
age
night
packag
pa
accessori
pa
replaceablesservic
averag
cost
home
ltv
around
pa
conclus
ltv
ventil
expens
treatment
use
analys
cost
benefit
analysi
similar
way
avail
treatment
object
assess
feasibl
recruit
studi
perform
interpret
aeeg
preterm
infant
assess
famili
staff
member
view
method
prospect
feasibl
studi
preterm
neonat
week
postmenstru
age
recruit
continu
aeeg
monitor
use
adhes
electrod
whilst
receiv
nicu
care
studi
optim
method
attach
lead
imped
data
number
electrod
chang
preliminari
aeeg
find
staff
parent
ask
feedback
process
involv
result
recruit
elig
babi
nuprep
sorbaderm
effect
combin
skin
prepar
aeeg
record
good
qualiti
staff
engag
knew
electrod
need
chang
four
seven
babi
show
seizur
activ
aeeg
none
diagnos
clinic
babi
seizur
born
earlier
lower
birthweight
complic
babi
without
seizur
feedback
show
parent
staff
posit
although
staff
report
care
babi
harder
parent
staff
would
definit
recommend
studi
parent
prematur
babi
conclus
use
continu
aeeg
preterm
neonat
feasibl
similar
recruit
rate
studi
depart
posit
experi
parent
staff
high
rate
electr
seizur
detect
background
magnet
reson
imag
mri
enhanc
diagnosi
fetal
development
brain
abnorm
utero
meridian
studi
show
improv
diagnost
accuraci
confid
detect
fetal
neurolog
abnorm
compar
ultrasound
addit
inform
provid
utero
mri
alter
prognosi
women
meridian
studi
report
whether
neurodevelopment
prognos
given
women
vari
clinician
accur
object
assess
variat
prognosi
given
pregnant
women
clinician
fetomatern
unit
differ
fetal
brain
abnorm
method
contact
one
clinician
meridian
fetomatern
unit
ask
percentag
chanc
normal
neurodevelopment
outcom
would
give
pregnant
women
fetal
neurolog
abnorm
isol
ventriculomegali
mm
unilater
hypoplasia
cerebellar
hemispher
isol
hypoplasia
cerebellar
vermi
isol
cisterna
magna
isol
blake
pouch
cyst
respond
ask
give
percentag
chanc
normal
outcom
although
use
free
text
answer
result
respons
receiv
senior
obstetrician
fetomatern
unit
gener
agreement
isol
mild
ventriculomegali
respond
repli
would
normal
development
outcom
wider
variat
seen
posterior
fossa
abnorm
suggest
chanc
normal
outcom
one
condit
rang
conclus
estim
longterm
neurodevelopment
outcom
base
antenat
detect
neurolog
abnorm
challeng
due
limit
highqual
data
data
highlight
high
variat
outcom
offer
differ
clinician
abnorm
work
need
determin
advic
given
obstetrician
potenti
development
outcom
wide
rang
fetal
brain
abnorm
current
practic
well
agre
publish
evid
whether
involv
paediatrician
experi
neurodevelopment
disord
improv
prognost
background
inutero
mri
iumri
detect
fetal
brain
abnorm
accur
ultrasonographi
uss
provid
addit
clinic
inform
around
half
pregnanc
littl
publish
data
whether
postnat
neuroimag
beyond
month
age
chang
diagnost
accuraci
iumri
abil
predict
development
outcom
method
famili
enrol
meridian
studi
whose
child
surviv
year
age
invit
case
note
review
assess
development
outcom
either
bayley
scale
infant
toddler
develop
age
stage
questionnair
paediatr
neuroradiologist
blind
iumri
result
review
postnat
neuroimag
clinic
report
differ
iumri
find
diagnost
accuraci
recalcul
paediatr
neurologist
neonatologist
categoris
particip
develop
normal
risk
abnorm
abil
iumri
uss
predict
development
outcom
assess
result
particip
case
note
review
mri
month
age
diagnost
accuraci
iumri
remain
higher
uss
absolut
ci
p
development
outcom
data
analys
particip
normal
normal
favour
prognosi
uss
iumr
differ
ci
statist
signific
differ
seen
infant
abnorm
outcom
differ
ci
conclus
iumri
remain
optim
tool
identifi
fetal
brain
abnorm
less
accur
predict
development
outcom
although
iumri
better
identifi
children
normal
outcom
uss
work
need
determin
prognost
abil
iumri
improv
poster
introduc
hypothermia
decis
algorithm
honda
guidelin
assess
neonat
follow
hypox
insult
birth
district
gener
hospit
sproul
j
courtney
mcgowan
ulster
hospit
belfast
uk
introduct
hypoxicischaem
encephalopathi
hie
account
case
cerebr
palsi
hie
caus
multipl
event
occur
birth
hypox
insult
time
birth
result
encephalopath
state
characteris
need
resuscit
birth
neurolog
depress
seizur
electroencephalograph
abnorm
tobi
studi
demonstr
induct
moder
hypothermia
within
hour
birth
hour
durat
infant
perinat
asphyxia
result
improv
neurolog
outcom
survivor
therapeut
hypothermia
proven
neuroprotect
treatment
hie
assess
tool
requir
standard
proforma
neurolog
assess
babi
low
cord
ph
district
gener
hospit
dgh
ensur
infant
met
tobi
criteria
receiv
appropri
treatment
within
recommend
timefram
method
honda
assess
tool
develop
use
tertiari
neonat
intens
care
unit
assess
tool
adapt
use
dgh
guidelin
honda
includ
criteria
tobi
studi
userfriendli
flow
chart
comprehens
neurolog
examin
outlin
text
imag
ensur
reliabl
repeat
find
differ
clinician
time
result
honda
tool
ensur
standard
algorithm
use
assess
infant
hypox
insult
birth
standardis
record
keep
repeat
neurolog
examin
atrisk
infant
conclus
honda
comprehens
userfriendli
algorithm
ensur
infant
meet
requir
therapeut
hypothermia
appropri
identifi
treat
poster
foetal
exposur
misoprostol
mobiu
syndrom
tilibshamoun
siddiqui
v
ramesh
king
colleg
hospit
london
uk
background
mobiu
syndrom
rare
condit
compris
collect
specif
congenit
anomali
usual
congenit
lower
motor
neuron
cranial
nerv
palsi
hydrocephalu
cerebellar
hypoplasia
orofaci
limb
deform
report
literatur
link
mobiu
syndrom
earli
foetal
exposur
misoprostol
synthet
prostaglandin
e
analogu
wide
use
medic
termin
pregnanc
abort
use
antiprogestogen
mifepriston
combin
effect
first
trimest
pregnanc
mechan
misoprostol
disrupt
brainstem
develop
result
hypoplasia
absenc
central
brain
nuclei
elucid
yet
suggest
mechan
includ
select
vulner
hypoperfus
ischaem
injuri
foetal
brain
stem
due
direct
disrupt
foetal
vasculatur
global
foetal
hypoxia
uterin
contract
placent
ischaemia
clinic
case
report
case
infant
known
exposur
misoprostol
fail
medic
termin
pregnanc
top
week
gestat
present
abnorm
increas
head
circumfer
multipl
lower
motor
neuron
cranial
nerv
palsi
cranial
nerv
mri
scan
show
hydrocephalu
due
cerebr
aqueduct
stenosi
inferior
vermian
hypoplasia
loss
bulk
right
facial
collculu
pon
conclus
vital
import
counsel
expect
mother
follow
exposur
misoprostol
fail
top
possibl
congenit
anomali
woman
elect
continu
pregnanc
poster
neurolog
examin
unwel
neonat
health
care
profession
perspect
fadilah
ar
hart
depart
paediatr
neurolog
sheffield
children
hospit
sheffield
uk
object
explor
health
care
profession
opinion
neurolog
examin
unwel
neonat
method
questionnair
design
assess
view
examin
unwel
neonat
neurolog
distribut
uk
neonat
paediatr
neurolog
unit
question
includ
likert
scale
score
rang
score
taken
posit
neg
equivoc
answer
compar
consult
staff
member
use
chisquar
test
p
assum
statist
signific
result
respons
receiv
although
everi
question
answer
respond
base
gener
paediatr
tertiari
neonat
unit
paediatr
neurolog
consult
perform
neurolog
examin
unwel
neonat
consult
felt
confid
perform
neurolog
examin
compar
health
care
profession
p
consult
also
confid
interpret
result
use
formul
manag
prognosi
p
find
highqual
neurolog
examin
document
routin
medic
note
half
unwel
neonat
report
use
classic
neurolog
examin
adapt
neonat
use
hammersmith
neonat
neurolog
examin
adapt
version
difficult
aspect
fundu
cranial
nerv
examin
frequent
cite
challeng
effect
medic
difficulti
interpret
equip
line
experi
time
limit
risk
handl
unwel
neonat
want
new
standardis
neurolog
examin
unwel
neonat
conclus
nonconsult
grade
health
care
profession
feel
less
confid
perform
neurolog
examin
unwel
neonat
respond
highlight
number
challeng
perform
interpret
result
around
threequart
respond
want
new
standardis
neurolog
examin
unwel
neonat
could
address
challeng
use
restandardis
griffith
scale
child
develop
edit
healthi
cohort
month
age
object
griffith
scale
child
develop
gscd
establish
tool
development
assess
children
birth
year
gscd
underw
signific
revis
restandardis
use
contemporari
cohort
date
studi
report
use
healthi
children
postmarket
aim
examin
use
gscdiii
healthi
popul
infant
age
month
provid
first
publish
data
use
revis
griffithsiii
method
prospect
observ
studi
healthi
fullterm
infant
particip
recruit
random
control
trial
infant
massag
griffith
iii
assess
perform
aricdtrain
practition
across
subscal
gener
develop
quotient
gd
month
result
children
consid
analysi
male
femal
ratio
mean
sd
birth
weight
kg
mean
birth
gestat
age
week
sd
mean
sd
age
assess
month
children
assess
accord
round
norm
norm
differ
found
either
arm
studi
subscal
score
consider
greater
averag
dq
subscal
particularli
subscal
b
gd
mean
sd
development
quotient
dq
use
publish
cutoff
found
cohort
score
averag
greater
gd
conclus
provid
first
data
use
griffithsiii
healthi
cohort
score
higher
expect
across
subscal
may
due
characterist
cohort
rais
concern
griffithsiii
may
overestim
abil
young
infant
object
metabol
investig
import
investig
children
disord
develop
aim
audit
determin
paediatr
metabol
investig
order
per
current
best
practic
evid
tallaght
univers
hospit
dublin
republ
ireland
method
use
recommend
seven
public
guid
audit
identifi
indic
perform
metabol
investig
review
metabol
investig
sent
paediatr
patient
tallaght
univers
hospit
januari
decemb
identifi
clinic
indic
investig
patient
review
dictat
clinic
letter
avail
hospit
intranet
confirm
investig
result
review
scan
copi
avail
hospit
intranet
compar
indic
metabol
investig
publish
expert
guidelin
result
metabol
investig
perform
patient
januari
decemb
six
patient
inconclus
result
refer
metabol
team
templ
street
children
univers
hospit
dublin
assess
metabol
diagnos
made
date
per
tallaght
univers
hospit
dictat
letter
patient
diagnosi
autism
spectrum
disord
asd
asd
confirm
suspect
intellectu
disabl
patient
met
best
practic
recommend
metabol
investig
patient
fulfil
recommend
children
asd
conclus
identifi
two
area
could
improv
patient
care
optimis
diagnost
yield
improv
resourc
utilis
hospit
first
recommend
clinician
send
target
investig
avoid
blanket
investig
children
disord
develop
includ
asd
second
recommend
clinician
includ
relev
clinic
detail
request
form
improv
diagnost
yield
final
question
valu
metabol
investig
intellectu
disabl
absenc
clinic
risk
factor
comorbid
suggest
requir
studi
earli
development
cours
babi
sturgeweb
syndrom
n
thapa
fosi
v
siyani
j
sloneem
h
richardson
aylett
univers
colleg
london
medic
school
london
uk
ucl
great
ormond
street
institut
child
health
london
uk
neurodis
great
ormond
street
hospit
london
uk
background
sturgeweb
syndrom
sw
rare
neurocutan
condit
aris
mutat
g
protein
subunit
alpha
q
hallmark
leptomening
angioma
often
associ
facial
portwin
birthmark
seizur
strokelik
episod
hemiplegia
common
clinic
present
object
describ
clinic
featur
infant
sw
year
development
trajectori
relat
seizur
onset
method
retrospect
case
note
review
conduct
children
age
year
sw
clinic
review
centr
medic
histori
standardis
development
test
result
languag
cognit
motor
visuospati
skill
contain
patient
assess
report
analys
result
common
clinic
featur
children
sw
age
year
seizur
patient
hemiplegia
patient
glaucoma
patient
development
trajectori
decreas
mean
percentil
languag
cognit
motor
skill
mean
development
quotient
visuospati
skill
first
month
infant
unilater
brain
involv
significantli
higher
cognit
percentil
bilater
brain
involv
p
group
show
aforement
pattern
children
epilepsi
wors
languag
cognit
outcom
children
without
seizur
onset
seizur
onset
first
year
infant
patient
earlier
seizur
onset
associ
higher
languag
percentil
age
month
time
seizur
onset
conclus
follow
treatment
earli
seizur
sw
languag
recoveri
appear
occur
time
rel
cognit
function
plastic
languag
might
account
observ
propos
seizur
prevent
optim
seizur
control
crucial
first
year
life
benefit
cognit
languag
develop
patient
sw
object
rett
syndrom
rtt
rare
neurodevelopment
disord
primarili
affect
femal
character
loss
speech
stereotypi
abnorm
hand
movement
motor
cognit
impair
diagnos
rtt
regress
occur
remain
challeng
increas
interest
earli
diagnosi
due
ongo
gene
therapi
clinic
trial
rtt
method
retrospect
case
note
review
patient
born
term
induct
labour
reduc
movement
meconiumstain
liquor
well
poor
cri
suck
note
birth
gradual
deterior
feed
frequent
chest
infect
necessit
pegfeed
month
peripheralaxi
muscl
weak
hypotonia
note
time
mri
brain
show
mild
underopercularis
sylvianfissur
thin
corpuscallosum
mr
mri
spine
echocardiogram
eeg
normal
vitamin
defici
found
treat
hydroxycobalamin
sleep
studi
show
hypoventil
frequent
apnoea
low
respiratori
rate
lead
nocturn
bipap
emg
myopath
muscl
biopsi
show
margin
loss
complexi
activ
respiratorychainenzym
analysi
result
videofluoroscopi
show
delay
swallow
disorganis
pharyng
stage
lead
peg
feed
follow
month
regress
note
minim
motor
progress
seen
interact
smile
month
regress
motor
abil
notedsh
stop
fix
follow
smile
progress
microcephali
hand
writh
movement
eeg
show
epilept
encephalopathi
tonicmyoclon
jerk
wholeexomesequenc
show
denovo
pathogen
mutat
gene
p
diagnosi
rtt
confirm
month
restart
smile
fixingfollow
make
motor
progress
continu
seizur
conclus
case
illustr
earlyonset
featur
atyp
rtt
central
breath
abnorm
bulbar
insuffici
gener
hypotonia
regress
evid
mitochondri
dysfunct
keep
recent
report
suggest
neuron
redox
imbal
rtt
one
diseas
pathogen
contributor
object
neurodegener
brain
iron
accumul
nbia
compris
group
rare
genet
disord
character
progress
extrapyramid
neurolog
symptom
due
focal
iron
accumul
basal
bpropel
proteinassoci
neurodegener
bpan
recent
identifi
subtyp
nbia
caus
heterozyg
variant
report
new
subtyp
bpan
caus
de
novo
variant
girl
method
case
report
new
subtyp
bpropel
proteinassoci
neurodegener
bpan
caus
de
novo
delet
girl
review
literatur
result
report
year
old
girl
bpan
due
larg
bp
de
novo
chrx
delet
present
earlyonset
global
development
delay
hypotonia
seizur
speech
apraxia
patient
present
age
month
hypotonia
motor
development
delay
follow
normal
birth
histori
month
develop
complex
partial
seizur
later
steroidrespons
electr
statu
epilepticu
slowwav
sleep
ese
made
minim
development
progress
remain
profoundli
global
development
delay
cognit
impair
still
achiev
independ
ambul
conclus
describ
clinic
neurophysiolog
neuroimag
find
girl
uniqu
combin
may
assist
diagnosi
similar
case
bpan
exceedingli
rare
sever
debilit
disord
broad
spectrum
clinic
heterogen
variabl
age
present
earlyonset
symptom
earli
detect
diagnosi
import
order
offer
proper
genet
counsel
affect
famili
provid
symptomat
treatment
patient
nextgener
broadspectrum
genet
analys
enabl
earli
detect
bpan
paediatr
age
group
order
patient
diagnos
prior
reach
adulthood
introduct
measur
effect
earli
intervent
program
low
resourc
set
assess
lead
intervent
improv
lead
new
intervent
new
assess
lead
new
intervent
system
measur
effect
improv
base
feedback
result
attempt
set
child
develop
centr
low
resourc
countri
use
softwar
app
elearn
method
year
data
earli
intervent
analys
lucknow
india
phase
children
nonprogress
neurolog
problem
given
best
avail
local
intervent
complianc
improv
seen
base
feedback
algorithm
written
creat
individu
profil
children
base
skill
uk
curriculum
excel
disabl
score
inform
process
prefer
educ
behaviour
problem
base
score
child
gener
individualis
profil
intervent
plan
deliv
app
parent
pbacdrv
app
tbacdrv
child
develop
centr
assess
repeat
everi
month
new
individualis
profil
gener
new
set
intervent
total
intervent
develop
algorithm
help
decid
main
area
target
one
time
result
current
system
low
resourc
set
either
servic
result
close
prevent
disabl
nonprogress
neurolog
problem
system
shown
prevent
disabl
children
support
govern
start
initi
program
top
data
innov
india
conclus
use
technolog
provid
train
exam
support
profession
low
resourc
area
solut
provid
effect
servic
pattern
recognit
key
deliv
softwar
auto
audit
place
measur
improv
system
introduct
medic
advanc
treatment
cn
tumour
enhanc
surviv
also
impact
level
residu
morbid
particip
servic
provis
increas
alongsid
improv
surviv
mani
patient
abl
return
previou
level
activ
particip
follow
oncolog
treatment
nice
cancer
servic
children
young
peopl
state
children
young
peopl
central
nervou
system
malign
receiv
specialist
neurorehabilit
care
packag
robbi
rehab
chariti
fund
physiotherapi
servic
embed
within
southampton
children
hospit
therapi
servic
launch
june
provid
supplementari
physiotherapi
children
diagnos
brain
spinal
tumour
care
southampton
children
hospit
object
accur
identifi
quantifi
need
servic
method
prospect
data
collat
review
june
result
year
patient
year
patient
new
episod
physiotherapi
averag
per
month
direct
clinic
contact
reason
access
servic
need
enhanc
intens
rehabilit
discharg
enhanc
inpati
rehabilit
bridg
gap
whilst
await
commun
servic
chang
symptom
preop
assess
support
palli
care
plan
support
complex
social
emot
need
diseas
progress
higher
level
rehabilit
fulfil
commun
criteria
facilit
access
local
exercis
facil
within
oncolog
clinic
assessmentoneoff
treatment
postop
assess
individualis
goal
orient
particip
patient
estim
week
reduct
acut
bed
day
conclus
robbi
rehab
referr
varieti
multifactori
reason
rereferr
often
need
within
pathway
enabl
earlier
discharg
improv
transit
commun
servic
opportun
therapi
access
previous
avail
result
proband
present
week
mark
stridor
bulbar
weak
normal
pregnanc
subsequ
develop
respiratori
failur
requir
nocturn
bipap
found
type
laryng
cleft
initi
met
development
mileston
develop
featur
axial
weak
regress
limb
weak
loss
deep
tendon
reflex
emg
confirm
denerv
genioglossu
well
proxim
distal
limb
muscl
without
evid
neuropathi
genet
gene
smard
neg
inherit
peripher
neuropathi
gene
panel
test
identifi
heterozyg
missens
variant
c
c
p
exon
variant
predict
alter
highli
conserv
amino
acid
report
identifi
control
databas
silico
predict
tool
support
pathogen
variant
mutagenesi
equival
amino
acid
mice
produc
impair
motor
control
denerv
conclus
gar
gene
encod
ubiquit
express
glycyl
trna
synthetas
integr
role
protein
synthesi
eukaryot
cell
missens
gar
mutat
lead
distal
hereditari
motor
neuropathi
well
sensorimotor
neuropathi
phenotyp
typic
adolesc
earli
adulthood
onset
object
discuss
sma
one
differenti
hypoton
child
bring
light
diagnosi
alway
cerebr
palsi
cp
method
descript
case
report
result
case
girl
admit
icu
sever
pneumonia
case
boy
admit
intens
care
unit
sever
pneumonia
case
girl
present
outpati
progress
floppi
limb
weak
swallow
breath
difficulti
case
attend
opd
worsen
respiratori
distress
difficulti
feed
difficulti
manag
secret
perinat
histori
uncompl
deliveri
subsequ
earli
respiratori
distress
oxygen
requir
first
day
life
floppi
sinc
birth
sever
gross
motor
delay
feed
difficulti
poor
weight
gain
recurr
chest
infect
case
diagnos
cp
despit
normal
neuroimag
examin
children
similar
consist
clinic
diagnosi
sma
find
includ
alert
interact
child
frogleg
postur
hypotonia
weak
leg
affect
arm
absent
deep
tendon
reflex
bellshap
chest
tongu
fascicul
genet
test
confirm
homozyg
delet
exon
gene
case
creatinin
kinas
level
normal
rule
myopathi
conclus
incid
sma
livebirth
diagnos
clinic
pathognom
featur
genet
test
unavail
consid
hypoton
child
irrespect
perinat
histori
wide
clinic
spectrum
rang
earli
death
nearnorm
adult
life
exist
famili
must
counsel
regard
implic
genet
diagnosi
correct
earli
diagnosi
multidisciplinari
intervent
vastli
improv
outcom
poster
syro
studylongterm
reduct
rate
respiratori
function
declin
patient
duchenn
muscular
dystrophi
dmd
treat
idebenon
l
servai
c
lawrenc
oh
mayer
cm
mcdonald
u
schara
voit
e
mercuri
gm
buys
respiratori
function
declin
dmd
caus
underli
weak
degener
respiratori
muscl
lead
impair
inspiratori
expiratori
effort
associ
complic
idebenon
reduc
rate
respiratori
function
declin
week
phase
iii
delo
trial
syro
longterm
studi
former
delo
patient
transit
idebenon
expand
access
program
follow
variabl
untreat
period
aim
character
longterm
effect
idebenon
respiratori
function
patient
manag
accord
routin
clinic
practic
respiratori
function
assess
calcul
annual
declin
forc
vital
capac
fvc
peak
expiratori
flow
pef
express
percent
predict
p
comparison
made
treat
untreat
period
match
extern
control
data
bronchopulmonari
advers
event
bae
hospit
collect
data
former
delo
patient
avail
delo
baselin
mean
sd
age
fvc
p
year
patient
glucocorticoid
nonus
nonambulatori
patient
treat
averag
minmax
year
compar
averag
untreat
period
year
annual
rate
fvc
p
declin
almost
halv
vs
compar
period
extern
comparison
declin
remain
lower
across
treatment
year
compar
match
group
untreat
patient
compar
result
seen
pef
p
risk
bae
reduc
longterm
idebenon
treatment
versu
untreat
period
lead
fewer
hospit
due
respiratori
caus
vs
event
per
year
longterm
treatment
idebenon
result
consist
sustain
reduct
rate
respiratori
function
declin
year
two
placebocontrol
trial
durat
phase
ii
delphi
phase
iii
delo
show
idebenon
consist
reduc
respiratori
function
declin
rate
patient
advanc
dmd
longterm
data
delphiextens
delphi
studi
syro
delo
patient
transit
idebenon
expand
access
program
present
aim
assess
consist
longterm
effect
idebenon
respiratori
function
across
placebocontrol
trial
respect
longterm
data
collect
delphi
syro
patient
abnorm
forc
vital
capac
percent
predict
fvc
p
treat
idebenon
averag
year
respect
annual
fvc
p
declin
rate
compar
untreat
patient
syro
match
extern
control
match
baselin
fvc
p
cinrg
duchenn
natur
histori
studi
cinrgdnh
mean
sd
baselin
age
year
delphi
delo
respect
fvc
p
first
period
data
avail
studi
averag
annual
declin
rate
compar
treat
patient
delphi
syro
lower
untreat
syro
patient
extern
control
untreat
cinrgdnh
year
annual
declin
rate
consist
lower
match
control
treatment
idebenon
result
sustain
reduct
rate
declin
respiratori
function
across
placebocontrol
studi
across
longterm
data
collect
followup
time
year
consist
observ
across
independ
dataset
add
robust
treatment
effect
idebenon
potenti
modifi
cours
respiratori
function
declin
dmd
poster
rare
mutat
caus
mix
clinic
phenotyp
spinal
muscular
atrophi
lower
extrem
predomin
hereditari
spastic
paraplegia
case
seri
famili
el
goh
jayaw
g
anand
object
describ
identif
rare
mutat
gene
caus
mix
clinic
phenotyp
spinal
muscular
atrophi
lower
extrem
predomin
smale
hereditari
spastic
paraplegia
hsp
method
case
seri
three
famili
member
father
two
son
across
two
gener
result
histori
earli
childhoodonset
progress
lower
limb
muscl
weak
atrophi
relev
famili
histori
neuromuscular
disord
report
patern
matern
side
famili
examin
reveal
markedli
diminish
tone
power
lower
limb
wast
posit
cross
adductor
reflex
abnorm
detect
upper
limb
sensat
preserv
throughout
neurophysiolog
test
show
moder
sever
chronic
denerv
lower
limb
muscl
spare
peripher
sensori
nerv
hsp
panel
neg
charcotmarietooth
cmt
panel
demonstr
heterozyg
sequenc
chang
gene
p
present
affect
famili
member
discuss
conclus
mutat
dynein
gene
typic
associ
smale
cmt
mix
smale
hsp
phenotyp
previous
shown
caus
mutat
encod
golgin
compon
dyneinbas
transport
play
key
role
mrna
transport
oogenesi
embryogenesi
present
first
case
seri
mix
clinic
phenotyp
smale
hsp
occur
due
mutat
first
observ
p
variant
laboratori
list
genom
aggreg
databas
suggest
extrem
rare
variant
open
lid
unilater
ptosi
paediatr
e
hassan
e
witter
z
mughal
l
robinson
weisburg
sa
robert
e
hupton
j
eelloo
e
burkitt
wright
garg
l
lewi
dg
evan
sm
stivaro
g
vassallo
introduct
neurofibromatosi
type
genet
disord
birth
incid
individu
preval
around
worldwid
ptosi
welldocu
featur
condit
known
associ
plexiform
neurofibroma
noonan
phenotyp
bilater
ptosi
unilater
ptosi
absenc
plexiform
neurofibroma
common
featur
describ
number
patient
demonstr
unilater
ptosi
method
retrospect
cohort
studi
carri
use
patient
databas
within
servic
base
st
mari
hospit
manchest
uk
children
young
adult
age
year
identifi
via
patient
databas
patient
present
ptosi
identifi
result
six
children
unilater
ptosi
identifi
four
femal
two
male
age
five
unilater
ptosi
affect
right
one
left
differ
observ
sporad
famili
diseas
five
patient
complex
diseas
howev
none
associ
complic
account
unilater
ptosi
apart
meet
diagnost
criteria
noonan
syndrom
none
plexiform
neurofibroma
orbit
peri
orbit
area
discuss
unclear
increas
incid
unilater
ptosi
cohort
patient
absenc
plexiform
neurofibroma
noonan
syndrom
ptosi
associ
noonan
syndrom
phenotyp
patient
gener
hypotonia
myopathi
observ
patient
could
also
factor
caus
ptosi
research
necessari
investig
aetiolog
increas
unilater
ptosi
patient
object
sma
sever
neuromuscular
disord
characteris
progress
muscl
atrophi
weak
scoliosi
highli
preval
complic
surgeri
almost
invari
requir
sitter
data
secondari
outcom
limit
studi
investig
postsurg
respiratori
fvc
motor
function
weight
gain
pain
satisfact
method
retrospect
review
note
patient
never
walk
lost
ambul
sma
type
iiiii
success
underw
scoliosi
surgeri
great
ormond
street
hospit
spinal
fusion
magnet
tradit
growth
rod
perform
phone
interview
run
focu
group
famili
pre
postsurg
satisfact
result
median
followup
surgeri
year
respect
mean
annual
rate
fvc
declin
improv
postsurgeri
sma
ii
versu
p
similar
trajectori
sma
iii
mean
annual
rate
hammersmith
function
motor
scale
score
declin
chang
significantli
vs
p
revis
upper
limb
modul
score
show
less
progress
deterior
vs
neg
deviat
previou
weight
curv
surgeri
observ
requir
food
supplement
signific
weight
loss
total
weight
need
gastrostomi
pain
frequent
document
especi
hip
pain
requir
painkil
intraarticular
steroid
surgeri
famili
particip
phone
interview
report
major
improv
postur
physic
appear
selfimag
rate
procedur
success
howev
report
signific
improv
qualiti
life
due
reduc
mobil
increas
unmet
care
need
five
famili
attend
focu
group
report
posit
neg
aspect
experi
conclus
studi
provid
relev
data
suggest
improv
current
multidisciplinari
approach
scoliosi
surgeri
children
sma
poster
sunfish
part
safeti
exploratori
outcom
risdiplam
treatment
patient
type
spinal
muscular
atrophi
sma
object
spinal
muscular
atrophi
sma
sever
progress
neuromuscular
diseas
caus
reduc
level
surviv
motor
neuron
smn
protein
due
delet
andor
mutat
gene
produc
fulllength
smn
protein
second
gene
produc
low
level
function
smn
protein
risdiplam
investig
oral
administ
central
peripher
distribut
small
molecul
modul
premrna
splice
increas
smn
protein
level
sunfish
ongo
multicentr
doubleblind
placebocontrol
studi
randomis
risdiplam
placebo
patient
age
year
type
sma
method
sunfish
part
dosefind
studi
assess
safeti
toler
pkpd
risdiplam
pivot
part
assess
safeti
efficaci
risdiplam
dose
level
select
base
result
part
sunfish
part
includ
patient
broad
age
rang
clinic
characterist
function
level
scoliosi
contractur
interim
analysi
part
data
cutoff
juli
show
sustain
increas
median
smn
protein
versu
baselin
year
treatment
advers
event
mostli
mild
resolv
despit
ongo
treatment
reflect
underli
diseas
despit
design
detect
efficaci
risdiplam
improv
motor
function
measur
month
versu
natur
histori
result
safeti
toler
pkpd
report
patient
part
receiv
treatment
risdiplam
minimum
month
updat
part
exploratori
efficaci
data
includ
motor
outcom
measur
also
present
clinic
benefit
risdiplam
assess
part
ongo
worldwid
object
encod
skelet
muscl
ryanodin
receptor
intracellular
calciumreleas
channel
crucial
excitationcontract
coupl
muscl
gene
variant
caus
heterogen
myopathi
includ
dominantli
inherit
central
core
diseas
autosom
domin
ad
autosom
recess
ar
pattern
inherit
report
method
retrospect
case
note
review
result
sibl
femal
present
first
year
life
motor
development
delay
year
age
abl
sit
unsupport
crawl
stand
walk
facial
weak
feed
difficulti
ophthlamplegia
axial
proxim
weak
antigrav
power
neck
flexor
hip
flexor
mrc
subgrav
power
hip
abductorsextensor
knee
flexorsextensor
mrc
sever
hip
knee
ankl
fix
contractur
power
joint
rang
normal
upper
limb
muscl
biopsi
show
fibr
predomin
corelik
structur
sibl
femal
present
birth
feed
difficulti
month
age
fulli
nasogastr
fed
facial
weak
ophthlamplegia
good
head
control
activ
head
lift
prone
antigrav
power
hip
knee
ankl
mild
hip
knee
contractur
shoulder
girdl
weak
sibl
confirm
heterozyg
pathogen
frameshift
variant
p
inherit
father
like
pathogen
missens
variant
c
p
inherit
mother
parent
asymptomat
conclus
clinic
patholog
featur
ad
myopathi
well
recogn
much
less
known
disord
secondari
ar
pattern
inherit
report
two
sibl
ar
myopathi
similar
genotyp
differ
phenotyp
featur
demonstr
intrafamili
variabl
expand
current
knowledg
disord
result
proband
second
third
children
consanguin
irish
parent
fourth
cousin
antenat
reduc
fetal
movement
amniot
fluid
note
proband
birth
arthrogryposi
second
sibl
requir
prolong
intub
birth
signific
development
delay
sever
phenotyp
younger
examin
myopath
faci
inabl
buri
eyelash
full
eye
movement
high
arch
palat
drool
weak
cri
micrognathia
preserv
suck
long
thin
finger
thumb
held
adduct
dimpl
elbow
hand
peripher
reflex
absent
good
antigrav
movement
lower
limb
note
pectu
excavatum
progress
scoliosi
muscl
biopsi
show
dystroph
featur
fibrosi
hypertrophi
atrophi
fibr
variat
fibr
size
increas
fibrou
connect
tissu
occasion
central
cord
multipl
mini
cord
also
seen
second
proband
whole
exom
sequenc
identifi
compound
heterozygot
mutat
ttn
combin
ttn
tp
ttn
p
conclus
mutat
titin
gene
ttn
implic
sever
skelet
cardiac
phenotyp
date
individu
variant
compound
heterozygot
report
pathogen
mutat
detect
gener
popul
frequenc
howev
presenc
tripl
count
may
certainli
account
sever
phenotyp
proband
poster
genereplac
therapi
grt
spinal
muscular
atrophi
type
longterm
followup
onasemnogen
abeparvovec
phase
clinic
trial
object
rapidli
progress
neurolog
diseas
caus
biallel
surviv
motor
neuron
gene
deletionmut
smn
grt
onasemnogen
abeparvovec
formerli
approv
us
treat
genet
root
caus
sma
design
immedi
sustain
smn
protein
express
phase
trial
start
patient
receiv
onetim
onasemnogen
abeparvovec
infus
low
dose
cohort
high
dose
cohort
demonstr
improv
outcom
versu
natur
histori
patient
start
receiv
nusinersen
followup
dose
patient
start
could
rollov
longterm
followup
studi
studi
primari
object
longterm
safeti
method
patient
annual
visit
phone
contact
addit
patient
record
transfer
request
safeti
assess
includ
medic
histori
record
review
physic
examin
clinic
laboratori
evalu
pulmonari
assess
efficaci
assess
includ
development
mileston
evalu
determin
mainten
highest
achiev
mileston
parent
studi
result
march
patient
cohort
cohort
enrol
studi
baselin
visit
patient
cohort
mean
rang
age
time
sinc
dose
year
year
respect
patient
cohort
aliv
development
mileston
achiev
start
lost
new
mileston
achiev
support
durabl
onasemnogen
abeparvovec
updat
data
present
conclus
onetim
onasemnogen
abeparvovec
administr
high
dose
continu
provid
prolong
durabl
efficaci
mileston
develop
poster
mitochondri
disord
mimic
congenit
muscular
dystrophyreport
sibl
variabl
phenotyp
fernandez
sa
v
gowda
evelina
london
children
hospit
london
uk
object
encod
select
calciumchannel
subunit
within
mitochondri
inner
membran
whose
function
essenti
buffer
cytosol
transient
activ
atp
product
mutat
report
differ
famili
muscl
weak
fatig
development
delay
normal
lactat
despit
mitochondri
disord
persist
elev
creatin
kinas
ck
usual
rang
congenit
muscular
dystrophi
cmd
phenotyp
spectrum
highli
variabl
keep
expandingoth
featur
includ
progress
extrapyramid
sign
learn
disabl
nystagmu
cataract
report
clinic
featur
sibl
consanguin
famili
homozyg
c
splice
mutat
method
retrospect
case
note
review
result
sibl
boy
older
sibl
present
age
year
short
statur
investig
found
ck
complain
occasion
cramp
muscl
biopsi
show
mild
dystroph
chang
reduc
alphadystroglycan
indic
possibl
congenit
disord
glycosyl
mri
brain
normal
diagnos
autism
sibl
girl
diagnos
antenat
cerebellar
hypoplasia
confirm
postnat
inferiorvermi
hypoplasia
present
year
occasion
cramp
mild
tight
tendoachil
ck
l
height
weight
centil
muscl
mri
show
small
area
high
signal
left
adductor
magnu
relat
group
normal
vascular
structur
neurophysiolog
studi
normal
system
involv
seen
either
next
gener
sequenc
reveal
mutat
describ
conclus
work
expand
phenotyp
spectrum
defici
highlight
variabl
patient
within
famili
target
analysi
gene
patient
high
ck
level
resembl
cmd
pictur
may
warrant
even
absenc
promin
muscl
featur
role
dystrophin
brain
isoform
earli
motor
develop
motor
outcom
young
children
duchenn
muscular
dystrophi
half
patient
central
nervou
system
cn
manifest
two
dystrophin
isoform
play
import
role
cn
function
lack
sever
cn
phenotyp
mark
lack
object
determin
whether
lack
also
advers
impact
earli
motor
develop
method
northstar
ambulatori
assess
nsaa
scale
motor
function
clinic
inform
dmd
particip
classifi
dmd
mutat
locat
effect
isoform
express
follow
absent
present
absent
present
absental
isoform
affect
result
amongst
year
old
median
total
nsaa
score
lower
group
markedli
exampl
old
median
total
nsaa
score
amongst
year
old
lower
percentag
particip
achiev
full
score
normal
achiev
goal
without
assist
nsaa
subitem
p
p
group
group
markedli
exampl
amongst
percentag
visit
full
score
record
jump
follow
conclus
addit
known
cn
phenotyp
young
dmd
patient
lack
also
exhibit
lower
median
total
nsaa
score
greater
earli
motor
delay
markedli
seen
lack
lack
dystrophin
brain
isoform
import
implic
patient
prognost
clinic
trial
design
background
commonli
known
rare
subtyp
guillainbarr
e
miller
fisher
syndrom
mf
evolv
sinc
first
describ
syndrom
characteris
triad
ophthalmoplegia
ataxia
areflexia
clinic
variat
occur
occur
often
men
woman
ratio
averag
age
onset
year
mf
associ
posit
anti
antibodi
concentr
cranial
nerv
iii
iv
viexplain
link
ophthalmoplegia
clinic
case
present
unusu
case
boy
background
macrocephali
preexist
development
delay
previou
mri
show
mild
signal
chang
periventricular
white
matter
bilater
admit
subacut
histori
proxim
muscl
weak
fatigu
obviou
focal
neurolog
sign
apart
intermitt
lid
hop
ptosi
differenti
diagnosi
includ
myasthenia
demyelin
disord
underli
preexist
luecodystrophi
anti
antibodi
check
along
extens
metabol
investig
lumbar
punctur
muscl
biopsi
anticholinesteras
antimusk
antibodi
along
repeat
mri
investig
neg
includ
mri
show
signific
chang
previou
find
strongli
posit
anti
antibodi
interim
patient
start
trial
pyridostigmin
signific
clinic
improv
conclus
atyp
variant
mf
differenti
children
subtl
eye
sign
without
ophthalmoplegia
lid
hop
fatigu
rais
suspicion
mf
anti
antibodi
test
pyridostigmin
report
effect
mf
potenti
util
muscl
mri
congenit
myasthenia
syndrom
secondari
agrn
mutat
found
whole
exom
sequenc
we
congenit
myasthenia
syndrom
cm
caus
genet
defect
affect
neuromuscular
transmiss
result
muscl
weak
fatig
agrin
extracellular
matrix
molecul
releas
nerv
essenti
neuromuscular
junction
larg
code
gene
agrn
number
exon
increas
variant
found
we
time
consum
complex
undertak
function
studi
defin
pathogencitiy
previou
report
agrn
mutat
phenotyp
promin
distal
leg
weak
chang
soleu
mri
describ
differ
present
strike
chang
mri
especi
posterior
compart
thigh
present
deterior
gait
difficulti
climb
stair
born
term
via
normal
vagin
deliveri
parent
consanguin
three
well
sibl
report
walk
year
examin
waddl
gait
unabl
run
hop
proxim
weak
posit
gower
sign
togeth
weak
eye
closur
muscl
biopsi
show
nonspecif
myopath
featur
howev
mri
lower
leg
found
widespread
fatti
muscl
atrophi
thigh
calf
rel
preserv
adductor
longu
rectu
femori
semitendonosi
we
reveal
agrn
mutat
homozyg
mutat
nebulin
gene
felt
clinic
relev
singl
fibr
emg
confirm
electrodecr
repetit
nerv
stimul
patient
commenc
treatment
salbutamol
patient
distinct
chang
mri
nonspecif
muscl
biopsi
chang
muscl
mri
chang
prompt
genet
test
symptom
fit
clinic
diagnosi
congenit
myasthen
syndrom
increas
variant
found
unknown
signific
patient
collat
mri
imag
tri
elucid
pattern
chang
import
mcardl
diseas
glycogen
storag
diseas
type
v
autosom
recess
condit
caus
pathogen
mutat
copi
muscl
glycogen
phosphorylas
pygm
gene
encod
musclespecif
isoform
glycogen
phosphorylas
myophosphorylas
exclus
affect
skelet
muscl
commonest
form
glycogenosi
mcardl
diseas
show
signific
clinic
variabl
symptom
rang
mild
discomfort
exercis
mark
muscl
weak
rhabdomyolysi
myoglobinuria
second
wind
phenomenon
uniqu
mcardl
diseas
consist
improv
exercis
toler
decreas
heart
rate
rest
despit
major
patient
recal
symptom
first
year
life
mcardl
infrequ
diagnos
children
patient
diagnos
year
age
accord
recent
review
report
two
patient
diagnos
mcardl
diseas
age
year
respect
case
one
present
fatigu
inabl
increas
pace
walk
age
hill
lead
earlier
fatigu
abl
particip
gymnast
danc
present
fluctuat
ck
level
second
wind
phenomenon
myoglobinuria
case
two
present
year
histori
month
reduc
exercis
toler
myalgia
low
intens
physic
activ
evid
myoglobinuria
second
wind
formal
assess
evid
muscl
weak
function
impair
ck
persist
rais
rang
light
symptom
ck
level
rhabdomyolysi
panel
request
case
lead
diagnosi
object
explor
characterist
anxieti
experienc
young
male
duchenn
muscular
dystrophi
dmd
use
qualit
analysi
focu
group
discuss
dmd
boy
parent
parentreport
scale
anxietyemot
problem
method
eight
boy
age
year
dmd
dmd
parent
particip
separ
child
parent
focu
group
perspect
anxieti
elicit
use
semistructur
discuss
framework
analysi
appli
identifi
theme
score
five
parentreport
scale
determin
scale
compar
content
sensit
result
group
discuss
six
characterist
anxieti
recurr
report
catastroph
conclus
rigidli
held
anxieti
extrem
distress
unexpectedunfamiliar
social
anxieti
physic
chang
need
mani
featur
echo
anxieti
phenotyp
autism
spectrum
disord
asd
four
theme
describ
relev
contextu
factor
individu
famili
social
environment
respons
parentreport
scale
younger
dmd
boy
significantli
higher
total
gener
social
anxieti
score
compar
popul
mean
least
two
scale
p
p
p
older
dmd
group
trend
toward
higher
score
total
gener
separ
anxieti
compar
popul
norm
differ
scale
vari
diagnost
sensit
item
content
may
influenc
util
dmd
conclus
anxieti
pervas
impact
issu
dmd
appear
share
trait
anxieti
asd
may
influenc
situat
factor
live
disabl
lifelimit
condit
screen
standard
anxieti
scale
may
accur
captur
full
spectrum
phenotyp
dmd
therefor
evalu
determin
optim
screen
instrument
dmd
warrant
howev
multimod
assess
tailor
dmd
key
identifi
need
support
optimis
mental
wellb
young
peopl
dmd
object
part
clinic
psycholog
servic
paediatr
neurolog
develop
tic
manag
group
support
young
peopl
parent
develop
posit
cope
relat
tic
group
combin
psychoeduc
emot
regul
habit
revers
therapi
hrt
compon
evalu
aim
establish
effect
group
reduc
tic
associ
distress
method
twentyeight
children
age
year
parent
attend
one
seven
tic
manag
group
facilit
februari
novemb
children
refer
clinic
psycholog
support
tic
group
consist
weekli
session
review
session
week
later
parent
group
held
parallel
young
person
parent
group
facilit
clinic
psycholog
team
homework
task
provid
support
hrt
skill
practic
consolid
learn
group
content
session
follow
pre
post
group
measur
complet
young
peopl
parent
paediatr
index
emot
distress
yale
global
tic
sever
scale
parent
tic
questionnair
session
rate
scale
measur
collat
descript
data
review
result
children
found
group
help
manag
tic
children
less
bother
tic
children
felt
confid
control
tic
parent
report
greater
understand
tic
reduct
sever
child
tic
conclus
result
indic
tic
manag
group
effect
build
young
peopl
understand
tic
confid
tic
manag
whilst
provid
peer
support
find
also
indic
parent
found
group
inform
valu
opportun
share
experi
other
background
patient
epilepsi
often
deficit
cognit
physic
psycholog
social
function
treatment
aim
allevi
deficit
epilepsi
surgeri
consid
medic
refractori
epilepsi
aim
improv
patient
qualiti
life
recent
studi
highlight
import
multidisciplinari
workup
prior
epilept
surgeri
includ
neuropsychiatr
assess
part
assess
identifi
patient
expect
epilepsi
surgeri
address
periop
king
colleg
hospit
kch
london
assess
routin
perform
paediatr
liaison
servic
part
children
epilepsi
surgeri
servic
cess
aim
analys
retrospect
data
preoper
patient
carer
expect
octob
septemb
kch
method
record
patient
carer
expect
routin
record
part
kch
cess
neuropsychiatr
assess
respons
compil
analys
use
qualit
content
analysi
result
preliminari
survey
case
averag
age
rang
identifi
respons
group
broader
classif
cognit
seizur
experi
social
process
school
experi
mental
state
gener
improv
simpl
analysi
show
carer
often
expect
surgeri
reduc
need
medic
ablat
seizur
increas
school
perform
independ
overal
qualiti
life
compar
child
respons
common
expect
reduct
lifestyl
restrict
cure
epilepsi
decreas
medic
increas
independ
conclus
consider
child
carer
expect
preepilepsi
surgeri
neuropsychiatr
assess
import
order
servic
manag
individu
expect
unmanag
unrealist
expect
may
lead
neg
psycholog
outcom
either
child
carer
expect
weigh
individu
clinic
profil
poster
neural
correl
convers
hemianaesthesia
adolesc
novel
fmri
case
studi
ray
zaman
alam
leed
teach
hospit
nh
trust
leed
uk
aim
highlight
novel
function
magnet
reson
imag
fmri
find
adolesc
rare
convers
hemianaesthesia
method
herebi
report
righthand
old
boy
present
inabl
perceiv
sensat
right
half
bodi
without
motor
weak
caus
frequent
injuri
right
leg
well
burn
right
hand
without
realiz
wore
jacket
felt
warm
one
side
bodi
birth
development
histori
noncontributori
neurolog
examin
unremark
except
right
hemisensori
disturb
mri
brain
spine
peripher
nerv
conduct
studi
somatosensori
evok
potenti
show
evid
dysfunct
normal
underw
fmri
philip
achieva
paradigm
consist
stimul
right
left
hand
feet
three
dissimilar
stimuli
cold
brush
pinprickpain
order
stimuli
pseudorandomis
stimuli
deliveri
feedback
obtain
result
hand
foot
sensori
motor
cortic
success
stimul
irrespect
hand
stimul
left
hemispher
sensori
motor
cortex
domin
brush
cold
stimuli
howev
selfreport
particip
confirm
detect
stimuli
leftsid
sensorymotor
activ
stimuli
deliv
right
hand
pain
stimuli
success
activ
part
pain
matrix
furthermor
enhanc
attent
effect
frontal
pole
activ
observ
rightsid
stimul
support
lack
stimuli
detect
abil
pain
stimuli
effect
hand
foot
reflect
increas
activ
also
selfreport
particip
conclus
fmri
find
uniqu
support
evid
neuroplast
current
studi
pave
way
futur
studi
investig
convers
hemianaesthesia
poster
chronic
paroxysm
hemicrania
present
facial
pain
child
autism
bipolar
disord
diagnost
challeng
case
present
boy
diagnos
disintegr
psychosi
age
revis
autism
bipolar
disord
carbamazepin
risperidon
poor
mood
control
withdraw
risperidon
produc
tardiv
oromotor
diskinesia
respons
clonidin
age
mood
improv
aripiprazol
carbamazepin
withdrawn
present
episod
distress
preced
withdraw
unilater
sidelock
facial
flush
addit
flush
neck
back
wrist
behaviour
includ
hit
wrist
wall
chew
hard
object
request
pressur
head
episod
occur
time
day
last
minut
show
rhinorrhea
tear
attribut
cri
event
attack
selftermin
result
mri
electroencephalogram
normal
fail
pharmacolog
trial
includ
paracetamol
amitriptylin
gabapentin
oxcarbazepin
diclofenac
provid
mild
pain
relief
morphin
reduc
incid
attack
reintroduct
carbamazepin
result
improv
elimin
pain
sequenc
normal
plan
wean
morphin
alongsid
trial
indometacin
initi
twicedaili
success
twicedaili
episod
ceas
includ
autonom
featur
exacerb
week
occur
context
intercurr
ill
manag
addit
dose
indometacin
conclus
cph
underreport
paediatr
age
group
case
patient
inabl
describ
event
addit
psychiatr
diagnosi
ad
complex
possibl
pain
caus
earli
psychot
breakdown
development
vulner
child
exclud
criteria
emphasis
sidelock
headach
autonom
featur
recognis
associ
symptom
elsewher
may
also
delay
recognit
children
object
piih
challeng
condit
diagnos
manag
risk
misdiagnosi
perman
sight
loss
frequent
comorbid
aim
review
practic
identifi
area
uncertainti
help
formul
import
question
address
within
clinic
guidelin
method
singl
centr
retrospect
case
note
review
case
refer
neurolog
suspect
piih
papilloedema
confirm
consult
ophthalmologist
case
period
result
case
identifi
age
rang
year
mean
year
bmi
centil
one
case
refer
obes
servic
comorbid
headach
disord
anxietydepress
case
neuroimag
mri
ct
dedic
venographi
case
lumbar
punctur
lp
conduct
gener
anaesthesia
ga
case
lp
done
due
presenc
chiari
malform
due
procedur
failur
relat
bodi
habitu
intracrani
pressur
icp
monitor
done
one
four
case
children
treat
acetazolamid
first
line
therapi
frusemid
zonisamid
topiram
also
use
singl
case
children
repeat
lp
due
failur
resolut
symptom
case
sight
threaten
piih
perman
visual
loss
one
case
case
discuss
neurosurgeri
one
child
evolv
visual
failur
emerg
ventriculoperiton
shunt
conclus
import
question
rais
obes
children
piih
access
specialis
obes
servic
children
dedic
venograph
imag
reliabl
measur
csf
open
pressur
ga
lp
possibl
icp
monitor
alway
done
repeat
lp
done
persist
symptom
csf
divers
surgeri
restrict
case
sight
threaten
piih
object
describ
case
revesz
syndrom
due
de
novo
missens
variant
case
report
male
infant
born
week
gestat
emerg
lsc
due
matern
hypertens
reduc
amniot
fluid
week
gestat
reduc
fetal
growth
identifi
proband
born
week
birth
weight
centil
occipitofront
circumfer
ofc
centil
spent
day
scbu
develop
thrombocytopenia
nadir
resolv
predischarg
periventricular
calcif
cranial
ultrasound
prompt
torch
screen
ophthalmolog
review
right
preretin
haemorrhag
overli
organis
vitreou
haemorrhag
identifi
remain
stabl
subsequ
review
age
week
smile
fix
follow
good
head
control
age
month
develop
new
wobbl
eye
movement
longer
fix
follow
bilater
retin
detach
identifi
ct
subsequ
mri
show
diffus
calcif
within
thalami
posterior
limb
intern
capsul
deep
white
matter
cerebellar
atrophi
thin
corpu
callosum
find
examin
includ
ofc
centil
rotatori
nystagmu
central
hypotonia
wholeexom
sequenc
identifi
pathogen
de
novo
variant
subsequ
develop
thrombocytopenia
anaemia
transfus
depend
discuss
interact
nuclear
protein
regul
telomeras
prevent
telomer
shorten
revesz
syndrom
sever
form
dyskeratosi
congentia
multisystem
involv
earli
onset
inutero
revesz
syndrom
characteris
intrauterin
growth
retard
iugr
microcephali
cerebellar
hypoplasia
bilater
exud
retinopathi
intracrani
calcif
progress
bone
marrow
failur
revesz
syndrom
distinguish
hoyeraalhreidarsson
syndrom
presenc
retinopathi
telomer
disord
consid
infant
background
iugr
thrombocytopenia
retinopathi
intracrani
calcif
neg
torch
screen
earli
featur
mimic
congenit
infect
object
current
commonli
report
neurolog
complic
sca
overt
stroke
revers
cerebr
vasoconstrict
syndrom
may
frequent
patient
sickl
cell
anaemia
report
present
scarciti
preval
studi
howev
make
difficult
improv
diagnost
accuraci
patient
method
ghanaian
femal
rush
paediatr
emerg
room
first
episod
sudden
sever
global
headach
initi
start
hour
prior
arriv
headach
excruci
describ
heart
beat
head
associ
neck
pain
back
pain
dizzi
vomit
fever
dark
urin
first
diagnos
sickl
cell
anaemia
genotyp
ss
year
age
treat
dactil
sinc
usual
state
health
histori
blood
transfus
surgeri
admiss
compliant
medic
folic
acid
mg
daili
physic
examin
investig
also
normal
day
six
admiss
patient
gener
tonic
clonic
seizur
degre
left
side
weak
bath
abort
intraven
diazepam
magnet
reson
imag
mri
brain
request
mri
brain
reveal
diffus
narrow
cerebr
arteri
area
bleed
oedema
revers
cerebr
vasoconstrict
syndrom
therefor
suspect
result
headach
rapidli
improv
start
nimodipin
repeat
angiographi
month
show
vasoconstrict
confirm
diagnosi
follow
well
academ
neurolog
deficit
conclus
true
incid
rcv
patient
sickl
cell
uncertain
thu
sensit
medic
practition
import
introduct
statu
dystonicu
sd
lifethreaten
disord
generalis
pain
dyston
movement
muscular
spasm
patient
sever
neurodis
rare
may
complic
rhabdomyolysi
multiorgan
dysfunct
death
infect
pain
gord
medic
failur
common
trigger
approxim
onethird
case
sd
idiopath
mordekar
et
al
identifi
seri
patient
sd
occur
secondari
gi
dysfunct
assist
feed
eg
via
gastrostomi
aberr
bowel
peristalsi
may
trigger
onset
sd
retrospect
analysi
aim
estim
incid
rate
feedinduc
sd
fisd
method
patient
present
sheffield
children
hospit
period
sd
identifi
episod
studi
assess
natur
onset
sd
likelihood
trigger
feed
relat
incid
fisd
proport
total
sd
calcul
calcul
perform
explor
rel
risk
sd
individu
trigger
factor
result
twentyfour
individu
episod
sd
identifi
aros
nonfeedrel
sourc
nfisd
felt
fisd
addit
patient
enter
feedinduc
dystonia
fid
group
show
clinic
evid
dystonia
relat
gi
sourc
sd
except
infect
rel
risk
sd
secondari
gi
dysfunct
significantli
higher
paingord
medic
failur
combin
ci
ci
respect
conclus
gi
dysfunct
coupl
sever
neurodis
could
serv
trigger
number
previous
idiopath
sd
case
disrupt
neuroenter
axi
howev
overlap
trigger
fisd
nfisd
signific
variat
group
evid
addit
lack
statist
studi
power
larg
prospect
studi
need
futur
corrobor
find
poster
dystonia
twist
patient
physician
scan
hypermanganesemia
rare
caus
dystonia
children
r
kumar
ali
liaqat
nation
hospit
karachi
pakistan
introduct
manganes
mn
chemic
element
symbol
mn
atom
number
mn
environ
caus
toxic
dystonia
movement
disord
waterborn
mn
greater
bioavail
dietari
manganes
accord
result
studi
higher
level
exposur
mn
drink
water
associ
increas
intellectu
impair
reduc
intellig
quotient
schoolag
children
recent
report
suspect
autosom
recess
inherit
syndrom
hepat
cirrhosi
dystonia
polycythemia
hypermanganesemia
case
without
environment
mn
exposur
rariti
diseas
becom
challeng
physician
recogn
caus
dystonia
children
also
characterist
find
mri
hyperintens
basal
ganglia
rather
case
report
present
case
girl
dystonia
previous
healthi
suffer
last
month
current
one
year
old
sister
start
show
similar
symptom
physic
examin
reveal
mark
dystonia
score
baryalbright
dystonia
scale
polycythemia
haematocrit
magnet
reson
imag
mri
brain
show
basal
ganglia
hyperintens
weight
imag
hypermanganesemia
suspect
sampl
send
serum
level
came
high
water
sampl
test
came
normal
chelat
done
dystonia
improv
conclus
dystonia
children
thoroughli
investig
rare
treatabl
caus
ignor
object
sodium
valproat
use
primarili
treatment
epilepsi
children
wellestablish
teratogen
babi
risk
development
disord
babi
risk
birth
defect
risk
known
sinc
yet
estim
sinc
children
uk
left
disabl
result
medicin
healthcar
product
regulatori
agenc
releas
guidanc
use
includ
risk
acknowledg
form
patient
safeti
alert
issu
ask
organis
identifi
femal
take
medic
aim
identifi
girl
take
sodium
valproat
south
eastern
trust
paediatr
requir
annual
risk
assess
patient
addit
care
neurologist
patient
receiv
annual
review
method
patient
identifi
paediatr
epilepsi
nurs
record
data
collect
electron
care
record
medic
note
august
decemb
result
girl
epilepsi
current
take
sodium
valproat
age
year
profound
learn
difficultiesdis
consid
low
risk
pregnanc
potenti
current
risk
addit
care
neurologist
review
past
year
conclus
sodium
valproat
must
consid
first
line
treatment
girl
epilepsi
girl
trust
receiv
receiv
major
felt
low
risk
due
young
age
andor
profound
disabl
identifi
two
patient
risk
step
taken
amelior
demonstr
good
awar
howev
lifelong
educ
famili
crucial
reduc
burden
fetal
valproat
syndrom
rett
syndrom
rtt
neurodevelopment
disord
affect
approxim
live
femal
birth
commonli
associ
mutat
gene
hand
stereotypi
gait
disturb
well
spastic
dystonia
note
rtt
sinc
first
descript
syndrom
object
review
aim
explor
preval
report
movement
disord
rtt
data
sourc
extract
pubm
embas
databas
paper
describ
featur
movement
disord
rett
syndrom
paper
select
inclus
review
includ
descript
case
report
cohort
caseseri
patient
rtt
includ
descript
clinic
featur
movement
disord
select
paper
divid
epoch
ii
iii
onward
result
studi
first
epoch
second
epoch
third
epoch
report
movement
disord
includ
stereotypi
rtt
patient
hand
stereotypi
almost
univers
report
case
diminish
disappear
time
gait
disturb
ataxiatremor
also
common
case
element
hypertonia
also
common
increas
age
earlier
descript
spastic
commonli
describ
frequent
refer
dystoniarigid
recent
report
myoclonu
choreoathetosi
uncommonli
report
rtt
conclus
movement
disord
beyond
hand
stereotypi
common
rtt
notabl
tremor
hypertonia
common
featur
seen
rtt
increas
preval
age
appar
chang
nomenclatur
time
ie
earli
epoch
spastic
late
epoch
dystonia
dystonia
specif
report
case
work
requir
explor
rel
contribut
dystonia
rigid
hypertonia
rtt
well
impact
impair
present
introduct
headach
common
complaint
children
sourc
great
deal
worri
gener
practition
parent
one
commonest
caus
headach
paediatr
migrain
method
prospect
studi
conduct
evalu
demograph
data
clinic
spectrum
grade
child
migrain
use
paediatr
migrain
disabl
assess
pedmida
questionnair
start
prophylact
treatment
higher
grade
depart
paediatr
tertiari
care
hospit
children
migrain
age
year
includ
type
headach
case
exclud
result
total
children
migrain
studi
approxim
children
complain
bilater
frontotempor
headach
present
throb
type
associ
featur
photophobia
phonophobia
nausea
vomit
skip
meal
follow
alter
sleep
exam
stress
aggrav
factor
requir
medic
headach
relief
headach
durat
frequenc
approx
day
daysmonth
case
diagnos
migrain
without
aura
case
diagnos
migrain
aura
loss
full
school
day
due
headach
approx
day
period
month
base
pedmida
score
children
migrain
grade
disabl
case
grade
ii
grade
iii
disabl
respect
correl
pedmida
score
frequenc
sever
signific
p
durat
headach
insignific
p
conclus
patient
higher
pedmida
grade
warrant
prophylact
treatment
pedmida
score
grade
success
use
assess
migrain
disabl
easier
less
time
consum
bedsid
diagnost
tool
use
wide
routin
clinic
evalu
manag
object
review
case
refer
ukwid
studi
children
possibl
variant
creutzfeldtjakob
diseas
vcjd
report
differenti
diagnosi
children
present
age
year
older
method
children
meet
case
definit
progress
intellectu
neurolog
deterior
pind
identifi
via
british
paediatr
surveil
unit
detail
obtain
standard
questionnair
result
april
august
children
notifi
studi
found
meet
pind
case
definit
underli
diagnosi
explain
deterior
differ
disord
includ
vcjd
case
last
identifi
children
present
clinician
age
year
includ
vcjd
case
disord
age
group
commonest
mitochondri
cytopathi
adrenoleukodystrophi
lafora
bodi
diseas
huntington
diseas
neuronalceroid
lipofuscinos
niemannpick
type
c
metachromat
leukodystrophi
sspe
wilson
diseas
review
underli
diagnosi
pind
case
diedonli
underw
autopsi
recent
identif
first
patient
vcjd
mv
heterozyg
prnp
codon
reinforc
need
continu
vcjd
surveil
particularli
studi
archiv
appendix
sampl
uk
hospit
publish
indic
approxim
uk
popul
carri
abnorm
prion
protein
gastrointestin
tract
absenc
valid
vcjd
screen
test
pind
studi
remain
mean
perform
systemat
surveil
neurodegen
diseas
make
differenti
diagnosi
vcjd
object
transient
lesion
splenium
corpu
callosum
scc
rare
find
mri
brain
paediatr
literatur
describ
revers
splenial
lesion
syndrom
resl
mild
encephalitisencephalopathi
revers
splenial
lesion
mer
condit
divers
aetiolog
wide
variabl
neurolog
present
prognosi
usual
favour
present
two
case
resl
predominantli
express
dysphasia
vari
causal
associ
method
retrospect
review
resl
case
seri
explor
clinic
cours
investig
neuroimag
treatment
recoveri
result
case
yearoldgirl
present
confus
fever
low
oxygen
satur
alagil
syndrom
partial
correct
tetralog
fallot
neurolog
manifest
express
dysphasia
dysarthria
difficulti
spatial
awar
interestingli
abl
use
occasion
word
abus
natur
mri
show
promin
focu
abnorm
signal
restrict
diffus
scc
blood
cultur
grew
staphylococcu
aureu
echo
reveal
infect
shunt
treatment
involv
shunt
replac
prolong
iv
antibiot
repeat
mri
show
resolut
splenial
lesion
continu
improv
neurolog
case
yearoldgirl
present
paroxysm
episod
head
turn
head
drop
stare
second
refus
feed
show
emot
labil
express
dysphasia
preserv
explet
neurolog
intact
mri
brain
show
high
signal
restrict
diffus
scc
blood
csf
investig
includ
mog
aquaporin
nmdar
lyme
antibodi
neg
except
asot
eeg
normal
receiv
cours
ivig
azithromycin
repeat
mri
show
resolut
lesion
splenium
made
complet
recoveri
next
month
conclus
splenial
lesion
rare
clinic
signific
nonspecif
express
dysphasia
promin
symptom
awar
reslesm
avoid
unnecessari
investig
assist
prognost
background
evidencebas
manag
paediatricheadach
spars
result
wide
variat
practic
nice
guidelin
commenc
year
age
studi
aim
evalu
outpati
manag
paediatr
headach
object
investig
paediatr
headach
referr
tertiari
hospit
period
explor
patient
demograph
headach
type
role
neuroimag
manag
outcom
method
prospect
studi
review
headach
referr
year
data
collect
follow
weekli
email
relev
clinician
patient
demograph
headach
classif
imag
manag
outcom
collat
proforma
electron
patientrecord
result
patient
median
age
patient
first
outpati
appoint
year
rang
femal
incid
headach
increas
age
femal
preponder
headach
exist
age
group
substanti
postpuberti
femaletomal
ratio
patient
age
year
migrain
common
diagnosi
affect
patient
refer
patient
underw
brain
mri
scan
normal
neurolog
examin
mri
scan
found
patholog
contribut
headach
present
patient
discharg
neurolog
clinic
first
second
neurolog
appoint
nonpharmacolog
manag
common
intervent
consist
headach
diari
lifestyl
advic
educ
relax
techniqu
common
medic
prescrib
bar
simpl
analgesia
sumatriptan
propranolol
pizotifen
conclus
multidisciplinari
biopsychosoci
approach
manag
paediatr
headach
consist
nonpharmacolog
pharmacolog
method
result
posit
outcom
major
discharg
tertiari
care
first
appoint
prescript
sumatriptan
propranolol
first
line
acut
prophylact
manag
respect
accord
current
clinic
recommend
role
mri
scan
paediatr
headach
requir
explor
perhap
stringent
guidelin
object
headup
tilt
test
hutt
gold
standard
autonom
function
test
identifi
disord
blood
pressur
bp
heart
rate
hr
regul
specif
excess
fall
bp
hr
well
excess
postur
tachycardia
pt
minut
activ
stand
test
ast
quicker
easier
appli
eg
outpati
clinic
may
sensit
demonstr
pt
aim
compar
yield
abnorm
use
ast
vs
hutt
method
retrospect
clinic
note
review
regist
clinic
audit
unselect
consecut
children
young
peopl
undergo
hutt
immedi
preced
ast
result
data
avail
children
young
peopl
femal
age
year
median
complet
data
set
first
minut
hutt
ast
abnorm
larg
drop
bp
hr
hutt
posit
hutt
also
posit
ast
howev
addit
posit
ast
hutt
give
posit
total
hr
data
set
minut
hutt
ast
abnorm
larg
rise
hr
hutt
posit
hutt
also
posit
ast
howev
addit
posit
ast
hutt
give
posit
total
hutt
yield
case
signific
fall
bp
hr
ast
vs
combin
test
gave
highest
yield
ast
yield
case
signific
rise
hr
hutt
vs
combin
test
gave
highest
yield
conclus
recommend
routin
undertak
minut
ast
prior
minut
children
young
peopl
object
aim
work
describ
respiratori
function
trajectori
correl
motor
function
cohort
spinal
muscular
atrophi
type
nonambul
paediatr
patient
method
retrospect
studi
patient
recruit
ismac
natur
histori
studi
uk
itali
us
follow
respiratori
data
collect
lung
function
data
forc
vital
capac
absolut
fvc
fvc
predict
noninvas
ventil
niv
requir
recumb
ulnar
length
use
surrog
height
fvc
pred
calcul
comorbid
affect
lung
function
aspir
collect
anthropometr
motor
function
score
hammersmith
function
motor
scale
hfm
revis
perform
upper
limb
rulm
note
exclud
patient
intervent
clinic
trial
nusinersen
therapi
result
data
avail
patient
mean
age
first
visit
year
signific
lesion
review
practic
ask
routin
nonurg
mri
request
consid
view
unlik
signific
result
retrospect
review
brain
magnet
reson
imag
referr
children
less
year
r
ultrarar
diseas
characteris
drugrefractori
epilepsi
cognit
impair
behaviour
problem
nonpharmacolog
treatment
consid
alongsid
antiepilept
drug
a
earli
diagnosi
benefit
prompt
seizur
control
preserv
cognit
function
aim
understand
use
experi
ketogen
diet
therapi
kdt
r
patient
famili
carer
pfc
healthcar
profession
hcp
assess
efficaci
safeti
contrast
nh
kdt
servic
provis
patient
demand
method
literatur
search
conduct
use
kdt
r
similar
complex
epilepsi
two
survey
develop
gather
demograph
diagnost
clinic
care
inform
survey
qualit
descript
patient
expert
collabor
assess
content
accuraci
readabl
respons
discuss
patient
expert
workshop
result
number
respons
pfc
hcp
consid
signific
given
ultrarar
statu
r
pfc
tri
kdt
seizur
activ
behaviour
cognit
outcom
rank
equal
import
hcp
pfc
signific
improv
seizur
activ
cognit
alert
report
sideeffect
typic
mild
one
report
increas
seizur
frequenc
high
rate
comorbid
older
age
present
behaviour
problem
cognit
impair
make
implement
kdt
r
challeng
pfc
report
qualiti
life
would
improv
reduc
a
sideeffect
hcp
report
would
consid
reduc
withdraw
a
kdt
success
conclus
kdt
may
suitabl
everi
r
patient
strong
consensu
consid
earli
intervent
uk
nh
kdt
servic
predominantli
avail
paediatr
patient
limit
adult
access
detail
health
econom
analysi
illustr
reduc
acut
care
cost
improv
qualiti
life
may
encourag
widespread
kdt
implement
object
whole
exom
sequenc
we
result
turnaround
time
becom
avail
nh
children
intens
care
set
aim
determin
diagnost
util
impact
clinic
care
we
region
paediatr
neurolog
centr
method
retrospect
case
note
review
result
six
case
identifi
three
patient
depend
longterm
respiratori
support
pathogen
mutat
detect
we
case
one
case
requir
revers
phenotyp
abnorm
transferrin
glycoform
electrophoresi
confirm
two
heterozygot
variant
gene
consist
congenit
disord
glycosyl
cdg
variant
unknown
signific
found
three
children
present
neonat
onset
epilept
encephalopathi
two
case
one
case
wwox
one
child
intract
epilepsi
month
age
mutat
associ
cdg
one
child
hypotonia
ventil
depend
respiratori
infect
month
age
mutat
associ
spinal
muscular
atrophi
respiratori
distress
we
found
pathogen
mutat
intracrani
calcif
microcephali
epilept
encephalopathi
sever
development
regress
case
singl
genespanel
sent
prior
initi
we
multipl
singl
genespanel
sent
case
case
we
detect
gene
thought
like
base
clinic
phenotyp
request
form
conclus
we
high
diagnost
yield
cohort
patient
reach
prompt
diagnosi
facilit
withdraw
care
one
case
help
exclud
epilepsi
surgeri
hypothesi
four
case
well
guid
prognosi
case
we
consid
costeffect
altern
multipl
singl
gene
andor
genet
panel
sent
parallel
due
clinic
urgenc
object
care
provid
time
surround
death
child
shape
longterm
memori
potenti
impact
griev
process
specif
guidelin
picu
staff
relat
good
care
look
like
time
sought
insight
practic
across
uk
build
evid
base
improv
care
provid
share
good
practic
conclus
survey
feedback
found
area
unit
believ
improv
relat
acp
hope
wide
introduc
know
patient
admit
picu
life
limit
difficult
convers
famili
help
guid
manag
understand
wish
formal
document
ensur
staff
awar
sever
unit
higher
uptak
hospicehom
care
found
earli
convers
famili
benefici
unit
dedic
palli
nurs
state
allow
time
famili
believ
becom
standard
care
staff
train
limit
unit
someth
difficult
frequent
encount
vital
equip
staff
better
prioritis
children
epilepsi
first
seizur
clinic
cp
white
brown
ka
hapgood
tuohi
children
epilepsi
servic
morriston
hospit
swansea
uk
object
rise
demand
limit
first
seizur
clinic
appoint
lead
increas
wait
time
feel
children
epilepsi
wait
long
first
assess
concern
also
express
famili
receiv
first
seizur
leaflet
given
instruct
captur
episod
either
video
make
written
record
initi
seen
method
april
famili
sent
letter
acknowledg
referr
ask
contact
specialist
epilepsi
nurs
concern
prior
appoint
later
modif
includ
seizur
inform
leaflet
seizur
record
document
analys
result
first
year
use
system
patient
identifi
clinic
databas
inform
obtain
review
clinic
letter
result
initi
concern
specialist
nurs
would
inund
phone
call
worri
parent
realis
parent
contact
servic
appoint
invari
parent
whose
children
second
episod
generalis
tonic
clonic
seizur
children
eeg
perform
first
appoint
includ
children
given
diagnosi
epilepsi
children
given
diagnosi
epilepsi
made
compar
referr
p
although
higher
percentag
famili
remind
video
episod
differ
two
group
statist
signific
unfortun
overal
wait
time
affect
conclus
simpl
chang
way
servic
deliv
led
earlier
identif
children
epilepsi
look
way
improv
accuraci
timeli
appoint
introduct
paediatr
idiopath
intracrani
hypertens
iih
uncommon
disord
present
vari
children
present
paediatrician
paediatr
neurologist
ophthalmologist
mani
area
diagnosi
manag
evid
limit
nation
adult
evid
consensusbas
guidelin
publish
nation
paediatr
guidelin
exist
aid
investig
manag
case
iih
meet
bpna
confer
januari
set
scene
collabor
work
topic
aim
develop
nation
paediatr
iih
guidelin
base
avail
literatur
modifi
dandi
criteria
friedman
classif
classif
consensu
amongst
variou
member
bpna
chan
group
member
rcpch
ophthalmolog
neurosurgeri
radiolog
patient
method
core
children
headach
iih
guidelin
develop
group
establish
met
four
nation
special
interest
group
meet
novemb
septemb
topic
discuss
includ
incid
papillioedmea
csf
dynam
iih
bpnsu
iih
data
ophthalmolog
good
practic
region
iih
pathway
uk
set
delphi
process
paediatr
iih
studi
day
septemb
invit
patientpar
repres
highlight
impact
famili
disord
need
better
commun
disord
clear
guidelin
share
good
practic
amongst
clinician
email
list
bpna
chan
group
rcpch
member
ophthalmologist
interest
guidelin
creat
result
set
statement
draft
delphi
consensu
work
current
review
core
guidelin
develop
group
prior
circul
wider
work
group
conclus
goal
set
next
process
delphi
process
work
core
committe
wider
work
group
present
bpna
confer
object
nh
england
margin
rate
emerg
threshold
mret
readmiss
fund
fund
chameleon
project
twitter
account
improv
children
end
life
care
fund
lead
disabl
paediatrician
expertis
paediatr
palli
care
children
palli
care
nurs
network
administr
addit
hour
paediatrician
critic
care
oncolog
neonat
unit
local
district
gener
hospit
total
method
tool
develop
aid
identif
children
last
year
life
support
anticipatori
care
plan
team
attend
ward
round
provid
teach
session
advic
support
children
die
expect
death
month
project
ascertain
child
death
review
team
nonelect
admiss
bed
day
cost
tabul
also
evalu
document
care
plan
post
bereav
famili
feedback
questionnair
result
children
die
expect
death
number
die
previou
month
median
number
nonelect
admiss
reduc
per
child
specialist
ward
bed
day
reduc
reduct
children
admit
picu
last
month
life
total
picu
bed
day
reduc
reduct
median
length
stay
reduc
day
day
maximum
length
stay
reduc
day
day
percentag
children
die
expect
death
document
anticipatori
care
plan
rose
conclus
network
clinician
expertis
paediatr
palli
care
work
togeth
across
region
improv
anticipatori
care
plan
reduc
admiss
bed
day
children
last
year
life
better
care
reduc
cost
child
boy
speech
languag
delay
present
year
age
selfresolv
episod
floppi
ataxia
disorient
associ
muscl
weak
drool
unusu
episod
occur
time
per
week
often
trigger
excit
especi
physic
emot
overstimul
last
minut
hour
residu
deficit
episod
could
also
trigger
late
meal
fast
episod
investig
includ
mrimra
brain
eeg
sleepdepriv
eeg
video
telemetri
reveal
signific
abnorm
metabol
endocrin
test
normal
present
symptom
consist
episod
ataxia
possibl
period
paralysi
spectrum
trial
acetazolamid
given
show
improv
number
sever
episod
year
age
genet
sequenc
result
reveal
child
recess
delet
within
long
arm
chromosom
band
homozyg
intragen
delet
within
gene
transport
golgi
organ
homolog
function
unknown
howev
previou
studi
deplet
drosophila
tissu
cultur
cell
observ
caus
fusion
golgi
er
recent
studi
individu
illustr
child
clinic
phenotyp
consist
previous
report
literatur
although
seizur
present
individu
child
seizur
date
although
effect
treatment
rare
condit
known
earli
diagnosi
import
individu
famili
awar
potenti
encephalomyopath
crise
arrhythmia
occur
research
elucid
structur
function
protein
may
lead
effect
therapi
futur
object
hie
affect
around
live
birth
prognost
reli
clinic
progress
neurophysiolog
neurolog
examin
magnet
reson
imag
mri
limit
inform
relationship
mr
brain
result
visual
appear
brain
mri
clinic
featur
work
studi
use
mr
cohort
method
mr
use
routin
neonat
hie
unit
approv
servic
evalu
obtain
clinic
govern
depart
identifi
neonat
hie
jan
march
mri
mr
first
day
life
medic
note
review
mri
result
categoris
normal
abnorm
mr
result
clinic
featur
compar
mri
group
use
parametr
nonparametr
test
correl
regress
analys
studi
relationship
clinic
featur
mr
result
pvalu
assum
signific
result
particip
identifi
exclud
meet
inclus
criteria
data
total
number
neonat
analys
use
r
studio
babi
abnorm
mri
scan
significantli
lower
birth
weight
gestat
age
higher
score
sarnat
stage
scale
analysi
mr
data
also
reveal
babi
lower
level
nacetylaspart
naa
parietooccipit
region
well
higher
level
lactat
lactat
cholin
parietooccipit
region
respect
final
signific
mr
variabl
significantli
correl
time
normalis
lactat
singl
linear
regress
background
children
young
peopl
surviv
acquir
central
nervou
system
injuri
traumat
nontraumat
first
nh
england
nhse
specialist
specif
paediatr
neurorehabilit
servic
written
evid
benefit
earli
neurorehabilitaion
adult
stroke
compellingevid
earli
neurorehabilit
cyp
emerg
method
servic
inform
collect
england
wale
pnr
unit
result
unit
contribut
activ
increas
major
trauma
unit
dedic
coordin
sever
unit
offer
daili
therapi
unit
discharg
cyp
home
conclus
consider
neurorehabilit
inpati
activ
take
place
remain
absenc
secur
fund
adequ
staff
dedic
bed
key
member
mdt
protect
time
proactiv
patient
specif
discharg
plan
neurorehabilit
integr
part
neurosci
clinic
pathway
children
deserv
fulli
resourc
servic
describ
servic
specif
tuberculosissarcoidosi
subcategori
group
refractori
seizuresstatu
epilepticu
like
repeat
imag
either
ct
mri
within
year
follow
group
ventriculoperiton
shunt
blockag
space
occupi
lesion
head
injuri
patient
refractori
seizur
statu
epilepticu
alreadi
known
epilepsi
also
repeat
imag
includ
subsequ
head
mri
conclus
common
indic
ct
head
head
injuri
shunt
blockag
neurosurg
centr
group
like
repeat
imag
refractori
seizuresstatu
epilepticu
shunt
blockag
children
present
known
epilept
seizur
emerg
depart
import
consid
clinic
data
seek
devolv
decis
imag
poster
isol
radial
nerv
palsi
rare
present
congenit
wrist
drop
c
duggan
n
mcsweeney
cork
univers
hospit
cork
ireland
isol
congenit
radial
nerv
palsi
rare
phenomenon
typic
spontan
recov
within
month
true
incid
known
recent
studi
infant
present
brachial
plexu
injuri
clinic
isol
congenit
radial
nerv
palsi
patient
male
present
birth
left
side
wrist
drop
follow
nontraumat
elect
caesarean
section
birthweight
centil
movement
wrist
digit
impair
absent
preserv
function
shoulder
elbow
nodul
note
left
upper
limb
anatom
superfici
radial
nerv
normal
pregnanc
antenat
postnat
issu
attend
physiotherapi
occup
therapi
provid
splint
examin
week
weak
extensor
left
wrist
digit
remain
fulli
flex
rest
could
extend
passiv
activ
extens
thumb
index
finger
recov
review
function
shoulder
elbow
joint
preserv
normal
flexion
wrist
digit
scar
note
superfici
radial
nerv
locat
lesion
describ
birth
remain
system
neurolog
examin
normal
typic
develop
appropri
growth
work
diagnosi
present
isol
radial
nerv
palsi
like
caus
inutero
compress
nodul
scar
note
consist
lesion
describ
previou
case
seri
hypothesis
area
fat
necrosi
secondari
compress
result
palsi
patient
lack
neurolog
generalis
brachial
plexu
palsi
make
birth
injuri
less
like
investig
followup
await
background
valproat
effect
antiepilept
medic
woman
becom
pregnant
take
valproat
babi
risk
congenit
malform
development
disord
furthermor
associ
increas
risk
autism
spectrum
disord
adhd
nhshse
recommend
new
restrict
use
valproat
includ
nation
pregnanc
prevent
program
prevent
avoid
prescrib
femal
patient
childbear
potenti
unless
treatment
ineffect
toler
object
review
use
valproat
welldefin
popul
risk
femal
moder
profound
intellectu
disabl
id
identifi
patient
risk
imb
guidelin
practic
method
retrospect
chart
review
carri
girl
age
year
attend
daughter
chariti
disabl
servic
doc
dublin
ireland
data
diagnosi
valproat
use
degre
idgross
motor
function
classif
system
gmfc
document
menarch
discuss
regard
risk
valproat
use
record
result
total
femal
age
year
identifi
current
use
valproat
chart
review
patient
identifi
moder
id
gmfc
iii
sever
profound
id
gmfc
ivv
menarch
document
risk
valproat
discuss
conclus
cohort
signific
number
girl
remain
valproat
compli
new
guidelin
regard
discuss
around
risk
valproat
highlight
patient
need
counsel
annual
risk
acknowledg
form
place
chart
prompt
discuss
next
visit
children
intellectu
disabl
convers
regard
contracept
difficult
essenti
valproat
use
risk
must
fulli
understood
parent
carer
evalu
manag
children
age
year
cerebr
palsi
southend
univers
hospit
larg
district
univers
gener
hospit
nice
guidelin
nice
guidelin
method
clinic
note
regist
children
cerebr
palsi
cp
year
age
june
includ
studi
earli
data
children
year
age
result
patient
age
year
patient
age
year
male
femal
hemipleg
quadripleg
dipleg
dyston
cp
gmfc
level
record
week
week
term
mri
head
find
white
matter
chang
includ
pvlin
hie
chang
basal
ganglia
chang
congenit
brain
malform
infarct
migrat
area
mri
report
children
receiv
multidisciplinari
team
mdt
input
includ
physiotherapi
comorbid
werechildren
medic
gastroesophag
reflux
peginsert
epilepsi
dystoniaspast
constip
poor
salivari
control
behavior
issu
note
adhd
medic
botulinum
toxin
inject
select
dorsal
rhizotomi
spastic
document
discuss
diagnosi
famili
patient
none
patient
patient
vitamin
level
check
conclus
manag
line
nice
guidelin
mdt
input
need
improv
document
evid
discuss
parent
gmfc
level
age
year
plu
hip
surveil
age
year
gmfc
level
iii
v
annual
vitamin
level
especi
gmfc
level
iii
v
peg
fed
children
multipl
antiepilept
medic
poster
intracrani
hypertens
children
updat
systemat
review
l
di
genova
n
desai
esposito
p
prabhakar
pediatr
clinic
depart
surgic
biomed
scienc
universit
degli
studi
di
perugia
perugia
itali
depart
paediatr
neurolog
great
ormond
street
hospit
nh
foundat
trust
london
uk
neurosci
great
ormond
street
hospit
nh
foundat
trust
london
uk
object
goal
provid
overview
paediatr
intracrani
hypertens
method
given
last
updat
diagnost
criteria
idiopath
intracrani
hypertens
publish
thorough
medlin
search
english
articl
conduct
result
intracrani
hypertens
may
primari
paediatr
annual
incid
rang
per
children
aris
secondari
caus
misdiagnosi
delay
intervent
lead
poor
qualiti
life
morbid
condit
reconsid
due
new
accept
valu
open
pressur
advanc
neuroimag
import
develop
effect
therapeut
strategi
order
prevent
blind
thu
highlight
date
main
strategi
describ
involv
medic
surgic
approach
nevertheless
paediatr
intervent
studi
diseas
monitor
play
key
role
definit
best
time
modal
treatment
recent
risk
stratif
propos
aim
facilit
adequ
evalu
proper
care
children
intracrani
hypertens
visual
monitor
could
repres
object
tool
manag
patient
recent
year
import
evid
efficaci
acetazolamid
emerg
idiopath
intracrani
hypertens
treatment
trial
surgic
treatment
modal
choic
children
worsen
vision
impair
intract
headach
despit
maxim
medic
manag
case
intoler
medic
therapi
conclus
poor
evid
paediatr
intracrani
hypertens
outcom
unfortun
children
qualiti
life
heavili
influenc
pain
perman
vision
loss
standard
therapeut
strategi
remain
uncertain
highlight
need
longitudin
studi
identifi
best
treatment
childhood
order
allevi
symptom
prevent
perman
chronic
sequela
care
clinic
evalu
ophthalmolog
monitor
could
use
guid
better
manag
medic
condit
object
cerebr
sinoven
thrombosi
childhood
lifethreaten
neurolog
entiti
uncertain
epidemiolog
potenti
complic
secondari
intracrani
hypertens
literatur
lack
evid
support
main
strategi
approach
medic
condit
object
highlight
valu
prompt
diagnosi
aim
defin
tailor
manag
approach
base
children
monitor
method
review
main
find
regard
cerebr
sinoven
thrombosi
intracrani
hypertens
children
illustr
case
otogen
sinu
thrombosi
secondari
intracrani
hypertens
result
boy
develop
local
venou
sinu
thrombosi
spread
primari
infect
process
middl
ear
sigmoid
sinu
complex
facilit
anaemia
dehydr
venou
outflow
disturb
led
secondari
intracrani
hypertens
manag
aim
treat
cerebr
thrombosi
anticoagul
intracrani
hypertens
medic
surgic
strategi
insert
lumbarperiton
shunt
necessari
medic
approach
fail
visual
function
deterior
evid
care
clinic
evalu
ophthalmolog
monitor
help
us
tailor
best
treatment
aim
allevi
symptom
prevent
sequela
increas
intracrani
pressur
literatur
paediatr
intervent
studi
regard
main
strategi
reduc
intracrani
pressur
publish
moreov
lack
evid
support
safeti
anticoagul
therapi
reduc
possibl
safe
manag
cerebr
thrombosi
childhood
conclus
children
multidisciplinari
approach
essenti
manag
cerebr
thrombosi
intracrani
hypertens
ensur
optim
followup
aim
prevent
visual
therapyrel
complic
possibl
relaps
earli
diagnosi
perspect
monitor
patient
clinic
manifest
visual
statu
help
us
plan
best
time
modal
treatment
intervent
